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Abstract 
Blood vessel patterning during angiogenesis is a guided process. Endothelial tip cells 
located at the end of vascular sprouts are important for vessel guidance. One of the 
aims of my studies is to determine how endothelial tip cell formation is regulated. 
Previous studies have shown that the Notch ligand, Delta-like 4 (Dll4), is 
prominently expressed in tip cells, therefore suggesting a role of Notch signalling in 
its regulation. In the mouse, suppression of Notch signalling by pharmacological 
inhibition of γ-secretase or genetic deletion of one Dll4 allele resulted in excessive 
endothelial tip cell formation and a poorly-patterned, hyperdense vessel network. 
Induction of Notch signalling by Jagged1 peptide treatment led to a decrease in tip 
cell formation and a sparse vessel network. Thus, the Notch pathway negatively 
regulates tip cell formation to promote a non-sprouting endothelial stalk cell.  
 The Notch-regulated ankyrin repeat protein, Nrarp, is a Notch target gene 
that is highly expressed in stalk cells and endothelial cells located at vessel 
branchpoints. Deletion of Nrarp in mouse and morpholino knockdown of nrarp-a 
and nrarp-b in zebrafish resulted in decreased endothelial cell proliferation and 
junctional instability, leading to ectopic vessel regression and the formation of a 
sparse vessel network. In endothelial cells, loss of Nrarp function increased Notch 
signalling but decreased Wnt signalling, thereby confirming its role as a negative and 
positive modulator of Notch and Wnt signalling, respectively. Mice null for 
Lymphoid enhancer factor 1 (Lef1) or deficient in endothelial Ctnnb1 also displayed 
increased vessel regression and decreased vessel density, suggesting a role of 
canonical Wnt/β-catenin signalling in maintaining vessel stability. 
 In conclusion, my studies show that Notch signalling regulates endothelial tip 
cell formation and vessel stability to fine-tune vessel patterning. Furthermore, I 
demonstrate that Nrarp provides a molecular link to Wnt signalling to regulate vessel 
stability. 
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1  Introduction 
1.1 THE VASCULAR SYSTEM 
The cardiovascular system is the first organ to develop during vertebrate 
embryogenesis. The generation of a closed circulatory system is essential for 
efficient delivery of oxygen and nutrients to growing tissues and organs with high 
metabolic demands, and also for efficient clearance of waste products. The vascular 
system is also a conduit through which immune cells such as leukocytes are 
transported to sites of infection. Two separate vascular systems exist in vertebrates: 
the blood vessels, which are the subject of my PhD studies, and the lymphatic 
vessels. These distinct vascular systems are interconnected through the largest 
lymphatic vessel, the thoracic duct, which drains lymph into the blood circulation.  
 Blood vessels develop from a common precursor cell, the angioblast.  
Angioblasts are mesoderm-derived endothelial precursor cells that are not fully 
differentiated. They aggregate to form multi-cellular structures called blood islands 
and later differentiate into endothelial cells (ECs) that coalesce to form cord-like 
structures, giving rise to a primitive vascular plexus with lumen (Figure 1). This 
process is known as vasculogenesis. The longitudinal axial vessels of vertebrates, 
 
Figure 1. The formation of the primary vascular plexus occurs through 
vasculogenesis. 
Mesodermal cells in the early embryo (E7) differentiate into endothelial precursor 
cells or angioblasts and form aggregates of blood islands. Angioblasts subsequently 
differentiate into endothelial cells (ECs). Coalescence of blood islands leads to the 
formation of honeycomb-shaped primary capillary plexus in the yolk sac and the 
embryo proper. 
 16 
 
Figure 2. The vascular system is composed of a hierarchical network of arteries, 
veins and capillaries. 
Arterial, venous and capillary endothelial and mural cells are morphologically 
distinct. Arterial ECs have a spindle-like morphology, align in the direction of blood 
flow and have low proliferation. Arteries are surrounded by extensive extracellular 
matrix (ECM), elastic fibres and layers of contractile vascular smooth muscle cells 
(vSMCs). The wall of mature arteries (such as the aorta) is composed of the inner 
tunica intima (ECs and basement membrane), the central tunica media with multiple 
alternating layers of matrix and vSMCs, and the outermost layer tunica adventitia, 
which is rich in collagen and fibroblasts. Veins have less extensive vSMC coverage 
and contain valves. Haemodynamic factors control arterial-venous differentiation 
and morphological changes in ECs and vSMCs. The mural cells that cover arteries, 
veins and capillaries are derived from mesenchymal or neural crest cell precursors, 
and possibly, from circulating cells. vSMCs undergo several steps of differentiation 
before they acquire their mature morphology and gene-expression profile. (Adams 
and Alitalo, 2007) 
 
the dorsal aorta and the cardinal vein, are the first vessels to form during 
embryogenesis through vasculogenesis. Vessel branches emanate from this primitive 
plexus through a separate process called angiogenesis, which will be covered in more 
detail in the following pages. 
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During blood vessel development, a hierarchical network comprising of 
arteries, veins and capillaries arises. Functionally, arteries (except for the pulmonary 
artery) carry oxygenated blood away from the heart under high pressure while veins 
return deoxygenated blood to the heart at lower pressure. The core component of 
blood vessels is the endothelial cell, which forms the lining of the vessel lumen. 
Additionally, mural cells envelop blood vessels. Mural cells consist of pericytes, 
which wrap around small vessels such as capillaries, and vascular smooth muscle 
cells (vSMCs), which are found around bigger vessels such as arteries and veins. 
Morphologically, arteries develop more extensive layers of elastic fibres and vSMCs 
compared to veins in order to support and regulate high blood flow and pressure. In 
addition, veins posses specialized structures, such as valves, to ensure uni-directional 
blood flow (Figure 2). 
 
1.2 ANGIOGENESIS 
Angiogenesis, in the simplest of definitions, is the formation of new blood vessels 
from a pre-existing network of vessels. This process is highly complex and 
comprises a multitude of cellular and morphogenic events. Angiogenesis occurs in 
two fundamental ways, either by sprouting angiogenesis or by intussusceptive 
growth. Intussusceptive angiogenesis is the splitting of two existing vessels. This 
event is initiated by the formation of a vascular pillar, which is a slender endothelial 
cell cylinder that stretches through the lumen from one part of the wall to the other. 
The pillar subsequently widens as a result of in-growth of mural cells, fibroblasts and 
extracellular matrix so that one vessel is split into two parallel vessels (Burri and 
Djonov, 2002).  
One of the interests of my studies is angiogenic sprouting, and in this section 
of the introduction, I will briefly illustrate the morphogenic events that occur during 
sprouting angiogenesis: the initial phase of new vessel formation, the process of 
vessel morphogenesis when endothelial cells form functional tubes, vessel 
stabilization and the process of vessel regression during vascular remodelling. 
1.2.1   VASCULAR SPROUTING AND PATTERNING 
The final vascular network established in a given tissue or organ is a highly 
organized one. The pattern that forms differs extensively between organs to suit the 
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anatomical and physiological needs of each organ. How does such an organized 
vessel network arise? There are two possible mechanisms that may lead to organ-
specific vascular patterns. Firstly, a primary vascular plexus may be formed by a 
random process and this is followed by specific branch regression or pruning to 
establish the final plexus. Secondly, angiogenic sprouting is triggered by selective 
cues and sprouting and fusion of vessels may be a guided process with directed 
collective cell motility. This would create specific primary vascular patterns. 
Although vessel regression does play a role in establishing the final organization of 
the vascular plexus, there is a wealth of evidence demonstrating that vessel 
patterning is a guided process.  
1.2.1.1 A specialized endothelial tip cell guides new vessel sprouts. 
Endothelial cells that compose an angiogenic sprout are not homogenous. Rather, 
there are different subpopulations of endothelial cells with unique morphologies 
within a sprout (Gerhardt et al., 2003). The tip of vascular sprouts consists of a single 
endothelial cell that extends multiple long filopodia in a polarized manner. This cell 
is active with motile and invasive behaviour and is referred to as an endothelial tip 
cell. Endothelial cells that trail the tip cell within the vascular sprout display fewer 
filopodia and are referred to as endothelial stalk cells. In addition, stalk cells form 
and line the vascular lumen, whereas tip cells do not. Endothelial tip and stalk cells 
also differ in their gene expression profile. Although a tip cell-specific marker has 
not yet been identified, tip cells express Pdgfb, Dll4, Unc5b, Kdr and Flt4 more 
strongly than stalk cells (Gerhardt et al., 2003; Claxton and Fruttiger, 2004; Lu et al., 
2004; Siekmann and Lawson, 2007; Tammela et al., 2008).  
The differences in cell morphology and gene expression suggest that 
endothelial tip and stalk cells have specialized functions. Indeed, as discussed in 
more detail below, tip cells function to guide the migration of nascent blood vessels 
into an avascular tissue so that an organized vessel network is formed. Stalk cells 
proliferate more frequently so that blood vessels grow in length and diameter. In 
addition, stalk cells undergo positional rearrangements within a vessel to form 
lumen.  
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1.2.1.2 Vessel patterning is regulated by attractive cues  
Vascular endothelial growth factor-A (VEGF-A) is one of six members of the VEGF 
family, whose other members include placental growth factor (PLGF), VEGF-B, 
VEGF-C, VEGF-D and the viral VEGF-Es encoded by strains D1701, NZ2 and NZ7 of 
the parapoxvirus Orf (Holmes and Zachary, 2005). VEGF-A consists of two 
monomers, which are arranged head-to-tail in a homodimer with two interchain 
disulphide bridges. Each monomer contains a cystine knot motif, which consists of 
eight conserved cysteine residues held together by three intrachain disulphide bonds 
(Muller et al., 1997). The expression and functions of VEGF-A are critically 
important for haematopoiesis and cardiovascular development. In vascular 
development, VEGF-A is required for chemotaxis and differentiation of angioblasts, 
endothelial cell proliferation, vasculogenesis and angiogenic remodelling. 
Inactivation of a single Vegfa allele in mice results in early embryonic lethality (E11-
12) as a result of deficient endothelial cell development and lack of vessels 
(Carmeliet et al., 1996; Ferrara et al., 1996).  
The generation of an extracellular gradient of VEGF-A is essential for 
directed migration of endothelial cells during vessel patterning. This property is 
 
Figure 3. An angiogenic sprout consists of endothelial tip and stalk cells. 
(A) A confocal image of vascular sprouts from a postnatal day 5 mouse retina. 
Endothelial tip cells (T) have many filopodia protrusions (arrowheads) compared to 
endothelial stalk cells (S). The retina has been stained with Isolectin-B4, which 
recognizes endothelial cells as well as microglial cells (m). (B) A simplified cartoon 
of a tip cell (green) with many filopodia and trailing stalk cells (blue) lining the 
vessel lumen. Tip and stalk cells are also molecularly different: tip cells express 
Pdgfb, Dll4, Kdr and Unc5b more strongly than do stalk cells. 
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Figure 4. VEGF-A isoforms and their binding properties. 
(A) The human VEGF-A gene consists of eight exons. Alternative splicing of VEGF-
A generates two mRNA isoform families, the pro-angiogenic VEGF-Axxx (left) and 
the anti-angiogenic family VEGF-Axxxb (right). Alternate 5’ and 3’ splice site 
selection in exons 6, 7 and 8 generate multiple isoforms. The VEGF-Axxx isoforms 
are generated by proximal splice site (PSS) selection in exon 8 and the VEGF-Axxxb 
from exon 8 distal splice site (DSS) choice. Thus, VEGF-A165 formed by PSS 
selection in exon 8 has VEGF-A165b has its DSS sister isoform; both isoforms encode 
proteins of the same length. xxx is the number of amino acids. (B) Protein structure of 
VEGF-A containing the dimerization sites and binding sites for heparin, VEGFR-1 
(encoded by exon 3) and VEGFR2 (encoded by exon 4), which are present in all 
isoforms. Exon 6 encodes a heparin-binding domain, while exons 7 and 8 encode a 
neuropilin/heparin-binding domain. The six amino acids at the extreme carboxyl 
terminus of the protein can be either pro-angiogenic (encoded by exon 8a) or anti-
angiogenic (encoded by exon 8b). (Harper and Bates, 2008) 
 
 
conferred by the heparin/heparan sulphate binding ability of VEGF-A. There are at 
least seven different human pro-angiogenic VEGF-A isoforms: VEGF-A121, VEGF- 
A 145, VEGF-A 148, VEGF-A 165, VEGF-A 183, VEGF-A 189 and VEGF-A 206  (see 
Figure 4; Harper and Bates, 2008). In mouse, the VEGF-A isoforms are one amino 
acid shorter i.e. VEGF-A120 etc. The isoforms differ in their ability to bind 
heparin/heparan sulphate and neuropilin-1 and -2 with the longer isoforms (e.g. 
VEGF-A183, VEGF-A189 and VEGF-A206) exhibiting greatest affinity to these 
molecules. In mouse postnatal retina and embryonic hindbrain, VEGF-A164 and 
VEGF-A188 are required for the establishment of a steep extracellular VEGF gradient  
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Figure 5. VEGF receptor-binding properties and signalling complexes. 
(A) Mammalian VEGFs bind to three VEGF receptor (VEGFR) tyrosine kinases, 
VEGFR1/Flt1, VEGFR2/Kdr/Flk-1 and VEGFR3/Flt4, leading to the formation of 
VEGFR homodimers and heterodimers. The VEGFRs contain a 750-amino-acid-
residue extracellular domain, which is organized into seven immunoglobulin (Ig)-
like folds. In VEGFR3, the fifth Ig domain is replaced by a disulphide bridge. The 
extracellular domain is followed by a single transmembrane region, a juxtamembrane  
domain, a split tyrosine-kinase domain that is interrupted by a 70-amino-acid kinase 
insert, and a C-terminal tail (Olsson et al., 2006). VEGF-A binds VEGFR1 and 
VEGFR2; VEGF-C and VEGF-D bind VEGFR2 and VEGFR3; PLGF and VEGF-B 
bind only to VEGFR1; and VEGF-E (not shown) binds only to VEGFR2. The 
unprocessed full-length forms of VEGF-C and VEGF-D preferentially bind 
VEGFR3 and have low affinity for VEGFR2; however, fully processed forms have 
increased affinity for VEGFR2 (Joukov et al., 1997; Stacker et al., 1999). (B) 
VEGFR signalling is modulated by different co-receptors. VEGFs as well as 
VEGFRs bind to co-receptors such as heparan sulphate proteoglycans (HSPGs) and 
neuropilins (Nrp1 and/or Nrp2). Neuropilins are transmembrane glycoproteins and 
are also co-receptors for the semaphorin class of proteins (Pellet-Many et al., 2008). 
Binding of VEGFs to Nrp1 is mediated by the basic heparin-binding domain and the 
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Nrp1/heparin-binding domain (Soker et al., 1998). The formation of a ternary 
complex of VEGF-A165, VEGFR2 and Nrp1 potentiates VEGF-A165 binding to 
VEGFR2 (Soker et al., 2002). PLGF, placental growth factor. Illustrations are from 
(Olsson et al., 2006). 
 
 
(Gerhardt et al., 2003; Ruhrberg et al., 2002). In the developing retina, astrocytes in 
hypoxic regions of the retina are the source of VEGF-A production; the highest 
VEGF-A concentration is therefore found in the avascular periphery of the retina, 
and the lowest is found in the vascularized centre, in particular close to arteries 
carrying oxygenated blood. Perturbation of this VEGF-A gradient results in defective 
tip cell filopodia formation – filopodia are shorter and aberrantly orientated 
(Gerhardt et al., 2003). A disturbed VEGF-A gradient also inhibits directed 
endothelial tip cell migration. The same phenotypes are also observed from ectopic 
activation of Kdr or VEGFR2, a receptor for VEGF-A, within the vasculature. These 
findings indicate that retinal endothelial tip cell migration depends on an intact 
gradient of Kdr agonistic activity that is highest at tip cells, where Kdr is expressed 
on the filopodia (Gerhardt et al., 2003). In addition, Neuropilin-1 (Nrp1), a 
transmembrane glycoprotein that binds to VEGF-A164 and associates with Kdr as a 
co-receptor (Soker et al., 2002; Soker et al., 1998), regulates endothelial tip cell 
guidance. In the hindbrain of mice deficient for Nrp1, the subventricular zone 
vascular plexus is mispatterned due to failure of tip cells to change direction at a 
specific location in the developing brain (Gerhardt et al., 2004).  
 Curiously, endothelial stalk cells do not respond to a VEGF-A gradient but to 
the local concentration of VEGF-A. Ectopic increase in Kdr activity increased stalk 
cell proliferation so that the number of endothelial cells per vessel length and the 
diameter of vessels are increased, whilst branching frequency is unaffected (Gerhardt 
et al., 2003). Vessel patterning therefore depends on the balance of guided tip cell 
migration and stalk cell proliferation. 
1.2.1.3 Vessel patterning is regulated by repulsive cues 
Besides attractive cues, there are also repulsive signals that restrict vessel sprouting 
within specific regions and also keep specialized blood vessels separate. Several 
pathways have been proposed to serve such a function. These include the 
semaphorin/plexin and ephrinB2/EphB4 pathways, which I will describe below, as 
well as the netrin/Unc5B signalling pathway. 
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 Semaphorins (SEMAs) are a large family of secreted and membrane-bound 
repulsive cues that are divided into seven classes (Pellet-Many et al., 2008). They 
were originally identified for their ability to modulate axon steering, fasciculation 
and branching in developing nervous tissue (Kruger et al., 2005). Of the family of 
SEMAs, members from class 3 (SEMA3) are important in vascular morphogenesis. 
The SEMA3 subfamily comprises seven members (SEMA3A to SEMA3G), each a 
disulphide-linked homodimer that binds to a receptor complex composed of 
Neuropilin (Nrp-1 or Nrp-2) and Plexin (PlexinA1-4 or PlexinD1). Nrp is the ligand-
binding subunit of SEMA3 receptor complexes whereas Plexin constitutes the 
signalling component of the receptor (Takahashi et al., 1999). 
 Data indicating that Class III semaphorins regulates endothelial cell guidance 
were derived from endothelial cell culture treatment with SEMA3A.  Binding to 
Nrp1 by SEMA3A inhibits directed endothelial cell motility, elicits the dismantling 
of their lamellipodia and actin stress fibers, and hampers capillary sprouting from 
aortic rings (Miao et al., 1999). A similar role of SEMA3/Nrp/Plexin also exists in 
vivo. In zebrafish embryos, semaphorins sema3aa and sema3ab are expressed in the 
developing somites, but are excluded from intersomitic boundaries. The co-receptor 
plexinD1 is complementarily expressed in endothelial cells of intersegmental vessels 
(ISVs) that sprout from the dorsal aorta adjacent to intersomitic boundaries. The 
knockdown of sema3ab or plexinD1 expression in zebrafish embryos results in the 
misguidance of ISVs during patterning (Torres-Vazquez et al., 2004). Instead of a 
regular, segmented pattern of ISVs, a chaotic, misrouted vessel network is formed. 
Conversely, overexpression of sema3ab in somitic muscle resulted in the inhibition 
of ISV growth (Torres-Vazquez et al., 2004). In the mouse, Sema3E is the ligand 
involved in PlexinD1 signalling. Similar to the zebrafish, Sema3E is expressed in the 
caudal region of the somites, immediately adjacent to the intersomitic blood vessels 
expressing PlexinD1. Genetic ablation of Sema3E and PlexinD1 in mice also 
produced a disorganized intersomitic vessel pattern (Gu et al., 2005). Interestingly, 
Nrp is not required for Sema3E-PlexinD1 signalling as Sema3E binds directly to 
PlexinD1 and Nrp-1Sema3-/-;Nrp-2-/- double-mutant mice, in which interactions 
between Sema3s and neuropilins are abolished, show normal segmental blood vessel 
patterns (Gu et al., 2005). Current experimental data therefore indicate a role for 
SEMA3E-PlexinD1 signalling in restricting blood vessel growth, for example, within 
the somite boundaries.  
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The large families of Eph receptor tyrosine kinases and their ephrin ligands 
transduce signals in a cell-cell contact-dependent fashion. Eph/ephrin interaction at 
the cell surface triggers bidirectional signals both in receptor- and ligand-expressing 
cells, respectively. In many settings and cell types, forward signalling leads to 
repulsion of the Eph receptor-expressing cell (Kuijper et al., 2007). For example, 
activation of Eph receptors on migrating axonal growth cones triggers retraction 
away from tissues expressing the corresponding ephrin ligand (Klein, 2004). As a 
result, the Eph-positive cells may stall, turn and change direction. Within the 
vascular system, arterial endothelial cells predominantly express ephrinB2 whereas 
venous endothelial cells specifically express EphB4. Arteries and veins are separated 
by a capillary bed; the failure to do so results in arteriovenous malformations, which 
permit arterial blood to enter the venous system directly. It has been proposed that 
during angiogenesis, EphB4/ephrinB2 signalling may provide repulsive cues to 
restrict cell movement across an arterial-venous boundary and inhibit the formation 
of arteriovenous malformations (Adams, 2003; Adams et al., 1999; Eichmann et al., 
2005). However, such a defect is not observed upon targeted deletion of Efnb2 and 
Ephb4 in mice, although they are essential for angiogenic remodelling and 
embryonic survival (Wang et al., 1998). In fact, ephrinB2 may not be a critical 
determinant of arterial-venous segregation since its transcript is still expressed in 
mouse deficient for endoglin, whose protein is a TGFβ co-receptor that is 
predominantly expressed in endothelial cells at embryonic and adult stages, and 
endoglin-deficient mice display a lack of distinct arterial and venous boundaries 
(Sorensen et al., 2003). 
1.2.1.4 Vessel patterning is also influenced by non-endothelial cells 
The formation of a new vascular sprout requires the degradation of basement 
membrane that envelops an existing vessel. This activity needs to be regulated to 
prevent excessive sprouting. The expression of a membrane-anchored matrix 
metalloproteinase, MT1-MMP, is confined largely to the sprouting tips of capillaries 
(Yana et al., 2007) where it degrades multiple basement membrane components such 
as type IV collagen, laminin and fibronectin (Hotary et al., 2006) thereby allowing 
endothelial cells to migrate and invade the surrounding tissue. This localized 
expression of MT1-MMP is regulated by vSMCs. vSMCs produce Angiopoietin 1 
(Ang-1), which is a major ligand for Tek (also known as Tie-2), a cell surface, 
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endothelial-specific receptor tyrosine kinase that plays a central role in vessel 
maturation. Tek negatively regulates the transcription of MT1-MMP in the stalk 
region and acts to confine MT1-MMP expression to the leading edge of the 
neovasculature (Yana et al., 2007). vSMCs therefore restrict excessive vessel 
sprouting. 
Non-vascular cells also influence vessel guidance and patterning. For 
example, the inner retinal vascular plexus develops in close association with a pre-
existing layer of astrocytes (Fruttiger, 2007). In fact, all endothelial tip cells are 
closely attached to astrocytes and stretch most of their filopodia along the astrocyte 
cell bodies and processes during plexus growth (Gerhardt et al., 2003). Alteration in 
the density of astrocytic network has a direct impact on vessel patterning. Astrocyte 
hyperplasia leads to the formation of a super-imposed multilayered vascular network 
whereas hypoplasia results in a sparser vascular network (Gerhardt et al., 2003). In 
both situations, tip cell filopodia remain closely associated with the astrocytes, 
suggesting that astrocytes provide the principal cues for guidance of endothelial tip 
cells and their filopodia in retinal vascularization. 
 
 
 
 
Figure 6. Angiogenic sprouting. 
Sprouting is controlled by the balance between pro-angiogenic signals (+) such as 
VEGF-A and factors that promote endothelial quiescence (-) such as tight pericyte 
contact and certain extracellular matrix (ECM) molecules. In the presence of VEGF-
A, some endothelial cells are selected to become tip cells. These tip cells migrate 
along an extracellular VEGF-A gradient that is inversely correlated to the oxygen 
tension of the tissue. In the retina, astrocytes ahead of the growing vascular plexus 
experience hypoxia (blue). As a result, they express high concentrations of VEGF-A; 
and, as the tissue becomes vascularized and oxygen tension increases, astrocytes 
express less VEGF-A. Tip cell filopodia are closely associated with the astrocytes 
during migration. Some components of ECM e.g. collagen I promote endothelial cell 
migration. Tip cells express certain matrix metalloproteinases (MMPs) that degrade 
vascular basement membrane (BM), thereby promoting migratory activity. Tip cells 
also express platelet-derived growth factor B  (PDGFB), which promotes the 
recruitment of pericytes to new sprouts. During sprouting, EC-EC junctions are 
dynamic or plastic to allow endothelial cell migration. However, once a lumen is 
formed, endothelial cell junctions are reinforced to maintain vessel   integrity and to 
prevent leakage. Tight interactions between endothelial cells and pericytes and 
endothelial cells and vascular basement membrane prevent sprout formation and 
maintain vessel integrity.  
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1.2.2   VESSEL MORPHOGENESIS 
Endothelial cells have the ability to undergo marked shape changes during the course 
of angiogenesis. Ex vivo, they can retract and exhibit a spindle-shaped morphology 
when exposed to matrix components such as collagen I. They can migrate and 
realign themselves to form solid cords organized in a polygonal pattern and within 
days, these cords mature to form tubes with hollow lumens (Davis and Senger, 
2005). Similarly, time-lapse imaging of developing blood vessels in zebrafish 
embryos revealed dynamic endothelial shape changes during the process of 
sprouting, migration and tube morphogenesis. Once a functional vascular network is 
established, the same endothelial cells become quiescent. These different 
morphogenic events occur while endothelial cells remain connected with each other, 
indicating that at the same time when endothelial cells exhibit explorative behaviour, 
they also maintain tight contacts with adjacent cells so that collectively, they 
preserve the tubular structure of blood vessels during sprouting. Endothelial cells are 
therefore very versatile in their morphology and, depending on the extrinsic and 
intrinsic cues they receive, they can adopt many cellular shapes that influence the 
morphology of blood vessels. 
1.2.2.1 Regulation of endothelial cell morphogenesis by the ECM 
The different matrix components surrounding endothelial cells influence cell 
morphology. For example, the binding of collagen I to α1β1 and α2β1 integrins in 
endothelial cells ex vivo suppresses cAMP and consequently protein kinase A (PKA) 
activity, which is cAMP-dependent. Suppression of PKA activity leads to an 
induction of actin polymerization that contributes to the formation of prominent 
stress fibres and endothelial cell contractility (Whelan and Senger, 2003). These 
intracellular changes are also observed during cord formation ex vivo (Whelan and 
Senger, 2003). Collagen I also induces activation of Src and Rho, both of which 
induce actin stress fibres that mediate cell retraction and vessel morphogenesis (Liu 
and Senger, 2004). RhoA has also been demonstrated to regulate endothelial cell 
assembly into new blood vessels in vivo (Hoang et al., 2004). However, exposure of 
endothelial cells to laminin-I does not regulate the level of cAMP nor induce actin 
polymerization, and this is correlated to the inability of laminin-1 to induce changes 
in cell shape (Whelan and Senger, 2003).  
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1.2.2.2 Lumen formation and tubulogenesis  
The morphogenesis of seamless, properly patterned endothelial tubes is essential for 
the development of a functional circulatory system. Work on 3D endothelial cell 
cultures demonstrate that the assembly of endothelial tubes depends on the formation 
and coalescence of integrin-dependent pinocytic intracellular vacuoles to create an 
ECM-free luminal space (Bayless et al., 2000; Davis and Bayless, 2003). These 
intracellular lumens subsequently undergo exocytic fusion with the plasma 
membrane and form endothelial junctional contacts and continuous luminal 
structures with adjacent endothelial cells (Davis and Bayless, 2003). The study of 
vascular lumens has also extended to an in vivo model of angiogenesis, the zebrafish. 
By using high-resolution time-lapse imaging of transgenic zebrafish, the sequence of 
intracellular vesicle formation, intracellular vesicle fusion and intercellular merging 
of vacuolar compartments to form continuous lumens were observed in endothelial 
cells during the formation of the ISVs (Kamei et al., 2006). 
The formation of an endothelial tube is regulated by intrinsic and extrinsic 
factors. Within the endothelial compartment, the activities of Rho GTPases Cdc42 
and Rac1 are required for the formation of vacuoles and lumens (Davis and Bayless, 
2003). Both ex vivo and in vivo, membranes of vacuoles and the developing lumen 
 
Figure 7. A model of vascular lumen formation by intracellular and 
intercellular fusion of endothelial vacuoles. 
The diagram illustrates the mechanistic sequence of steps proposed to lead to 
intercellular lumen formation: intracellular vesicle formation, intracellular vesicle 
fusion, and finally intercellular merging of vacuolar compartments and lumen 
formation. (Kamei et al., 2006) 
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are strongly labelled with Cdc42 and Rac1 (Davis and Bayless, 2003) (Kamei et al., 
2006) and dominant negative Cdc42 and Rac1 proteins markedly inhibit the 
formation of vacuoles and lumens in collagen matrices (Davis and Bayless, 2003). 
Lumen formation also requires rearrangement of the actin and microtubule networks 
within endothelial cells. The addition of actin- or microtubule-disrupting agents such 
as cytochalasin B or nocodazole completely inhibits endothelial cell vacuole and 
subsequent lumen formation (Davis and Camarillo, 1996). Furthermore, genes 
associated with cytoskeletal regulations e.g. coronins 2A and 2B, myosin IC and 
myosin VI are up-regulated during endothelial cell morphogenesis (Davis and 
Bayless, 2003).  
Tubulogenesis also requires junctional rearrangements between endothelial 
cells. For example, during the formation of the primitive dorsal aorta and cardinal 
vein, there are intimate tight junctions between angioblasts that becomes less 
extensive as arterial and venous angioblasts separate to form distinct tubular 
structures (the dorsal aorta and cardinal vein). The retention of such extensive tight 
junctions prevents the separation of arterial and venous angioblasts, lumen formation 
and also prevents differentiated endothelial cells from acquiring the squamous shape 
that lines the aorta and vein (Parker et al., 2004). This defect is observed in zebrafish 
deficient in EGF-like domain 7 (Egfl7), an endothelial-specific secreted factor (De 
Maziere et al., 2008; Parker et al., 2004). 
Non-vascular cells also influence endothelial tube formation. For example, 
the presence of fibroblasts promotes intercellular lumen formation by the secretion 
and organization of an ECM that is conducive for tube formation (Berthod et al., 
2006). The ECM also regulates the size or diameter of the vessel lumen. In laminin 
α4 and α5 knockout mice, there is an increase in vessel diameter (Miner et al., 1998; 
Thyboll et al., 2002). In an assay where embryonic stem cells with targeted deletions 
of lamc1 (the gene coding LM-γ1) were induced to differentiate into endothelial cells 
and form vascular sprouts, the loss of laminin in vascular basement membrane 
resulted in an increase in vessel diameter due to an increase in endothelial cell 
proliferation (Jakobsson et al., 2008). Therefore, in this model of angiogenesis where 
there is an absence of flow and vascular tone, laminin may function through an 
integrin-dependent signalling pathway to fine-tune tube morphogenesis by regulating 
endothelial cell proliferation. The development of the lumen diameter is also 
influenced by endothelial cell shape and motility. For example, in zebrafish mutants 
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that do not express ccm1, which is a protein that associates with the cytoskeleton and 
components of signal transduction pathways and cell junctions, a progressive 
vascular dilation is observed in the cardinal vein and subintestinal vein (Hogan et al., 
2008). This is a result of increased broadening and spreading of endothelial cells and 
thinning of vessel walls, without changes in endothelial cell number and cell-cell 
contact (Hogan et al., 2008). 
 
1.2.3   VESSEL STABILITY 
Once a functional vessel network is established, active angiogenesis such as 
sprouting and endothelial cell proliferation is switched off or dampened. Instead, 
factors that help to promote endothelial quiescence and vessel homeostasis are turned 
on to stabilize the vessel network. Vessel stability is achieved through tight 
interactions between endothelial cells and also between endothelial cells and non-
endothelial components such as mural cells and the vascular basement membrane.  
1.2.3.1 Endothelial cell junctions 
Endothelial cell junctions are composed of a complex network of adhesion proteins 
that are linked to the intracellular cytoskeletal network and signalling molecules. 
These proteins are organized into distinct structures called adherens junctions and 
tight junctions. In addition, several adhesion proteins such as platelet endothelial cell 
adhesion molecule (PECAM or CD31), intercellular adhesion molecule 2 (ICAM2) 
and others cluster at cell-cell contacts that are different from adherens and tight 
junctions. Adherens junctions have a pivotal role in vessel integrity while tight 
junctions are important in maintaining the barrier functions of endothelial cells, 
controlling vascular permeability and leukocyte extravasation (Wallez and Huber, 
2008). 
There is considerable variability in tight junctions among different segments 
of the vascular network. For example, tight junctions are less complex in capillaries 
than in arterioles, and even less in venules, which is the primary site of leukocyte 
extravasation. The blood-brain-barrier (BBB) and blood-retinal-barrier (BRB) are 
rich in complex tight junctions (Wallez and Huber, 2008). Three types of structural 
transmembrane components form tight junctions: the IgG-like family of junctional 
adhesion molecules (JAMs) and members of the claudin and occludin families. 
Although tight junctions without occludin are rare, tight junctional strands and 
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barrier function are still present in cells and epithelial tissues deficient for occludin 
(Niessen, 2007), indicating that occludin is not essential for tight junction formation. 
Instead, members of the claudin family can induce cell-cell adhesion and are crucial 
in the formation of tight junction strands. Claudins exhibit homophilic and 
heterophilic (with other claudin subtypes) adhesive activities through their 
extracellular domain to form tight junction strands. Occludins, claudins and JAMs 
are unable to directly interact with each other at the tight junction. Instead, 
scaffolding proteins such as the zonula occludens proteins (ZO-1, ZO-2 and ZO-3), 
MUPP1 and MAGI proteins cluster the transmembrane proteins together at tight 
junctions (Niessen, 2007). For example, ZO proteins bind directly with occludin and 
claudins via their PDZ domains and associate with actin through their C-terminus, 
thereby providing a direct link with the cytoskeleton (Schneeberger and Lynch, 
2004). 
Adherens junctions are formed by members of the cadherin family of 
adhesion proteins. Endothelial cells express relatively high levels of two cadherins: 
vascular endothelial–cadherin (VE-cadherin), which is endothelial specific, and  
 
Figure 8. Schematic representation of the basic structural components of tight 
junctions. 
ZOs, cingulin, MUPP1 and MAGI can provide a link for claudins, occludins and 
JAMs to the actin cytoskeleton to form tight junctional strands. ZO, zona occludens; 
MUPP1, multiple PDZ domain protein; MAGI, membrane-associated guanylate 
kinase. (Niessen, 2007) (Furuse and Tsukita, 2006). In endothelial cells, Claudin 5 is 
the principal member from the claudin family that forms tight junctions (Morita et 
al., 2003). 
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Figure 9. Schematic representation of adherens junctions and complexus 
adherens in endothelial cells. 
(A) In complexus adherens, VE-cadherin associates with vimentin filaments via 
plakoglobin/desmoplakin or p0071. (B) In adherens junctions, VE-cadherin directly 
interacts with β-catenin and plakoglobin at the membrane-distal site, and with p120 
and p0071 at the juxtamembrane site. The exact molecular link between the VE-
cadherin-catenin complex and the actin filaments is still obscure. (Wallez and Huber, 
2008) 
 
neuronal cadherin (N-cadherin), which is also expressed in other cell types such as 
neural cells and smooth muscle cells (Bazzoni and Dejana, 2004). VE-cadherin is a 
type II cadherin that harbours high adhesive activity. In endothelial cells, it is the 
major component of adherens junctions and is a crucial determinant of vascular 
integrity. It is proposed that VE-cadherin dimers interact in trans through their 
extracellular domain 1 and VE-cadherin trimers interact in cis via their extracellular 
domain 4 to form a hexameric structure (Hewat et al., 2007; Legrand et al., 2001). 
The intracellular domain of VE- cadherin contains a proximal binding site for p120 
and p0071, and a distal binding site for β-catenin and plakoglobin (Wallez and 
Huber, 2008). β-catenin and plakoglobin bind to α-catenin, which interacts with 
several actin-binding proteins including α-actinin, ajuba and zonula occludens-1 
(ZO-1). It is believed that the interaction of α-actinin to β-catenin is dynamic in that 
α-catenin shuttles between the junction and the cytoskeleton, where it induces actin 
bundling after detaching from the cadherins (Dejana et al., 2008). The VE-cadherin 
complex may also associate with the vimentin cytoskeleton in some vascular 
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locations. This association is mediated by the interaction of either plakoglobin or 
p0071 to desmoplakin, which in turn associates with vimentin (Kowalczyk et al., 
1998; Schmelz et al., 1994). The indirect association between VE-cadherin and the 
cytoskeletal network is required for control of junction stabilization. Deletion of the 
domain that is responsible for binding to β-catenin and plakoglobin jeopardizes the 
strength of the cell junction (Navarro et al., 1995). In the mouse, truncation of this 
domain impairs vascular remodelling and results in embryonic lethality that is 
similar to the phenotype caused by complete absence of VE-cadherin (Carmeliet et 
al., 1999). Importantly, VE-cadherin is important in the maintenance of nascent 
vessels since endothelial cells that lack VE-cadherin or are subjected to VE-cadherin 
blocking antibodies disassemble from the vessels (Crosby et al., 2005) 
 
1.2.3.2 Endothelial-Pericyte interactions 
Pericytes are vascular mural cells that are embedded within the vascular basement 
membrane of blood microvessels. They differ from vSMCs by their localization to 
blood vessels, their morphology and also their marker expression. Pericytes are 
found around blood capillaries, pre-capillary arterioles, post-capillary venules and 
collecting venules where they extend long cytoplasmic processes that wrap around 
the abluminal endothelium wall. vSMCs, however, are separated from the vascular 
basement membrane by a layer of mesenchymal cells and the intima, and compose a 
separate ECM layer called the media. They are usually localized to bigger vessels 
such as arteries and vein where they mediate vascular tone and contraction (Armulik 
et al., 2005).  
 In the CNS, there is a high percentage of pericyte coverage of microvessels 
(e.g. in the retina, the ratio of pericytes to EC is 1:1 (Shepro and Morel, 1993)) 
probably because pericytes contribute to the formation of the blood-brain-barrier 
(Armulik et al., 2005). Although their contractile forces can serve as a supporting 
scaffold for vessels, pericytes also synthesize and promote assembly of basement 
membrane components (Davis and Senger, 2005), therefore enriching the 
perivascular scaffold. The interaction between pericytes and endothelial cells induces 
transforming growth factor-β (TGFβ) activation (Sato et al., 1990), which results in 
increased ECM synthesis and deposition and decreased ECM turnover through 
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secretion of proteinase inhibitors such as TIMP3 (Davis and Senger, 2005) (Saunders 
et al., 2006). 
Pericytes also communicate with endothelial cells by direct physical contact 
and paracrine signalling pathways. Gap junctions between the cytoplasm of pericytes 
and endothelial cells allow exchange of ions and small molecules; adhesion plaques 
anchor pericytes to endothelial cells; and peg-and-socket contacts enable the cells to 
penetrate through interruptions in the vessel basement membrane and touch each 
other (Rucker et al., 2000).  
 The functional importance of pericyte recruitment and attachment to 
endothelial cells became apparent from genetic studies in mice where signalling 
pathways such as that of Angiopoietin 1 (Ang1)/Tie2, platelet-derived growth factor 
B (PDGFB)/PDGF receptor β (PDGFRβ) and sphingosine-1-phosphate (S1P)/S1P 
receptors (S1P1) have been perturbed. Ang1, which is expressed mainly by mural 
cells, is an agonistic ligand of Tie2, which is specifically expressed by endothelial 
cells (Suri et al., 1996). Mice null for Ang1 or Tie2 die at midgestation from 
cardiovascular failure, and their vessels exhibit a poorly organized basement 
membrane, reduced pericyte coverage and detachment of pericytes from endothelial 
cells (Dumont et al., 1994; Suri et al., 1996). Overexpression of Ang1, on the other 
hand, leads to an expanded and stabilized, leakage-resistant vasculature (Suri et al., 
1998) (Thurston et al., 1999; Uemura et al., 2002). These studies indicate that 
pericytes mediate the maturation and quiescence of the microvascular endothelium 
by producing Ang1.  
The PDGFB/PDGFRβ pathway is critically important for the expansion of 
the pericytic population and also for pericyte migration along growing vessels. 
During angiogenesis, endothelial cells, in particular endothelial tip cells, express and 
secrete PDGF-B, which signals through PDGFR-β expressed by mural cells to 
induce mural cell proliferation and migration during vessel maturation (Armulik et 
al., 2005). Mice homozygous for targeted disruption of genes encoding PDGF-B or 
PDGFR-β lack pericytes, resulting in endothelial hyperplasia, abnormal junctions 
and excessive luminal membrane folds (Hellstrom et al., 2001) and these mice die 
perinatally from vascular dysfunction (Leveen et al., 1994) (Lindahl et al., 1997) 
(Soriano, 1994). In addition, the level of PDGF-B expression and the ability of 
PDGF-B to binding to heparan sulphate proteoglycans (HSPGs) to create a gradient 
of PDGF-B in the vicinity of endothelial cells also contribute to proper pericyte 
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coverage of vessels. Mice heterozygous for the gene encoding PDGF-B have reduced 
pericyte numbers compared to wild-type mice (Hammes et al., 2002) and pericytes of 
mice that express retention motif-deficient PDGF-B are partially detached (Lindblom 
et al., 2003).  
Sphingosine-1-phosphate (S1P) is a secreted sphingolipid that binds to G-
protein coupled receptors, denoted as S1P1 to 5. During embryonic development, S1P1 
is expressed in the endothelium (Liu et al., 2000) and endothelial-specific deletion of 
S1p1 results in defects in mural coverage of vessels (Allende et al., 2003). The 
proposed role of S1P1 in mural cell attachment is its signalling through Rac1 in 
endothelial cells to induce microtubule polymerization and trafficking of N-cadherin 
to polarized plasma membrane domains to endothelial-mural cell contacts, thereby 
strengthening pericyte attachment to endothelial cells (Paik et al., 2004).  
1.2.3.3 The extracellular matrix (ECM) 
The vascular basement membrane is composed of laminins (predominantly laminin-
8/laminin α4β1γ1 and laminin-10/laminin α5β1γ1), type IV collagens, perlecan, 
nidogens, collagen XVIII and von Willebrand factor (Hynes, 2007). Laminins are the 
primary determinants of basement membrane assembly while the others listed above 
are accessory components (Davis and Senger, 2005). The structural integrity of 
vascular basement membrane is particularly important during mechanical stress since 
mice homozygous for loss of collagen IV, perlecan and laminin α5 chain display 
dilated blood vessels (Costell et al., 1999; Miner et al., 1998; Poschl et al., 2004). In 
mice lacking collagen IV, perlecan or laminin α4, the vascular basement membrane 
matrix forms but becomes unstable and breaks-down over time (Costell et al., 1999; 
Poschl et al., 2004; Thyboll et al., 2002).  
In addition to the mechanical function of the ECM, the adhesion of 
endothelial cells to specific components of the basement membrane promotes 
endothelial cell quiescence. For example, it is thought that laminins play a role in 
stabilizing endothelial tubes by interacting with laminin-binding integrins (e.g. α6β1, 
α3β1) expressed by endothelial cells. Activation of these receptors may promote 
vessel stabilization by suppressing endothelial cell proliferation and signalling 
pathways that regulate endothelial cell activation such as the Ras-MAPK and NFκB 
pathways (Klein et al., 2002; Mettouchi et al., 2001). Laminin-1 also induces 
persistent activation of GTPase Rac and PKA and suppresses Rho activity to 
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maintain endothelial cells in a quiescent state (Davis and Senger, 2005). Therefore, 
the laminin-rich basement membrane that envelops established vessels sustains Rac 
activity in endothelial cells and also bars endothelial cells from interstitial collagen I 
(which induces EC morphogenesis), thereby keeping vessels stabilized (Davis and 
Senger, 2005). 
The ECM also serves as a source of substrates for the production of inhibitors 
of angiogenesis. For example, endostatin is a C-terminal proteolytic fragment of 
collagen XVIII and is recognized as a negative regulator of angiogenesis especially 
in a tumour setting (Folkman, 2006). However, the mechanism of action of 
endostatin remains obscure (Hynes, 2007) although there are reports that binding to 
integrin α5β1 on endothelial cells down-regulates RhoA activity and consequently 
disrupts focal adhesions and actin stress fibres (Wickstrom et al., 2003). Tumstatin is 
also a product of an ECM molecule, collagen α3 (type IV), and binds to αvβ3 on 
endothelial cells ex vivo and in vivo, and appears to be an endogenous inhibitor of 
angiogenesis (Hamano et al., 2003). Endorepellin, a proteolytic fragment of perlecan, 
also has anti-angiogenic activity by blocking endothelial cell migration and tube 
formation in vitro, and inhibits growth factor-induced angiogenesis in Matrigel plugs 
and the CAM assay (Bix et al., 2004).  
 It therefore appears that the anti-angiogenic activity of ECM is dependent on 
the activities of proteases such MMPs and serine proteinases. For example, the 
generation of tumstatin from collagen α3 is mediated by MMP-9 (Hamano et al., 
2003). Other MMPs are also known to degrade basement membrane matrix 
components, and these include membrane-type MMPs (MT-MMPs), MMP-3 and 
MMP-10 (Davis and Senger, 2005). However, the activities of these enzymes need to 
be tightly regulated since degradation of the matrix also leads to destabilization of 
the vessel structure. The tissue inhibitor of metalloproteinase (TIMP) class of 
enzymes provides native protection to endothelial cells by inhibiting the function of 
MMPs. In the vascular milieu, endothelial-derived TIMP-2 and pericytic TIMP-3 
block the activities of MMP-1, MMP-10, ADAM15 and MT1-MMP (Baker et al., 
2002; Saunders et al., 2006), thereby stabilizing the vascular structure. It is also 
interesting that the pericytic expression of TIMP-3 is increased when co-cultured 
with endothelial cells (Saunders et al., 2006), highlighting the importance of 
intercellular interactions in regulating vessel homeostasis.  
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1.2.4 VESSEL REGRESSION. 
Although angiogenesis is largely viewed as the formation of new blood vessels, this 
term also encompasses the process of vessel regression, which occurs during vessel 
network remodelling and maturation. The molecular mechanisms that govern vessel 
regression are still relatively unknown. However, it is assumed that for vessel 
regression or pruning to occur, vessels have to lose integrity or stability as a result of 
degradation of the vascular basement membrane, detachment of mural cells from the 
vessels and/or unstable endothelial cell junctions. Although unidentified, the 
mechanism behind vessel regression requires temporal and spatial regulation as loss 
of a tight regulation can lead to vessel rupture and excessive vessel regression.  
Vessel regression is observed when pro-angiogenic factors are removed 
(Benjamin et al., 1999). In the eye, the hyaloid vessels that surround the lens during 
embryogenesis regress within the first two weeks of birth (Ito and Yoshioka, 1999). 
The regression of hyaloid vessels requires endothelial cell apoptosis, an event that is 
induced by Wnt signalling (Lobov et al., 2005). However, it is also possible that 
apoptosis may not be a cause but rather a consequence of vessel regression. The 
latter case is supported by various studies. Activation of Rho-kinase signalling and 
cell contractility in endothelial cells result in retraction of sprouting vessels in an in 
vitro 3D culture system that is also accompanied by cell death (Mavria et al., 2006). 
The observed apoptosis is the result of changes in cell shape and detachment from 
the extracellular matrix since apoptosis followed cell rounding (Im and Kazlauskas, 
2007a; Mavria et al., 2006). In addition, inhibition of apoptosis by the caspase 
inhibitor ZVAD failed to prevent cell rounding and retraction induced by Rho-kinase 
(Mavria et al., 2006).  
 Vessel regression may also be a consequence of loss or decrease in signals 
that promote endothelial cell survival and vessel stability. For example, PI3K/Akt 
pathway is important in the formation and stabilization of vessel tubes (Im and 
Kazlauskas, 2007a). Reduction of PI3K/Akt signalling by limiting the amount of 
PI3K substrate, PtdIns-4,5-P2, results in tube regression without an effect on tube 
formation (Im and Kazlauskas, 2007a). This is mediated through the competing 
activity of PLCγ for PtdIns-4,5-P2, therefore antagonizing PI3K/Akt signalling (Im 
and Kazlauskas, 2007a). Another pathway that prevents vessel regression is the 
ERK1/2-MAPK pathway. ERK1/2 inhibits Rho-kinase activation, whose activity has 
been demonstrated to induce vessel regression in vitro and in vivo (Im and 
 38 
Kazlauskas, 2007b; Mavria et al., 2006). In addition, the Src family kinases (SFKs) 
have been demonstrated to prevent tube regression by activating the ERK pathway 
and thereby antagonising Rho/ROCK pathway (Im and Kazlauskas, 2007b). 
 As mentioned above, vessel stability is promoted by vascular basement 
membrane and by vascular mural cells. It is therefore possible that the loss of vessel 
stability from disintegration of the basement membrane or detachment of mural cells 
can lead to vessel regression. In a 3D collagen matrix, the soluble proteases MMP-1 
and MMP-10 increase tube regression by degrading collagen type I without 
compromising tube morphogenesis (Davis and Senger, 2005; Saunders et al., 2005). 
As MMP-10 also cleaves collagen IV, laminin and perlecan, which are responsible 
for the establishment of basement membrane and maintenance of vascular tube 
networks, it is also plausible that MMP-10 activity can contribute to vessel 
regression in vivo. Angiopoietin 2 (Ang2) antagonizes Ang1-mediated Tie2 
signalling and causes vessel destabilization involving detachment or loss of 
pericytes. This conclusion is drawn from experiments where upregulation of Ang2 
expression in the eye induced pericyte detachment from retinal vessels (Hammes et 
al., 2004). Furthermore, systemic overexpression of Ang2 resulted in impairment in 
the association of tumour pericytes and endothelial cells, leading to tumour vessel 
regression within 24 hours without a concomitant decrease in VEGF signalling (Cao 
et al., 2007).  
 The integrity of endothelial cell junctions is also essential for maintaining 
vascular integrity and VE-cadherin serves such a function. However, tight adhesion 
between cells is diminished when VE-cadherin is cleaved by proteases such as the 
disintegrin and metalloprotease ADAM10 to release a carboxyl-terminal membrane 
stub, which is a substrate for γ-secretase cleavage (Schulz et al., 2008). Although, 
ADAM10 activity increases vascular permeability and facilitates leukocyte 
transmigration (Schulz et al., 2008), it is not known whether it also regulates vessel 
regression by its ability to weaken adhesion junctions.  
 
1.2.5   SUMMARY  
As outlined above, angiogenesis is a very dynamic and complex process that 
involves multicellular components at different phases of vascular development. The 
formation of an organized, hierarchical vessel network requires tight coordination of 
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cell proliferation, differentiation, migration, matrix adhesion and cell-cell signalling 
during vessel morphogenesis.  
 
1.3 NOTCH SIGNALLING 
The Notch pathway is an evolutionarily conserved signalling system that is required 
for normal embryonic development and also functions to regulate tissue homeostasis 
and maintenance of stems cells in adults (Artavanis-Tsakonas et al., 1999; Gridley, 
1997). The pathway was originally identified in Drosophila, where the first mutant 
allele gave rise to a notched wing. Since then, proteins of the Notch pathway have 
been discovered in virtually all metazoans and studied extensively in flies, worms 
and mammals. These studies have unravelled the multiple roles of Notch signalling 
in cell fate specification, patterning and morphogenesis through effects on 
differentiation, proliferation, survival and apoptosis (Bray, 2006; Fiuza and Arias, 
2007). Furthermore, Notch signalling integrates with other core signalling networks 
such as Hedgehog, transforming growth factor β (TGFβ) and Wnt to form a larger, 
more complex signalling system to achieve the morphological complexity of 
metazoans. 
 The importance of Notch signalling during development and in adults is 
underscored by the finding that several diseases are associated with irregular Notch 
signalling. Aberrant Notch signalling has been identified in several cancers such as 
head and neck squamous cell carcinoma (Zeng et al., 2005) and T-cell acute 
lymphoblastic leukaemia (Weng et al., 2004), and also in congenital diseases such as 
the Alagille syndrome and the cerebral autosomal dominant arteriopathy with 
subcortical infarcts and leukoencephalopathy (CADASIL), both of which affect the 
blood vasculature. Although the link between Notch pathway and disease is very 
interesting, I will, however, only discuss Notch signalling in the context of 
developmental biology in this thesis. 
 
1.3.1 THE CORE PATHWAY 
In mammals, there are five canonical Notch ligands, Delta-like 1 (Dll1), Delta-like 3 
(Dll3), Delta-like 4 (Dll4), Jagged1 (Jag1) and Jagged 2 (Jag2), which are classified 
as DSL (Delta, Serrate, LAG-2) ligands. The ligands are type 1 cell-surface proteins  
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Figure 10. Protein structure of the vertebrate DSL family of ligands. 
The canonical DSL ligands are type 1 cell–surface proteins that have multiple 
tandem epidermal growth factor (EGF) repeats in their extracellular domains. The 
DSL domain, the flanking N-terminal (NT) and the first two EGF repeats are 
required for DSL ligands to bind Notch (Parks et al., 2006; Shimizu et al., 1999). As 
well as having almost twice the number of EGF repeats as Delta-like ligands, Jag1 
and Jag2 have an additional cysteine-rich region (CR). The intracellular regions of 
DSL ligands lack obvious sequence homology except that most, but not all, contain 
multiple lysine residues and a C-terminal PDZ (PSD-95/Dlg/ZO1) ligand motif, 
which are required for ligand signalling activity and interactions with the 
cytoskeleton, respectively. Striped boxes, DSL domain; white boxes, EGF repeat; 
grey boxes, calcium-binding EGF repeat. NT, N-terminal domain; DSL, 
Delta/Serrate/LAG-2 domain; EGF, epidermal growth factor-like; CR, cysteine-rich 
region; TM, transmembrane domain; PDSL, PDZ ligand motif. (D'Souza et al., 
2008) 
 
 
with multiple tandem epidermal growth factor (EGF) repeats in their extracellular 
domains (ECDs) (Figure 10). DSL ligands bind to Notch receptors, which are large 
(300kDa) single-pass type I transmembrane receptors (Figure 11). In mammals, there 
are four Notch receptors, Notch1 to Notch 4. Binding of a DSL ligand to the 
extracellular domain of Notch receptor (NECD) triggers a series of proteolytic 
cleavages of Notch, first by a member of the disintegrin and metalloproteases 
(ADAM) within the juxtamembrane regions (known as S2), followed by γ-secretase 
within the transmembrane domain (known as S3; See Figure 12). The final cleavage 
releases the Notch intracellular domain (NICD) from the cell membrane, which 
translocates to the nucleus where it directly interacts with the CSL (CBF1, Su(H), 
LAG1) transcription factor. In the absence of NICD, CSL represses transcription 
through interactions with a co-repressor complex that contains a histone deacetylase 
(Kao et al., 1998). However, binding of NICD to CSL displaces the co-repressor 
complex and replaces it with a transcriptional activation complex that includes 
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NICD, Mastermind-like 1 and histone acetyltransferases such as p300 to turn on 
expression of Notch target genes such as the basic helix-loop-helix (bHLH) proteins 
Hairy/Enhancer of Split (Hes), Hes-related proteins (Hey/HRT/HERP) and Notch-
regulated ankyrin repeat protein (Nrarp). However, the subset of Notch primary 
target genes transcribed is cell type-dependent. The Hes and Hey genes are, in turn, 
transcriptional repressors of their own expression and also of further downstream 
genes. 
 
 
 
 
Figure 11. Domain organization of Notch receptors. 
Proteolytic cleavage by furin produces two subunits, Notch extracellular domain 
(NECD) and Notch intracellular domain (NICD), which remain noncovalently 
associated at the cell surface. EGF-like modules 11 and 12 participate in ligand 
binding (shaded, EGF repeats in yellow). C-terminal to the EGF repeats are three 
LNR repeats, which play a role in maintaining the receptor in its resting 
conformation when not bound to ligand. Two consecutive proteolytic cleavages 
induced upon ligand activation release the intracellular domain of NICD. NICD 
consists of the RAM domain, which binds to CSL, NLS, ankyrin repeats, TAD , EP 
domain, which binds to the histone acetylase p300, and the PEST/OPA motif. 
NECD, Notch extracellular domain; NICD, Notch intracellular domain; EGF, 
epidermal growth factor; LNR, lin-Notch repeats; RAM, RBPjk-associated molecule; 
NLS, nuclear localization signal; TAD, transactivation domain, PEST, proline, 
glutamate, serine, theronine-rich; OPA, glutamine-rich sequence. (Lubman et al., 
2004) 
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Figure 12. Current overview of Notch signal transduction.  
The canonical Notch pathway mediates the regulation of a diverse array of cell fate 
decisions through juxtacrine signalling. In the ER and Golgi, the NECD is modified 
by a series of glycosylation events mediated by Fringe and other 
glycosyltransferases. In the trans-Golgi, Notch undergoes proteolysis by a furin-like 
convertase (S1 site), generating a glycosylated, presumably divalent-cation-stabilized 
Notch heterodimer. Upon ligand binding, NECD is removed through cleavage by an 
ADAM metalloprotease, TNF-α converting enzyme (TACE, site S2). NECD 
remains bound to the ligand, and both proteins may be endocytosed by the ligand-
presenting cell. The physical force generated by this ligand/NECD internalization 
may be required for receptor cleavage by TACE. After cleavage by TACE, cleavage 
by the γ-secretase complex (S3 site) releases NICD from the cell membrane. NICD 
translocates to the nucleus and associates with the CSL transcriptional regulator. In 
the absence of NICD, CSL is part of a repressor complex. Upon NICD binding, co-
repressors are exchanged for co-activators including Mastermind and p300, leading 
to the activation of target genes such as members of the Hes and Hey families and 
Nrarp. Both the ligand and receptor can undergo ubiquitin-regulated internalization 
and degradation. Note that the cellular compartments where modifications of Notch 
receptors are depicted are only hypothetical. It is possible that S2 and S3 cleavages 
occur in an endosomal compartment. (Hurlbut et al., 2007) 
 43 
1.3.2 REGULATION OF NOTCH RECEPTOR ACTIVITY. 
The activation of Notch signalling is highly regulated. Prior to localization at the cell 
membrane, the Notch receptor is cleaved at the S1 site in the extracellular domain by 
a furin-like protease to produce a mature heterodimeric Notch (hNotch) receptor in 
the trans-Golgi network ((Logeat et al., 1998);Figure 12). The extracellular and 
membrane-bound intracellular furin-cleavage fragments of hNotch are held together 
through non-covalent interactions that prevent receptor activation in the absence of 
ligand.  
The EGF repeats of Notch receptor are further modified by glycans such as 
O-fucose glycans, O-glucose glycans and complex N-glycans (Stanley, 2007). 
Inactivation of protein O-fucosyl transferase 1 (POFUT1) or other activities required 
for O-fucose glycans synthesis results in inactive Notch receptors and Notch 
signalling defects in Drosophila (Haines and Irvine, 2003), zebrafish (Appel et al., 
2003) and mammals (Lu and Stanley, 2006). O-fucosylation of Notch is therefore 
absolutely required for Notch signalling. It is postulated that O-fucosylation is 
necessary for the stable cell surface expression of Notch receptors by regulating the 
trafficking of the receptor between the endoplasmic reticulum and the cell membrane 
(Okajima et al., 2005) (Sasamura et al., 2007). 
The transfer of N-acetylglucosamine (GlcNAc) to fucose on Notch is also 
required for Notch activity. In Drosophila, the glycosyltransferase responsible for 
this event is Fringe (Fng), while in mammals, there are three Fringe genes, Lunatic 
Fringe (Lfng), Manic Fringe (Mfng) and Radical Fringe (Rfng). Modification of O-
fucose by Fringe affects the strength of Notch-ligand binding so that different Notch 
signalling output arises (Yang et al., 2005). For example, in the Drosophila wing 
disc Fringe enhances Notch signalling induced by Delta but inhibits Notch signalling 
induced by Serrate to restrict Notch signalling to a stripe of cells at the dorsal/ventral 
boundary (Haines and Irvine, 2003). In mammals, Lfng and Mfng generally inhibit 
Jag1-induced Notch1 signalling and increase Dll1-induced Notch signalling (Stanley, 
2007). 
Modification of Notch by Fringe is followed by addition of Gal residues to 
GlcNAcβ(1,3)Fuc-O dissacharide by a Gal-transferase (Moloney et al., 2000). 
Again, this modification of Notch receptor regulates Notch activity since mice 
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lacking β4GalT-1 have poor expression of several Notch targets genes at mid-
gestation and these embryos have an extra lumbar vertebra (Chen et al., 2006). 
 
1.3.3 REGULATION OF DSL LIGANDS. 
The expression of DSL ligands is itself regulated by Notch signalling. Notch-
mediated lateral inhibition and inductive signalling negatively and positively regulate 
DSL ligand expression, respectively, in neighbouring cells (D'Souza et al., 2008). 
There is therefore a feedback loop, whereby the signal-receiving cell is induced to 
express less or more ligand after Notch receptor activation. In addition, the Notch 
pathway interacts with a number of different signalling pathways, which also 
influence DSL ligand expression. For example, activation of Kdr up-regulates the 
expression of Dll4 (Liu et al., 2003; Patel et al., 2005). 
Apart from cell type-specific expression of DSL ligands, the ligands are 
regulated post-translationally by ubiquitination, endocytosis and proteolysis, 
processes that also modulate Notch signalling in the signal-receiving cell. 
Ubiquitination of DSL ligands regulates ligand signalling activity and cell surface 
expression (Le Borgne and Schweisguth, 2003). The intracellular domains of Dll1, 
Dll4, Jag1 and Jag2 contain multiple lysine residues that can serve as potential 
ubiquitination sites. There are two structurally distinct RING-containing E3 ligases 
that influence Notch signalling, Neuralized (Neur) and Mind bomb (Mib), which 
function to enhance ligand endocytosis. In mammals, there are two Neur proteins, 
Neur1 and Neur2, and two Mib proteins, Mib1 and Mib2. Mib ubiquitination is 
responsible for DSL ligand endocytosis that activates Notch signalling and Neur 
functions downstream of Mib to direct lysosomal degradation of internalized ligands 
and thereby regulate the level of ligand available for Notch activation (Song et al., 
2006). In vertebrates, Neur and Mib do not appear to be functionally equivalent in 
modulating Notch signalling. Of the E3 ligases, only the disruption of Mib1 in mice 
produces the known Notch phenotypes and Notch embryonic lethality (Koo et al., 
2005; Koo et al., 2007). For example, Neur1 and Neur2 are dispensable for normal 
neurogenesis in mice, but Mib1 mutant embryos have strong neurogenic phenotypes 
in the brain and neural tube (Koo et al., 2005; Koo et al., 2007). Although Mib1 and 
Mib2 are functionally redundant (Zhang et al., 2007), Mib2 is not strongly expressed 
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during embryonic development. There is therefore the requirement for Mib1 in 
Notch-dependent embryonic processes (Koo et al., 2007). 
The endocytosis of DSL ligand is required for Notch activation and this 
occurs in a ubiquitination- and clathrin-dependent manner (Le Borgne et al., 2005; 
Nichols et al., 2007b). In the absence of endocytosis, the ligands accumulate at the 
cell surface where they are unable to activate Notch (Nichols et al., 2007a; Parks et 
al., 2000). There are several proposals for the requirement of DSL ligand 
 
Figure 13. Notch-induced DSL endocytosis. 
DSL ligands are ubiquitinated (orange circles) by the E3 ligases Neuralized (Neur) 
and/or Mind bomb (Mib). Binding of ubiquitinated ligand to Notch receptor on 
adjacent cell stimulates clustering of ligands and generate multiple interaction sites 
within DSL clusters for the ubiquitin-interacting motif-containing adaptor epsin. 
Multiple epsin-DSL interactions may stabilize ligand within the clathrin-coated 
vesicle during its internalization of bound Notch. A ‘pull’ generated by DSL 
internalization is proposed to dissociate the bound Notch heterodimer, allowing 
NECD to be internalized along with DSL. Internalized NECD-DSL complexes may 
be dissociated and sorted during endosomal trafficking to allow DSL to be recycled 
back to the plasma membrane, while NECD is degraded. DSL recycling may involve 
deubiquitination by an unknown deubiquitinating enzyme. (Nichols et al., 2007b) 
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endocytosis. As soluble DSL ligands require clustering for activity, it is possible that 
endocytosis clusters ligands, which are then recycled back to the cell surface for 
receptor interaction. Another suggestion is that sorting of ligands to an intracellular 
compartment may convert the ligand to an active form. Alternatively, recycling 
could direct ligand to a specific plasma membrane microdomain or maintain 
effective levels of ligand at the cell surface. Also, DSL recycling may be required to 
return the ligand to the cell surface following its internalization with NECDs during 
receptor activation (Nichols et al., 2007a), a process known as transendocytosis 
whereby the NECD is taken up into the signal-sending cell (Nichols et al., 2007a; 
Parks et al., 2000). Such a process would inflict a mechanical strain in Notch to 
expose the ADAM cleavage site and allow proteolytic activation for downstream 
signalling (D'Souza et al., 2008).  
Like the Notch receptor, the activity of DSL ligand can be regulated by the 
proteolytic activities of ADAMs and γ-secretase. Following cleavage by ADAMs in 
the juxtamembrane region, the extracellular domains of DSL ligands are released 
extracellularly as soluble proteins. However, not all soluble forms of DSL ligands 
activate Notch (Zolkiewska, 2008). For example, the soluble form of Drosophila 
Delta is inactive in vivo and, in cultured mammalian cells, soluble extracellular 
domains of Dll1, Dll4 or Jag1 block Notch activity (Zolkiewska, 2008). In addition, 
increase in cleavage of DSL ligand leads to downregulation of Notch activity in 
trans (Muraguchi et al., 2007). DSL ligands can also bind to Notch receptors present 
in the same cell through their extracellular domains at the cell surface. Unlike trans 
interaction, cis interaction between ligand and receptor is antagonistic, an effect 
known as cis inhibition(Dyczynska et al., 2007; Zolkiewska, 2008). 
 Following ADAM-mediated processing, DSL ligands become substrates of γ-
secretase (Ikeuchi and Sisodia, 2003; Six et al., 2003) and the intracellular fragment 
of the ligand is released. All DSL ligands contain positively charged residues that 
can serve as nuclear localization signals (NLS), thereby targeting the ligand to the 
nucleus (LaVoie and Selkoe, 2003; Zolkiewska, 2008). It may therefore be possible 
that DSL ligands themselves regulate gene transcription. Indeed, the soluble 
intracellular domain of Dll1 can bind to Smad2, Smad3 and Smad4 and enhance 
Smad3 transcriptional activity in response to stimulation of cells with TGFβ 
(Hiratochi et al., 2007). These findings point towards a bi-directional signalling 
between Notch-expressing and ligand-expressing cells. 
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1.3.4 NON-CANONICAL NOTCH LIGANDS. 
Unlike canonical Notch ligands that share many features, non-canonical ligands are 
structurally diverse and include integral membrane, glycosylphosphatidylinositol 
(GPI)-linked and also secreted proteins (D'Souza et al., 2008).  
Delta-like 1 (Dlk-1) is an example of a membrane-tethered non-canonical 
ligand that binds to Notch. Only cis-interactions between Dlk-1 and Notch occur to 
induce cis-inhibition and not trans-activation of Notch signalling (Baladron et al., 
2005). Non-canonical ligands can also activate Notch signalling, as shown for 
F3/contactin1, which encodes a GPI-linked neural cell adhesion molecule. 
Contactin1 can interact with Notch in trans to activate Notch signalling to induce 
oligodendrocyte differentiation (Hu et al., 2003). Although contactin binding to 
Notch produces NICD, in a γ-secretase manner, that can translocate to the nucleus 
for signalling, it is unable to activate canonical CSL-induced Notch signalling. 
Instead, contactin induces Notch signalling that involves Deltex (Cui et al., 2004; Hu 
et al., 2003).  
In vertebrates, two types of secreted, non-DSL proteins have been identified 
as putative Notch ligands: CCN3, a member of the connective tissue growth 
factor/cysteine-rich 61/nephroblastoma overexpressed gene (CCN) family of 
proteins, and MAGP-1 and -2, members of the microfibril-associated glycoprotein 
family (Gibson et al., 1996; Gibson et al., 1991). CCN3 is able to interact with the 
EGF repeats of Notch1 through its C-terminal cysteine knot domain (Sakamoto et al., 
2002). The findings that co-expression of CCN3 in cell cultures can potentiate 
endogenous CSL-dependent Notch signalling and that gains and losses in CCN3 lead 
to corresponding changes in Hes1 expression suggest that CCN3 may activate Notch 
in an autocrine fashion (Sakamoto et al., 2002; Minamizato et al., 2007). The 
interaction between MAGP-1 and -2 with Notch induces γ-secretase-dependent 
NICD generation and CSL-dependent activation (Miyamoto et al., 2006). Like DSL 
ligands, MAGP-2 can induce ADAM-independent dissociation of the Notch 
heterodimer that is required for proteolytic activation and downstream signalling. 
Interestingly, MAGP-2 has an angiogenic function. It is able to promote endothelial 
cell sprouting by antagonizing Notch signalling induced by Jag1 (Albig et al., 2008; 
Albig et al., 2007). 
 It is still unclear whether endocytosis of non-canonical ligands is required for 
inducing Notch activity. As non-enzymatic dissociation of Notch is required for 
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signal activation, it has been postulated that tethering of the non-canonical ligands to 
the ECM may generate sufficient pulling force on the Notch receptor (D'Souza et al., 
2008). 
1.3.5 CSL-INDEPENDENT SIGNALLING 
Although much of Notch activation is effected through the CSL-dependent pathway, 
there is growing evidence that the activation of Notch receptor triggers cellular 
responses through CSL-independent pathways. One such pathway is the activation of 
β1 integrins by Notch1 (Hodkinson et al., 2007). This event also relies on the 
production of NICD1 from S3 cleavage of the Notch receptor. NICD1 specifically 
activates R-Ras, which antagonizes H-Ras-mediated integrin suppression to increase 
integrin affinity (Hodkinson et al., 2007). The increase in integrin activity enhances 
cell adhesion to extracellular matrix proteins. For example, human myeloid cells 
(K562) that have been transfected with NICD1 or that have been activated with 
recombinant Dll4 exhibit increased adhesion to fibronectin (Hodkinson et al., 2007). 
Also, overexpression of intracellular domain of Notch4 (NICD4) in endothelial cells 
results in β1 integrin-mediated increase in adhesion to collagen and these cells have 
reduced capacity to sprout in response to VEGF both in vitro and in vivo (Leong et 
al., 2002). The activation of R-Ras does not require CSL-mediated transcription and 
may therefore transmit rapid changes in cellular signalling in response to interaction 
with Notch ligands expressed on adjacent cells (Hodkinson et al., 2007). 
 Another CSL-independent pathway that is activated after Notch receptor 
binding is Abl tyrosine kinase and its accessory proteins Disabled and Trio. 
Interesting studies performed in Drosophila showed that Notch binds directly to 
Disabled and Trio to regulate Abl signalling (Crowner et al., 2003; Le Gall et al., 
2008). Specific deletion of the Disabled binding domain in Notch results in defects in 
embryonic axon patterning with little or no effect on neurogenesis (Le Gall et al., 
2008). In addition, the authors showed that the canonical Notch signalling pathway is 
dispensable for axonal function. Therefore, although axon patterning and 
neurogenesis are dependent on Notch signalling, the mechanisms that drive their 
processes differ. In the former case, a CSL-independent pathway that involves 
Disabled and Abl is required while in the latter case, the canonical CSL-dependent 
pathway is important. 
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1.3.6 NOTCH SIGNALLING IN VASCULAR DEVELOPMENT 
Notch receptors and DSL ligands are expressed in vascular cells, suggesting that 
Notch signalling may have important roles in growth and differentiation of blood 
vessels. For example, the transcripts of Notch1 and Notch4 are expressed in 
endothelial cells and Notch3 is expressed in vascular smooth muscle cells (vSMCs) 
of arteries. The ligands Dll1, Jag1 and Dll4 are also expressed in endothelial cells 
(Claxton and Fruttiger, 2004; Villa et al., 2001). The requirement of Notch signalling 
in blood vessel formation is reflected in the failure of proper blood vessel 
development after genetic deletion of different Notch components in mouse as well 
as in zebrafish (see Table 1). 
1.3.6.1 Notch regulates arterial-venous differentiation 
It is now apparent that genetic factors underlie blood vessel identity and that the 
Notch pathway acts at a specific step in arterial-venous differentiation to repress a 
venous cell fate program (Lawson et al., 2001). There are differences in the spatial 
expression of certain Notch receptors and ligands among blood vessels. For example, 
during zebrafish embryonic vascular development, notch5 and grl are expressed in 
the dorsal aorta (DA) but not in the posterior cardinal vein (PCV) (Zhong et al., 
2000). In the mouse, Notch4 is expressed more strongly in arterial endothelium than 
in venous endothelium (Claxton and Fruttiger, 2004). Also, the ligand Dll4 is mostly 
restricted to arterial endothelium in the mouse and zebrafish (Claxton and Fruttiger, 
2004; Leslie et al., 2007; Mailhos et al., 2001; Siekmann and Lawson, 2007).  
Analyses of several mouse mutants where a Notch receptor, a DSL ligand or 
a Notch effector has been genetically knocked out revealed deformities in arterial-
vein formation (Table 1). Dll4 heterozygous mouse embryos exhibit malformations 
of arteries that include stenosis and atresia of the aorta, defective arterial branching 
and loss of arterial markers such as Ephrin-B2 (Gale et al., 2004; Krebs et al., 2004). 
The loss of arterial markers is also observed in the zebrafish mindbomb (Lawson et 
al., 2001) and gridlock mutants and in mice where Rbpj (Krebs et al., 2004) and both 
Hey1 and Hey2 (Fischer et al., 2004) are deleted. The reduction or loss of Notch 
signalling is accompanied by an expansion of veins and ectopic expression of venous 
markers such as flt4 and ephB4 in the dorsal aorta of the zebrafish (Lawson et al., 
2001; Zhong et al., 2001). The converse experiments, where Notch signalling is 
ectopically activated, results in decreased flt4 expression in venous vessels (Lawson 
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et al., 2001). These findings suggest that Notch signalling acts to repress the venous 
fate within the developing arterial primordium. This hypothesis is further 
strengthened by the finding that COUP-TFII, a venous marker, suppresses Notch 
signalling in venous endothelium. COUP-TFII (chicken ovalbumin upstream 
promoter-transcription factor II) is an orphan nuclear receptor that has a cell-
autonomous role in the formation of the venous endothelium and is also important in 
the maintenance of venous cell fate (You et al., 2005). Endothelial-specific deletion 
of COUP-TFII results in ectopic expression of the arterial endothelial marker, 
Ephrin-B2, and Notch pathway genes such as Notch1, Jag1 and Hey2 in the veins of 
mutant mice (You et al., 2005). Conversely, overexpression of COUP-TFII in all 
endothelial cells completely converts cells of arterial lineage to the venous lineage.  
Together, the genetic studies in mouse and zebrafish have revealed the 
requirement of Notch signalling in arterial-venous differentiation.  
 
1.3.6.2 Notch regulates vascular smooth muscle cell (vSMC) differentiation 
Notch signalling plays an important role in the differentiation, physiology and 
function of vSMCs. Inactivation of Notch signalling specifically in mouse neural 
crest cells revealed that Notch signalling is required for the differentiation of cardiac 
neural crest cells into smooth muscle cells (High et al., 2007). In addition, Jag1-
mediated Notch signalling promotes SMC differentiation from human aortic smooth 
muscle cells and murine embryonic fibroblast cell line (Doi et al., 2006). 
Furthermore, the smooth muscle cell markers smooth muscle myosin heavy chain 
and smooth muscle α-actin have been demonstrated to be direct Notch target genes 
(Doi et al., 2006) (Noseda et al., 2006).  
 Genetic deletion of mouse Notch3, which is expressed in vSMCs of arteries 
but not of veins, results in a thinner vSMC coat around arteries than that found 
around wildtype arteries (Domenga et al., 2004). Arterial vSMCs are distinct from 
venous vSMCs in its gene expression. For example, arterial, but not venous, vSMCs 
express smoothelin (van der Loop et al., 1997) and have active SM22α promoter 
activity (Moessler et al., 1996). In Notch3-/- mice, vSMCs that surround arteries lose 
their arterial identity and acquire a venous one, as observed by loss of smoothelin 
and SM22α promoter-driven β-galactosidase protein (Domenga et al., 2004). 
Although the arteries in Notch3-/- mice consequently fail to mature and exhibit 
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marked defects, they still express endothelial cell arterial markers such as ephrin B2 
and connexin 40 (Domenga et al., 2004), indicating that the arterial identity of 
endothelial cells and of vSMCs that surround them is specified independently. 
Together, these studies demonstrate that Notch signalling not only regulates 
differentiation of vSMCs but also regulates the arterial specification of vSMCs.  
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Table 1. Vascular phenotypes of mice deficient in Notch signalling components. 
   
Gene disrupted Lethality? Vascular Phenotype? 
DSL Ligand   
   Dll1 E12 Severe haemorrhage at E10. (Hrabe de Angelis et al., 1997) 
   Dll3 P0-P10 None. 
   Dll4 Viable Dll4+/-: 
E10.5  
The Dll4 gene is haploinsufficient so that even heterozygosity causes malformation of arteries 
(stenosis and atresia of the aorta), defective arterial branching. There is also absence of vessel 
remodelling in yolk sacs. (Gale et al., 2004; Krebs et al., 2004) 
   Jag1 E11.5 Embryos have severe haemorrhages and lack vascular remodelling. 
Yolk sacs lack large vessels. (Xue et al., 1999) 
   Jag2 Perinatal viable None.(Jiang et al., 1998) 
   
Receptor   
   Notch1 E11.5 Yolk sacs display disorganized, confluent vascular plexus and lack large vitelline blood 
vessels. 
In the embryo proper, there is defective cardinal vein, lack of intersomitic vessels and 
collapsed dorsal aorta. (Krebs et al., 2000) 
   Notch2 E10.5 Cardiovascular dysfunction and pericardial oedema. (McCright et al., 2006) 
   Notch3 No Arterial defects: enlarged artery, defective arterial myogenic responses. 
vSMC defects: thinner vSMC coat around arteries, altered cell morphology (thin, elongated 
cytoplasmic processes). 
Thin, disorganized tunica media composed of discontinuous layers of non-cohesive vSMCs. 
   Notch4 Viable None.(Krebs et al., 2000) 
   Notch1 + Notch4 E9.5 More severe phenotype than Notch1 null mutant. (Krebs et al., 2000) 
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Notch effectors and 
target genes 
  
   Rbpj  Lack of vascular remodelling in yolk sac and primitive vasculature in embryo. 
Loss of arterial markers. (Krebs et al., 2004) 
   Hey1  None. 
   Hey2 or gridlock P10 In mouse, deletion of Hey2 leads to ventricle septum defects and other cardiac abnormalities 
without vascular defects. (Gessler et al., 2002) (Donovan et al., 2002) 
Mutations of grl in zebrafish results in defective arterial-venous differentiation. Decrease of 
grl function ablates regions of the artery while expands contiguous regions of the vein. (Zhong 
et al., 2001) 
   Hey1 + Hey2 E11.5 Hey1 and Hey2 double knockout mice have severe haemorrhage and enlarged pericardial sac.  
Yolk sacs lack vessel remodelling and vitelline vessels, which may have degenerated. 
Reduction or loss of aorta and cardinal vein.(Fischer et al., 2004) 
   
Notch modulators   
   Mindbomb  
 
 
EC-specific: 
E11.5 
 
Mibta52b zebrafish mutants show: defects in arterial-venous differentiation with dysregulation 
of arterial and venous endothelial markers, cranial haemorrhage, lack of circulation, arterial-
venous shunts and aberrant ISV projections (Lawson et al., 2001). 
Endothelial specific deletion of Mib1 in mouse using Tie2-Cre results in embryonic lethality 
at E11.5. There are defects in vascular remodelling: avascular yolk sac, pericardial effusion, 
and also abnormal formation of dorsal aorta with loss of arterial markers.(Koo et al., 2007) 
   Pofut1 E10.5 Defects in the formation of head vessel and ISVs. Disorganized vessels.  (Shi and Stanley, 
2003) 
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1.4 ANIMAL MODELS OF ANGIOGENESIS 
Two animal models were used intensively to study the mechanisms of angiogenesis 
during my PhD: the postnatal mouse retina and the embryonic zebrafish, where I 
have focused on the development of intersegmental vessels. 
1.4.1 THE EARLY POST NATAL MOUSE RETINA 
Unlike primate retinas, rodent retinas become vascularized soon after birth through 
sprouting angiogenesis. Endothelial cells migrate into the retina through the optic 
nerve head and form a primary vascular network that spreads radially, reaching the 
periphery of the retina within 7 to 8 days after birth. Retinal vascularization is 
closely associated with the astrocytic network that forms prior to the emergence of 
endothelial cells (see 1.2.1.4).  The astrocytic network serves as a scaffold for 
nascent blood vessels and is also a source of VEGF-A production. Astrocytes at the 
periphery of the retina, which is hypoxic, express abundant amounts of VEGF-A 
whereas those nearer the optic nerve and are in close proximity to blood vessels 
express less. A gradient of VEGF-A is therefore established, and this gradient 
induces guided migration of endothelial cells toward hypoxic regions of the retina. 
As the vessels expand radially to vascularize the surface of the retina, they undergo 
 
Figure 14. Retinal vessel development in the mouse. 
Retinas from post-natal day 3 (P3, A), 5 (P5, B) and 7 (P7, C and D) mice were 
stained with Isolectin-B4, which binds to endothelial and microglial cells, and flat-
mounted for imaging. Endothelial cells migrate into the retina through the optic 
nerve head (O) and expand radially so that by P7, the entire surface of the retina is 
vascularized and a hierarchy of arteries (A), veins (V) and capillaries is formed. 
Furthermore, there is a new wave of endothelial sprouting commencing at P6-P7 
from the vein and venous vessels (arrows in C and D). These sprouts migrate 
perpendicular to the primary plexus to form two more vessel plexuses. Image D 
shows Claudin 5 (red) staining outlining endothelial tight junctions as well as 
filopodia of new endothelial sprouts (arrows). Bars, 100µm. 
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differentiation and extensive remodelling so that a hierarchical network of blood 
vessels comprising of arteries, veins and capillaries is formed. 
Two further vascular plexuses, the inner and outer deeper plexuses, develop 
in the retina independently of retinal astrocytes. At about 1 week after birth, 
endothelial cells sprout from veins, venules and capillaries near veins of the primary 
vascular plexus and migrate into the retina perpendicular to the primary plexus. This 
process commences from the centre of the retina and expands towards the periphery. 
It is likely that this process is stimulated by the transient expression of VEGF in the 
somatas located in the inner nuclear layer (INL) (Stone et al., 1995). These nascent 
sprouts grow along Müller cells, which are glial cells found in vertebrate retinas, and 
branch laterally when they reach the inner and outer boundaries of the INL to 
establish two further networks parallel to the primary plexus.  
 The post-natal retina has gained popularity as a model system to study 
angiogenesis in recent years. As vessels develop in a central to peripheral manner,  
vessels at the migrating front of the developing plexus are less mature compared to 
more central vessels. There is therefore a spatial separation of different aspects of 
angiogenesis such as vessel sprouting and anastomosis at the growing edge of the 
plexus, and tubulogenesis, arterial-venous differentiation and vessel regression at the 
 
Figure 15 Vascular networks in the retina. 
A schematic of a retinal cross-section (A, (Fruttiger, 2007)) and a cross section of a 
whole-mount P14 retina stained with Isolectin-B4 (B) showing the primary, inner 
deeper and outer deeper plexuses. RGC, retinal ganglion cells; IPL, inner plexiform 
layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear  
layer; RPE, retinal pigment epithelium.  
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more proximal plexus. Thus, it is possible to study and compare various 
morphogenic events in a temporal manner in the retinas of normal, as well as, mutant 
animals. Another advantage of the retina as a useful model is the flat nature of the 
primary plexus, which allows high-resolution imaging. 
 
1.4.2 ZEBRAFISH (DANIO RARIO) 
The developing zebrafish is another useful model system in which to examine the 
mechanisms of blood vessel formation and patterning during development because of 
its genetic and experimental accessibility and the optical clarity of the embryos 
(Vogel and Weinstein, 2000). In addition, the development of several tools has 
facilitated the study of developing blood vessels in living embryos in high resolution. 
The first of these is confocal microangiography, where small fluorescent 
microspheres are injected into the circulation of living embryos or larvae (Weinstein 
et al., 1995). Optical sections of the fluorescent blood vessels are then collected 
using a confocal microscope and with 3D rendering, the spatial structure of the 
functioning, patent vasculature is determined.  The second significant tool is the 
generation of transgenic fish that express fluorescent proteins specifically in blood 
vessels. To date, the most widely used such model is the Tg(fli1:EGFP)y1 transgenic 
fish, which expresses stable green fluorescent protein (GFP) under the endothelial 
fli1 promoter. The use of this fish has permitted the visualization of not only 
functional blood vessels but also non-patent vessels and even migrating progenitor 
cells (Isogai et al., 2001; Isogai et al., 2003) (Lawson and Weinstein, 2002). The 
third reason for its popularity is the possibility to knockdown gene expression in the 
embryos using morpholino antisense oligonucleotides. Morpholino oligonucleotides 
are specifically designed either to block translation or modify pre-mRNA splicing of 
the gene of interest, thereby permitting functional analysis of the gene during 
embryonic development. 
 The blood vessels of the developing trunk are ideal for studying the cues and 
mechanisms guiding vascular patterning during development (Isogai et al., 2003). At 
approximately 16.5 hours post-fertilization (hpf), the dorsal aorta and posterior 
cardinal vein (PCV) begin to form by vasculogenesis at the trunk midline and by 
approximately 23hpf, they develop a patent lumen and circulation initiates shortly 
thereafter. In contrast to the axial vessels, the intersegmental vessels (ISVs) and 
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parachordal vessels (PAV) form by angiogenesis that is independent of circulatory 
flow. At 19-20 hours post-fertilization (hpf), pairs of endothelial sprouts (termed 
primary sprouts) emerge bilaterally from the dorsal aorta adjacent to the vertical 
myotomal boundaries between somites. These primary sprouts grow dorsally 
between the somites and notochord and then between the somites and the neural 
tube, tracking along vertical myotomal boundaries. The endothelial tip cells of each 
sprout extend numerous dynamic filopodia during the process of sprout elongation. 
Once the ISVs reach the dorsolateral roof of the neural tube (at ~28hpf), they divide 
caudally and rostrally, elongate and then fuse with neighbouring tip cells to form the 
bilateral dorsal longitudinal anastomotic vessels (DLAVs). By 1.5 dpf, two 
completed lattices of endothelial vessels are present on each side of the trunk. As the 
formation of the primary, aorta-derived vessel network is completed, a new 
secondary set of vascular sprouts begins to emerge at ~1.5dpf. These secondary 
sprouts emerge exclusively from the posterior cardinal vein at every myotomal 
segment and grow dorsally, often towards and/or alongside the nearest primary 
vessel. Approximately half of the secondary sprouts eventually make a connection to 
the adjacent primary vessel segment, linking the PCV to the primary vascular 
network. Once this connection to the vein is made and the secondary vessel segment 
begins to carry robust venous blood flow, the adjacent ventral-most regions of the 
primary vessel will regress and disappear. This vessel then assumes its final identity 
as an intersegmental vein. The remaining secondary sprouts do not connect to 
adjacent primary vessel segments. Some simply regress and disappear, however, 
most contribute to the formation of and serve as ventral venous roots for a separate 
set of vessels, the parachordal vessels (PAVs). PAVs form along the horizontal 
myosepta to either side of the notochord. They are composed of the secondary 
sprouts from PCV and from additional sprouts that emerge form ISVs at the level of 
the horizontal myoseptum. When a secondary sprout forms a root for the parachordal 
system, the adjacent primary segment almost always becomes an intersegmental 
artery. Parachordal sprouts only rarely emerge from intersegmental arteries, and 
intersegmental arteries do no initially connect to the parachordal system (Isogai et 
al., 2003). 
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1.5 AIMS OF PHD 
Notch signalling has been described to regulate arterial-venous differentiation and 
also vascular smooth muscle differentiation. However, its role in the patterning of 
blood vessels during developmental angiogenesis had not yet been explored. Thus, 
one of the projects undertaken was to investigate whether the Notch signalling 
pathway regulates vessel patterning in the postnatal mouse retina. In a second 
project, I embarked on the study of the Notch target gene, Nrarp, to determine 
whether it has a role in angiogenesis. 
 
 
Figure 16 Anatomy of a 3dpf zebrafish trunk and its blood vessels. 
A, overview of a 2dpf Tg(fli1:EGFP)y1 transgenic fish that expresses GFP in its 
blood vessels. B, a cross-section cartoon of the zebrafish trunk (white line in A). At 
3dpf, intersegmental vessels have differentiated into either intersegmental arteries 
(ISA) or veins (ISVs) and are linked together dorsally via paired dorsal longitudinal 
anastomotic vessels (DLAV). There is active blood flow through the dorsal aorta 
(DA), posterior cardinal vein (PCV) and most intersegmental arteries (ISAs) and 
veins (ISVs). At this stage, parachordal vessels (PAVs) are developing longitudinally 
to either side of the notochord, along the horizontal myoseptum . The PAVs are 
linked to the PCV and ISVs (arrows). G, gut; M, myotomes; N, notochord; NT, 
neural tube; P, left pronephric duct; and Y, yolk mass. From (Isogai et al., 2003). 
A 
B 
B
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2 Methods and Material 
2.1 MOUSE EXPERIMENTS 
2.1.1   ANIMALS 
Mice were maintained by the Biological Resources Services provided by Cancer 
Research UK. All animal breeding and experiments conformed to legal and UK 
ethical standards. Unless otherwise stated, the different strains of transgenic mice 
(see Table 2) have been bred on a C57Bl6/J background.  
 
Mouse line Reference 
BAT-gal (Maretto et al., 2003) 
BATlacZ (Nakaya et al., 2005) 
Ctnnb1lox (Brault et al., 2001) 
Ctnnb1lox(Ex3) (Harada et al., 1999) 
Dll4 (ICR background) (Hellstrom et al., 2007) 
Lef1 (van Genderen et al., 1994) 
Pdgfb-iCreER (Claxton et al., 2008) 
Rosa26R-EYFP  (Srinivas et al., 2001) 
TNR  (Duncan et al., 2005) 
Table 2. List of mice used. 
 
Nrarp null mice were generated by Regeneron (New York, USA), where the 
entire coding sequence of the single-exon Nrarp gene was replaced by a LacZ gene 
fused to the endogenous ATG by the Volocigene technology (Figure 17; Valenzuela 
et al., 2003). Briefly, a bacterial artificial chromosome (BAC) containing the Nrarp 
gene was modified to replace the coding region by a LacZ gene. This vector was then 
linearized and used to target the Nrarp gene in F1H4 (C57Bl/6:129 hybrid) mouse 
embryonic stem (ES) cells. Correctly targeted ES cells were identified by using the 
loss of native allele (LONA) assay as described in (Valenzuela et al., 2003) and were 
used to generate chimaeric male mice that were complete transmitters of ES-derived 
sperm. Chimaeras were then bred to C57Bl6/J females to generate F1 mice, which 
were genotyped by LONA assay and β-galactosidase histochemical assays. In order 
to establish our own Nrarp mouse colony, frozen sperm from Nrarp+/- males were 
sent to the UK from the USA and were used for in vitro fertilization (IVF) in 
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C57Bl6/J mice. Nrarp+/- mice generated by in vitro fertilization were used for further 
breeding; offspring of appropriate Mendelian ratio were obtained. 
To activate Cre recombination in an inducible manner, 4OH-tamoxifen was 
injected intraperitoneally into early postnatal pups at 80µg/g.  
 
 
Figure 17. Generation of Nrarp knockout mice. 
 
2.1.2 ANIMAL EXPERIMENTS 
Experimental procedures on mice were conducted by myself, staff from the 
Biological Resources Service (Sue Watling, Craig Thrussell and Claire 
Darnborough) and my supervisor, Holger Gerhardt, who performed the intraocular 
injections. Unless otherwise stated, mice were culled by decapitation at the end of 
experiments before collecting eyes for analyses. 
2.1.2.1 Suppression of Notch signalling by γ-secretase inhibition. 
γ-secretase activity was inhibited pharmacologically using DAPT (N-[N-(3,5-
Difluorophenacetyl-L-alanyl)]-S-phenylglycine t-Butyl EsterMerck, Cat. No. 
565770). A working solution of 10mg/ml DAPT dissolved in 10% ethanol and 90% 
corn oil was prepared by addition of 50µl ethanol to 5mg DAPT, heating to 40°C for 
a few minutes until dissolved and addition of 450µl corn oil. The dissolved DAPT 
was used on the same day or stored at -20ºC for use the next day (warmed before 
use). Early postnatal mice were treated with DAPT at 100mg/kg (10µl/g of 10mg/ml 
working solution) 
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2.1.2.2 Genotyping 
Mouse Wildtype Mutant/transgenic allele 
Nrarp Fwd:GCTGCAGTCGCTGCTGCAGAAC 
Rev:CTCATCACCAAGGCCAAGTACG 242bp 
Fwd:ATACTGTCGTCGTCCCCTCAAACTG 
Rev:ACCACGCTCATCGATAATTTCA 600bp 
TNR  Fwd:ATGGTGAGCAAGGGCGAGGA 
Rev:TTACTTGTACAGCTCGTCCA 800bp 
BATlacZ  Fwd:ATACTGTCGTCGTCCCCTCAAACTG 
Rev:ACCACGCTCATCGATAATTTCAC 600bp 
Ctnnb1lox Fwd:AAGGTAGAGTGATGAAAGTTGTT 
Rev:CACCATGTCCTCTGTCTATTC 221bp 
Fwd:AAGGTAGAGTGATGAAAGTTGTT 
Rev:CACCATGTCCTCTGTCTATTC 324bp 
Ctnnb1lox(Ex3) Fwd:GCTGCGTGGACAATGGCTAC 
Rev:GCTTTTCTGTCCGGCTCCAT 359bp 
Fwd:gctgcgtggacaatggctac 
Rev:GCTTTTCTGTCCGGCTCCAT 550bp 
Pdgfb-
iCreER 
 Fwd:GCCGCCGGGATCACTCTCG 
Rev:CCAGCCGCCGTCGCAACTC 450bp 
Rosa26R-
EYFP  
Fwd:AAAGTCGCTCTGAGTTGTTAT 
Rev:GGAGCGGGAGAAATGGATATG 650bp 
Fwd:AAAGTCGCTCTGAGTTGTTAT 
Rev:GCGAAGAGTTTGTCCTCAACC 350bp 
Table 3. Primers used for genotyping. 
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subcutaneously for 3, 6 or 48 hours. For 48 hour treatments, mice were injected once 
a day for 2 days.  
2.1.2.3 Ectopic activation of Notch signalling by Jagged1 peptide treatment. 
Jagged1 (CDDYYYGFGCNKFCRPR) or scrambled (RCGPDCFDNYGRYKYCF) 
peptide was dissolved in 50% DMSO and 50% dH2O and injected at 500mg/kg 
subcutaneously for 6 or 48 hours. For 48 hour treatments, mice were injected twice a 
day at alternate sites for 2 days.  
2.1.2.4 BrdU administration for proliferation assay. 
A working stock of 10mg/ml bromodeoxyuridine (BrdU, Sigma) dissolved in PBS 
was prepared and stored at -20oC. Mice were injected once at 50 mg/kg (5µl/g of 
10mg/ml working solution) intraperitoneally and eyes were collected 3 hours later.  
2.1.2.5 Dll4-Fc administration 
Dll4-Fc and hFc were a gift from Regeneron (Lobov et al., 2007). A working 
solution of 10µg/µl peptide in sterile PBS was prepared fresh for each experiment 
and stored at 4°C. 4µg (in 0.4µl) of Dll4-Fc or hFc were injected once intraocularly 
and eyes were collected 24 hours later. To carry out this procedure, mice were deeply 
anaesthetized by isoflurane inhalation. Injections were performed using 10µl gastight 
Hamilton syringes equipped with 33 gauge needles attached to a micromanipulator.  
 
2.1.3 ENDOTHELIAL CELL ISOLATION AND CULTURE 
2.1.3.1 Tissue digestion 
Lungs were removed from mice and kept in DMEM (Dulbecco’s modified Eagle’s 
medium) containing 10% foetal calf serum, penicillin/streptomycin and amphotericin 
B on ice. Lungs were chopped into small pieces (e.g.1mm3 or as small as possible) 
using scissors in a Petri dish placed on ice. Tissue pieces were washed in 20ml 
Hank’s Buffered Salt Solution (HBSS, Ca2+/Mg2+-free) containing 
penicillin/streptomycin and amphotericin B in a 50ml Falcon tube. Lung pieces were 
poured through a 40µm cell strainer, placed on a 50ml Falcon tube, to remove blood 
constituents. Tissue pieces were digested in 5ml 2.4U/ml dispase II (GIBCO) in 
HBSS containing penicillin/streptomycin and amphotericin B for 1 hour at 37°C, 
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with rotation and occasional vortexing. At the end of incubation, the cell suspension 
was filtered through a 40µm cell and cells were pelleted by centrifugation at 
1200rpm for 3 min at 4°C.  
2.1.3.2 Endothelial cell isolation 
Cell pellets were resuspended in PBS containing 0.5% bovine serum albumin (BSA) 
and EDTA (PBS/BSA/EDTA). To prevent isolation of non-endothelial cells, cells 
were incubated with an irrelevant mouse antibody, anti-OKT8 (4µg/ml in 
PBS/BSA/EDTA), to block Fc receptors on macrophages for 20 minutes on ice with 
occasional agitation. This was followed by incubation of cells with rat anti-mouse 
CD31 (also known as PECAM-1; BD Pharmingen) at ~10µg/ml in PBS/BSA/EDTA 
for 30 minutes at 4°C with gentle shaking, and then goat anti-rat IgG microbeads for 
15 minutes at 4°C with gentle shaking. Microbead-coated endothelial cells were 
separated from non-endothelial cells using magnetic cell sorting using the MACS 
MS column (Miltenyi Biotec). 
2.1.3.3 Culture of mouse lung endothelial cells 
Isolated endothelial cells from 1 pair of lungs were seeded on 1 well of a 24-well 
culture plate that was coated with fibronectin and mouse recombinant Dll4 protein 
(R&D Systems). Cells were cultured in Endothelial Cell MV medium (PromoCell) 
supplemented with 10% FCS, 0.4% ECGs/H (this contains bovine hypothalamus 
extract supplemented with heparin), 0.1ng/ml epidermal growth factor, 1µg/ml 
hydrocortisone, 1ng/ml basic fibroblast growth factor, penicillin/ streptomycin, 
50ng/ml amphotericin B and glutamine at 37°C and 5% CO2. 
2.1.3.4 Culture of bEND5 cells 
The cell line bEND5 has been established from brain endothelial cells of BALB/c 
mice. Immortalisation has been carried out by infection of primary cells with 
retrovirus coding for the Polyoma virus middle T-antigen. bEND5 cells were 
cultured in DMEM supplemented with 10% FCS and penicillin/streptomycin at 37°C 
and 5% CO2. 
2.1.4 IMMUNOFLUORESCENCE STAINING 
For most immunofluorescent procedures, eyes were fixed for 2 hours at room 
temperature or overnight at 4°C in 4% paraformaldehyde (PFA) in phosphate 
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buffered saline (PBS). Eyes were then washed in PBS followed by dissection of 
retinas and removal of hyaloid vessels. An exception was when retinas were to be 
stained with antibodies against VE-cadherin and zona occludens-1 (ZO1). In this 
case, mice were anaesthetized by injection of a combination of Hypnovel 
(Midazolam) and Ketaset intraperitoneally before transcardiac perfusion with PBS 
until blood has drained from body. Eyes were subsequently removed, fixed briefly in 
4% PFA for 5-10 minutes at room temperature, and dissected in PBS to remove 
hyaloid vessels. Retinas were then flattened by making 4 to 5 incisions. Excess PBS 
was removed and retinas were fixed in cold methanol while flattened. Retinas were 
stored at -20°C in methanol until use. Before staining with antibodies, the retinas 
were rehydrated in increasing proportion of PBS/methanol and finally in PBS. 
Retinas were blocked in PBS containing 1% bovine serum albumin (BSA, 
Sigma) and 0.5% Tween-20 for 2 hours at room temperature. All antibodies were 
incubated for 2 hours at room temperature or overnight at 4°C in PBS containing 
0.5% BSA and 0.25% Tween-20 except for Isolectin-B4 and antibodies against 
Endomucin and NG2, which were incubated in PBS (pH6.8), 1% Tween-20, 1mM 
CaCl2, 1mM MgCl2 and 0.1mM MnCl2 (PBlec). Secondary antibodies conjugated 
with Alexa Fluor 488, 568 and 633 from Molecular Probes were used to detect 
primary antibodies. Retinas were washed in PBS containing 0.1% Tween-20 (PBT; 3 
times, 15 minutes each) in between antibody incubations. After antibody staining, 
retinas were post-fixed in 4% PFA for 15 minutes before flat-mounting in 
MOWIOL. For flat-mounting of retina, 4 to 5 short incisions were made and excess 
PBS removed.  
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Antibody Conjugated? Raised in… Reactivity Company Cat. No. Dilution 
β-catenin (Ctnnb1)   mouse clone 14 mouse BD Transduction      
BrdU    mouse   Molecular Probes A21300 1:50 
Claudin 5   mouse clone 4C3C2 mouse Zymed Lab. 35-2500 1:100 
Collagen IV   rabbit mouse AbD Serotec 2150-1470 1:100-1:200 
Delta-like 4  goat mouse R&D Systems AF1389 1:100 
Endomucin   rat mouse Dietmar Vestweber   1:20 
GFAP   rabbit mouse DakoCytomation Z0334 1:75 
GFAP Cy3 mouse mouse Sigma  C9205   
GFP   rabbit   Molecular Probes A11122 1:100 
GFP Alexa Fluor 488 rabbit   Molecular Probes A21311 1:100 
Isolectin B4 Biotin     Sigma  L2140 1:10 
Isolectin B4  Alexa Fluor 488     Molecular Probes I21411 1:100 
Isolectin B4  Alexa Fluor 568     Molecular Probes I21412 1:100 
NG2 (Chondroitin 
sulfate proteoglycan 4)   rabbit mouse Chemicon AB5320 1:100 
Notch 1 intracellular 
domain (NICD1)  Rabbit 
Human, 
mouse Abcam Ab8925  
VE-cadherin (CD144)   rat clone 11D4.1 mouse BD Biosciences 555289 10µg/ml 
Table 4. Antibodies used for immunofluorescent staining in mouse retinas. 
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2.1.4.1 Additional treatment before BrdU staining. 
Retinas were incubated with 10µg/ml Proteinase K in PBT for 20 minutes. Digestion 
was stopped by treatment of retinas with 2mg/ml glycine dissolved in PBT for 10 
minutes, washed in PBT (2 x 5 min), post-fixed in 4% PFA for 20 minutes and then 
washed in PBT. Retinas were treated with 0.1unit/µl DNase I diluted in 50mM Tris-
HCl, 10mM MgCl2, pH 7.5 for 2 hours at 37oC. DNase I was heat-inactivated by 
incubating samples for 10 minutes at 70oC with preheated 50 mM Tris-HCl, pH 7.5 
and then cooled on ice for 3 min. All steps were carried out at room temperature 
unless stated otherwise. Retinas were subsequently used for anti-BrdU staining. 
 
2.1.5 IN SITU HYBRIDIZATION (ISH) 
2.1.5.1 Isolation of RNA for cDNA generation 
Retinas were dissected from postnatal day 5 C57Bl6/J mice quickly and snap-frozen 
and stored at -80°C. Tissue was lysed in Buffer RLT (RNeasy Mini Kit, Qiagen) and 
homogenized using QiaShredder (Qiagen). Total RNA was isolated using the 
RNeasy Mini Kit, according to the manufacturer’s protocol. RNA was stored at -
80°C. 
2.1.5.2 Generation of vector encoding template of interest 
cDNA was generated by reverse transcription of RNA isolated from retina using 
SuperScript III (Invitrogen) and oligodT(20), according to the manufacturer’s 
guidelines. Primers designed to generate in situ probes were then used to amplify 
genes of interest (Table 5) using Taq DNA Polymerase HotMasterMix (Eppendorf). 
5µl of PCR reaction was run on an agarose gel to check that a product of the 
anticipated size was obtained. The PCR product in 2µl of the reaction mix was 
subsequently cloned into the pGEM- Easy (Promega) using the T4 DNA ligase 
according to the manufacturer’s instructions. Competent XL-Blue subcloning–grade 
competent cells (Stratagene) were transformed with ligated plasmid and cultured on 
LB agar containing ampicillin overnight at 37°C. Clones were picked, cultured in LB 
broth containing ampicillin and plasmid DNA was isolated. The correct sequence 
and orientation of insert was determined by DNA sequencing using the Applied 
Biosystems 3730 DNA Analyser and the ABI BigDye  chemistry. 
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Gene Forward primer (5’-3’) Reverse primer (5’-3’) Ta (°C) Size 
(bp) 
Nrarp ctagctctgcggcaacatga agcccggtaatggttgtttg 64 830 
Vegfa agccagaaaatcactgtgagc aagaaaatggcgaatccagtc 60 418 
Table 5. Primers used for generating in situ riboprobe. 
 
2.1.5.3 In vitro transcription 
Plasmids containing template for riboprobe generation were linearized ( 
 Table 6). In vitro transcription was performed by adding 1µg linearized DNA, 1X 
transcription buffer, 1X DIG-labelled RNA Labelling Mix (2µl; Roche), 25U/µl 
RNase inhibitor (Promega) and 2U/µl T7 RNA polymerase (Stratagene) in nuclease-
free water to a total volume of 20µl. Incubated reaction in 37°C for 2 hours. To test 
probe quality, 0.5µl of reaction mix was run on a 1% agarose gel. At the end of the 
transcription, 2µl RNAse-free DNase I (Ambion) was added to the reaction and 
incubated for 30 minutes at 37°C. To precipitate the riboprobe, 2.5µl 4M lithium 
chloride and 75µl cold ethanol were added to the reaction, mixed well and incubated 
at -80°C for 30 minutes or -20°C overnight. Precipitated RNA was pelleted by 
centrifugation at 13,200 rpm at 4°C. RNA concentration was measured using a 
NanoDrop ND-1000 spectrophotometer. An equal volume of hybridization mix was 
added to the resuspended riboprobe and stored at -20°C. 
 Table 6. Enzymes used to generate antisense riboprobes. 
2.1.5.4 Tissue preparation 
Eyes were fixed for 1 to 2 hours in 4% PFA and washed briefly in PBS. Eyes were 
dissected in PBS to remove hyaloid vessels and then returned to 4% PFA for 
Gene Restriction enzyme RNA polymerase Vector 
Dll4 EcoR1 T7 pBluscript SK+ 
Nrarp Sal1 T7 pGEM-T Easy 
Pdgfb XbaI T7 pBluscript SK+ 
Vegfa Sal1 T7 pGEM-T Easy 
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continued fixation overnight at 4°C. The next day, eyes were washed in PBS and 
retinas were flattened by making 4 to 5 incisions. Excess PBS was removed and 
retinas were fixed in cold methanol while flattened. Retinas were stored at -80°C in 
methanol until use. 
2.1.5.5 Buffers and reagents required for ISH 
2.1.5.5.1 Hybridization mix 
50% deionized formamide (Sigma), 1.3X SSC, 5mM EDTA (2-[2-
(Bis(carboxymethyl) amino)ethyl-(carboxymethyl)amino]acetic acid), 50Mg/ml 
yeast RNA (Sigma), 0.2% Tween-20, 0.5% CHAPS (3-[(3-Cholamidopropyl) 
dimethylammonio]-1-propane sulfonate; Sigma) and 50mg/ml heparin (Sigma) 
prepared in nuclease-free water.  
2.1.5.5.2 TBST 
137mM NaCl, 2.7mM KCl, 25mM Tris-HCl, pH7.5, 0.1% Tween-20 and 2mM 
levamisole hydrochloride (Sigma) in Milli-Q water (ultrapure laboratory grade water 
that has been filtered and purified through reverse osmosis). 
2.1.5.5.3 MABT 
0.1M Maleic acid, pH 7.5, 0.15M NaCl and 1% Tween-20 in Millipore water. 
MABT was made fresh on the day of use. 
2.1.5.5.4 NTMT 
100mM NaCl, 100mM Tris-Cl, pH9.5, 50mM MgCl2, 0.1% Tween 20 and 2mM 
levamisole in Milli-Q water.  
2.1.5.6 Wholemount retina ISH 
Reagents were prepared or diluted in PBT unless stated otherwise. Incubations were 
carried out at room temperature except where indicated. Solutions used on Day 1 
were prepared in an RNAase-free manner. 
2.1.5.6.1 Day 1 – Pre-treatments and hybridization 
Retinas were rehydrated in 75%, 50% and 25% methanol, and finally in PBT for 5 
min at each step. This was followed by bleaching in 6% hydrogen peroxide for 1 
hour and washes in PBT. Retinas were digested in 10µg/ml Proteinase K for 25 
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minutes followed by incubation in 2mg/ml glycine and washes in PBT. Retinas were 
fixed in 4% PFA/0.1% glutaraldehyde for 20 minutes, washed in PBT, rinsed in 1:1 
PBT/hybridisation mix and then in hybridisation mix for 1 hour at 65°C. Retinas 
were then incubated with approximately 0.2µg/ml DIG-labelled RNA probe diluted 
in hybridization mix overnight at 65°C with gentle and intermittent shaking. 
2.1.5.6.2 Day 2 – Post-hybridization washes 
Hybridization mix containing RNA probe was removed from retinas and stored for 
future use at -20°C. While keeping samples on the heating block, retinas were rinsed 
twice with pre-warmed hybridization mix. This was followed by further washes: 2 x 
30 minutes in pre-warmed hybridization mix at 65°C, 20 minutes in 1:1 
hybridization mix/TBST at 65°C and 2 x 30 minutes in TBST at room temperature. 
Finally, retinas were incubated in MABT for more than 1 hour before incubation 
overnight at 4°C with anti-digoxigenin-alkaline phosphatase (AP), Fab fragments 
(Roche) diluted 1:1000 in MABT containing 10% sheep serum. 
2.1.5.6.3 Day 3 – Post-antibody washes 
Retinas were washed throughout the day at room temperature and overnight at 4°C in 
MABT. 
2.1.5.6.4 Day 4 –Colorimetric detection 
Retinas were washed in NTMT before incubation in NBT (Nitro-Blue Tetrazolium 
Chloride; Roche)/BCIP (5-Bromo-4-Chloro-3'-Indolyphosphate p-Toluidine Salt; 
Roche) diluted in NTMT at room temperature. Some probes required a longer 
incubation period such that retinas were left overnight at 4°C in NBT /BCIP. 
2.1.5.7 Counterstaining with antibodies 
After colorimetric detection of RNA, the retinas were washed in PBS and post-fixed 
in 4% PFA. This was followed by incubation with Isolectin-B4 or GFAP (see 2.1.4 
for procedure). 
 
2.1.6 REAL-TIME PCR 
2.1.6.1 RNA isolation 
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Eyes were immediately placed in RNALater (Qiagen) after removal from animals 
and kept at 4°C. Retinas were dissected in RNALater, snap-frozen on dry-ice and 
stored at -80°C until use. To isolate RNA, 1 or 2 retinas were lysed in Buffer RLT 
(RNeasy Mini Kit, Qiagen) and homogenized using QiaShredder (Qiagen). Total 
RNA was isolated using the RNeasy Mini Kit, according to the manufacturer’s 
protocol. An on-column DNAse I (Qiagen) reaction was carried out to remove 
genomic DNA. RNA concentration was measured using a NanoDrop ND-1000 
spectrophotometer and stored at -80°C. 
2.1.6.2 cDNA synthesis 
cDNA was generated by reverse transcription of RNA isolated from retinas using 
SuperScript III (Invitrogen) and oligodT(20), according to the manufacturer’s 
guidelines. A final incubation with RNase H was carried out at 37°C for 20 minutes. 
The reverse transcription reaction was used immediately for PCR or stored at -20°C 
for a few days before use. An exception was when isolated endothelial cells from 
mouse lungs were used for qPCR analysis. In these experiments, the TaqMan Gene 
Expression Cell-to-Ct Kit (Applied Biosystems) was used to lyse and synthesize 
cDNA from the cells. 
2.1.6.3 Relative quantitative PCR 
TaqMan Gene Expression Assays developed by Applied Biosystems were used for 
relative quantitative PCR (qPCR) experiments to compare differences in gene 
expression between different treatment groups or between animals of different 
genotypes. The TaqMan Gene Expression Assay is a pre-formulated assay that 
contains 2 unlabelled PCR primers (900nM each final concentration) and 1 FAM 
dye-labelled TaqMan MGB probe (250nM final concentration) specific for the gene 
of interest. Duplex PCR reactions were carried out; primers and VIC-labelled MGB 
probe for endogenous β-actin were added into each reaction containing specific 
primers and probes for the gene of interest (see Table 7). Reactions were performed 
in duplicates. PCR was carried out in TaqMan Universal PCR Master Mix (Applied 
Biosystems) using Applied Biosystems 7900HT sequence detection system. Gene 
expression was normalized to the endogenous control, β-actin, and an average ΔCt 
value was calculated for each animal. 
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Gene Product number 
CyclinD1 Mm00432360_m1 
Dll4 Mm00444619_m1 
Flt1 (VEGFR1) Mm00438980_m1 
Hey1 Mm00468865_m1 
Hey2 Mm00469280_m1 
Kdr (VEGFR2) Mm00440099_m1 
Lnfg Mm00456128_m1 
Nrarp Mm00482529_s1 
Nrp1 Mm00435372_m1 
Pdgfb Mm00440678_m1    
Slc2a Mm00441473_m1 
Vegfa Mm00437304_m1 
         Table 7. TaqMan probes used. 
 
2.1.7 SDS-PAGE AND WESTERN BLOTTING 
Retinas were lysed in RIPA buffer (50mM Tris-HCl, pH 7.5, 150mM NaCl, 1mM 
EDTA, 1% Nonidet P-40, 0.25% Na-deoxycholate and protease inhibitor mixture). 
Protein was quantified by bicinchoninic acid assay (Pierce). 30µg protein were 
separated by NuPAGE Novex Bis-Tris Gel (Invitrogen) and transferred onto 
polyvinylidene difluoride membranes (Amersham). Membranes were incubated with 
mouse anti-LEF1 (Chemicon) and rabbit anti-actin (Sigma). Binding of antibodies to 
the blots was detected using chemiluminescence ECL Western Blotting detection 
reagent (Amersham). 
2.1.8 CONFOCAL IMAGING 
Confocal laser scanning microscopy was performed using a Zeiss LSM 510 Meta 
microscope. Objectives frequently used were: 63x water immersion NA1.2 C-
APOCHROMAT (especially for endothelial tip cells), 40x water immersion NA1.2 
C-APOCHROMAT, 25x water immersion NA0.8 Plan-NEOFLUAR and 2.5x 
NA0.075 Plan-NEOFLUAR (for overviews of retinas).  
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2.1.9 METHODS USED FOR QUANTIFYING VESSEL FEATURES. 
2.1.9.1 Radial expansion of retinal vasculature  
For vessel migration, the distance of vessel growth from the optic nerve to the 
periphery was measured. 4 to 5 measurements were made from each retina per 
animal. The average distance of vessel migration per animal was used in 
comparisons between animals of different genotypes. 
2.1.9.2 Quantification of vessel branchpoints 
To assess vessel density, the number of vessel branchpoints in 100µm2 fields was 
counted. At least 6 images of the capillary plexuses or vascular fronts were taken 
from each animal and at least 3 animals per genotype were analyzed. A 40X 
objection was used to take the images.  
2.1.9.3 Filopodia quantification 
Images of endothelial tip cells were taken with a 40X objective in settings that 
revealed the filopodia clearly. The number of filopodia at the circumference of the 
vascular front was counted. The number of filopodia/100µm distance was plotted.  
2.1.9.4 Quantification of vessel regression  
For vessel regression, the skeletal length of Isolectin-B4-positive and collagen IV-
positive vessels was measured and the ratio calculated (Figure 18). 
 
       Figure 18. Quantification of vessel regression. 
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2.1.9.5 Proliferation 
The number of BrdU-positive endothelial cells in 10,000µm3 volume of vessels 
(measured by Volocity software, Improvision, UK) in the sprouting vascular front 
was counted. 
2.1.10  STATISTICAL ANALYSES 
Statistical analysis was performed with Prism 5 software (GraphPad) using two-
tailed, unpaired t test. 
 
2.2 ZEBRAFISH EXPERIMENTS 
2.2.1 GENERAL CARE 
Zebrafish were maintained at 28°C in dechlorinated London tap water on a 14/10 
hour light/dark cycle. Embryos were collected from spontaneous spawning. Staging 
was according to Kimmer et al (Kimmel et al., 1995). 
 
2.2.2 TRANSGENIC FISH 
Tg(fli1:EGFP)y1 (Lawson and Weinstein, 2002) embryos were obtained by crossing 
GFP-positive (either heterozygous or homozygous) adults. 
 
2.2.3 MORPHOLINO INJECTION 
Antisense morpholino oligonucleotides (Gene Tools) were diluted in Danieau buffer 
(58mM NaCl, 0.4mM MgSO4, 0.6mM Ca(NO3), 5mM HEPES, pH 7.1-7.3) 
containing 0.2% phenol red. 2nL oligonucleotide was injected into the yolk of 2- to 
4-cell-stage embryos. The morpholinos used (Table 8) were published by (Ishitani et 
al., 2005), where the authors showed significant knockdown in the protein expression 
of Nrarp-a, Nrarp-b and Lef1. The control oligonucleotide is the standard control 
offered by Gene Tools that should have no target or no significant biological activity 
in zebrafish. 
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Morpholino Dose/embryo Sequence 
nrarp-a 5 or 10ng 5′-GATGCTTCACACTGGGAGAAACTCG-3′ 
nrarp-b 10ng 5′-ATGATTTCAGCAGG TTGACCAAAACG-3′ 
lef1 2ng 5’-CTCCTCCACCTGACAACTGCGGCAT-3’ 
control 2, 5 or 10ng 5'-CCT CTT ACC TCA GTT ACA ATT TAT A-3' 
Table 8. Morpholino sequences. 
 
2.2.4 WHOLEMOUNT IN SITU HYBRIDIZATION 
Wholemount zebrafish ISH was performed according to Ariza-McNaughton and 
Krumlauf (Ariza-McNaughton and Krumlauf, 2002) and is similar to that described 
in 2.1.5.6 for wholemount retina ISH. A difference was in the washing step on Day 
3, when embryos were washed in PBS containing 0.1% Tween-20 for 2-4 hours at 
room temperature. 
2.2.5 WHOLEMOUNT IMMUNOFLUORESCENCE 
Embryos were dechorionated before fixation in 4% PFA for 2 hours at room 
temperature or overnight at 4°C. This was followed by washes and storage of 
embryos in PBS containing 0.1% Tween-20 (PBT). For GFP staining, embryos were 
incubated in rabbit anti-GFP-Alexa Fluor 488 antibody (Molecular Probe) in PBS 
containing 0.5% BSA and 0.25% Tween-20. Embryos were post-fixed in 4% PFA 
after staining with antibodies. 
2.2.5.1 Zona occludens 1 (ZO-1) staining 
This staining protocol was kindly provided by Yannick Blum and Markus Affolter 
from Biozentrum, Basel, Switzerland. Embryos were blocked in PBS containing 
0.1% Tween-20 and 0.1% Triton-X (PBTX) containing 10% BSA and 1% normal 
goat serum for 2 hours and incubated in mouse anti-human ZO-1 (1:200 dilution; 
Zymed) in PBTX containing 1% BSA and 0.1% goat serum overnight at 4°C. 
Embryos were then washed in PBTX containing 1% BSA and 0.1% goat serum for 6 
hours (with changes) and incubated with goat anti-mouse Alexa Flour 568 antibody 
in PBTX containing 1% BSA and 0.1% goat serum overnight at 4°C and washed in 
PBT. 
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2.2.5.2 Collagen XII staining 
The anti-Collagen XII antibody and staining protocol were generously provided by 
Florence Ruggiero and Hanah Bader, Lyon. Embryos were permeabilized in acetone 
for 1 hour at -20°C and then washed in water and PBT. This was followed by 
blocking in PBS containing 2% normal goat serum, 1% BSA, 1% DMSO and 0.1% 
Tween-20 (PSBDT) for 30 minutes at room temperature. Guinea pig anti-Collagen 
XII antibody (1:250 dilution) was incubated in PSBDT overnight at 4°C. The next 
day, the embryos were washed in PBS containing 1% DMSO and 0.1% Tween-20 
(PDT) for 2 hours with several changes of wash buffer. Goat anti-guinea pig 
conjugated to Rhodamine (Abcam) was incubated in PSBDT overnight at 4°C and 
embryos were washed in PDT. 
 
2.2.6 PROLIFERATION ASSAY 
A stock of 5% BrdU dissolved in water was diluted to 0.5% in E3 Buffer (5mM 
NaCl, 0.17mM KCl, 0.33mM CalCl2, 0.33mM MgSO4). At 19hpf, Tg(fli1:EGFP)y1 
embryos were transferred to E3 buffer containing 0.5% BrdU until 48hpf, when 
embryos were fixed in 4% PFA for 2 hours at room temperature or overnight at 4ºC. 
Embryos were then washed in PBT, rinsed once in methanol and incubated in 
methanol at -20ºC for 1 hour. Embryos were then permeabilized in 20% DMSO/80% 
MeOH at room temperature for at least 2 hours with gentle rocking and rehydrated in 
50% and 25%PBT/MeOH and finally PBT (10 minutes each). Embryos were washed 
in water for 10 minutes, and incubated for 1 hour in 2N HCl at room temperature 
with gentle rocking. This was followed by washes in PBT and incubation in PBS 
containing 1% BSA and 0. 5% Tween-20 for 1-2 hours. To detect BrdU, the embryos 
were incubated with mouse anti-BrdU antibody (1:50 dilution; Molecular Probes) in 
PBS containing 0.5% BSA and 0.25% Tween 20 overnight at 4ºC, washed in PBT 
for 1 hour and incubated in goat anti-mouse IgG1 Alexa Fluor-568 antibody in PBS 
containing 0.5% BSA and 0.25% Tween-20 overnight at 4ºC. 
 
2.2.7 TUNEL ASSAY 
Embryos were fixed in 4% PFA for 2 hours at room temperature or overnight at 4ºC. 
Embryos were then washed in PBT, rinsed once in methanol and incubated in 
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methanol at -20ºC for at least 1 hour. Embryos were then permeabilized in 20% 
DMSO/80% MeOH at room temperature for at least 2 hours with gentle rocking and 
rehydrated in 50% and 25%PBT/MeOH and finally PBT (10 minutes each). They 
were blocked in PBS containing 0.25mg/ml BSA for 10 minutes. Apoptosis was 
detected by using the In Situ Cell Death Detection Kit containing TMR red labelling 
nucleotides (Roche) according to the protocol provided by the manufacturer. 
 
2.2.8 CONFOCAL MICROSCOPY 
Confocal laser scanning microscopy was performed using a Zeiss LSM 510 
microscope. For live imaging of Tg(fli1:EGFP)y1 zebrafish, the embryos were 
anaesthetized in aquarium water containing 320µg/ml Tricaine (Sigma) and mounted 
on a glass-bottom dish (MatTek) in 0.2% agarose. Images were captured with a Zeiss 
LSM 510 Meta inverted confocal microscope using a 40X NA1.2 water immersion 
lens. Embryos were maintained at 28ºC in an environmental chamber during the 
course of the experiment. 
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3 Notch signalling regulates endothelial tip and stalk cell 
formation 
3.1 INTRODUCTION 
The formation of endothelial tip cells is required for directed vessel migration and 
patterning. Thus far, the regulation of tip cell selection has been attributed to VEGF 
signalling through Kdr (VEGFR2) (Gerhardt et al., 2003). The aim of the work 
described in this chapter is to investigate whether Notch signalling also modulates tip 
cell selection using the early post-natal mouse retina as a model system. This 
hypothesis is extrapolated from the observation that tip cells express the endothelial 
specific Notch ligand, Dll4 (Claxton and Fruttiger, 2004).  
 This project was highly collaborative involving close interactions between 
the laboratories of Holger Gerhardt and Christer Betsholz in Sweden. In the 
following pages, I shall describe the experiments that I performed in this project. 
Most of my experiments are pharmacological manipulations of the Notch pathway 
whereas the Betsholz Lab performed the genetic experiments and analyses. The 
conclusions that I will later state are based on the combined results of these studies 
and in some regions of the text, I will cite our published article ‘Hellstrom et al., 
2007’ to refer to data that was generated by our collaborators and not by myself.  
 
3.2 RESULTS 
3.2.1 NOTCH ACTIVITY DURING SPROUTING ANGIOGENESIS. 
During sprouting angiogenesis in the retina, Dll4 mRNA is highly expressed in 
endothelial cells at the leading front of the migrating vasculature in a salt-and-pepper 
manner ((Claxton and Fruttiger, 2004), Figure 25B). However, localization of 
endothelial Notch activity has not been demonstrated. We therefore investigated 
endothelial Notch activity by using a transgenic Notch reporter mouse (TNR) that 
has a transgene composed of a CBF-1 response element with four CBF-1 binding 
sites and a minimal SV40 promoter followed by an enhance green fluorescent protein 
(EGFP) sequence (Duncan et al., 2005). We observed Notch signalling, as shown by 
GFP expression, in endothelial cells of the developing retinal vasculature in a non- 
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Figure 19. Dll4 expression and Notch signalling in migrating blood vessels of 
early postnatal mouse retina. 
P5 retinas from TNR mice were stained with anti-GFP (green), anti-Dll4 (red), 
Isolectin-B4 (blue or grey) and DAPI (nuclear blue). A, Notch signalling (green) is 
detected in a subset of endothelial cells at the migrating vascular front. Some 
microglial cells also display Notch activity. Note that some extravasated erythrocytes 
(bottom left of image) autofluoresce (green). B, Dll4 protein is often found localized 
to cell membrane (arrowheads); however, it is also localized intracellularly (arrow), 
indicating that the ligand had recently undergone ligand-receptor activation and 
subsequent endocytosis. This intracellular localization of Dll4 is commonly detected 
in tip cells. In B’ and B”, Notch signalling is activated in stalk cells adjacent to tip 
cells with intracellular Dll4 protein, suggesting lateral signalling occurs between 
endothelial tip and stalk cells. T, tip cell; S, stalk cell. 
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Figure 20. Dll4 expression and Notch signalling in artery and arterioles of early 
postnatal mouse retina. 
P5 retinas from TNR mice were stained with anti-GFP (green), anti-Dll4 (red), 
Isolectin-B4 (blue). Notch signalling is intermittent in endothelial cells of arteries 
and arterioles. There is also active Dll4-Notch signalling as indicated by intracellular 
localization of Dll4 in some endothelial cells lining the artery (C, arrows). Microglial 
cells also express Dll4 (m in C). 
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uniform manner (Figure 19). At the sprouting front, we detected endothelial cells 
with active Notch signalling amid endothelial cells without Notch signalling (Figure 
19A,B). There is also a similar pattern of Notch-active and –inactive endothelial cells 
in arteries (Figure 20). Notch activity was also detected in other cell types such as 
microglial cells (Figure 20C).  
Staining with an anti-Dll4 antibody revealed widespread membrane-localized 
Dll4 expression (Figure 19B, Figure 20). However, in some endothelial cells, Dll4 
was internalized to a perinuclear localization (Figure 19, Figure 20C), indicating 
previous engagement with Notch receptor and consequent activation of Notch 
signalling in the adjacent cell. This is exemplified in Figure 19B’ and B’’ where 
endothelial tip cells of vascular sprouts display internalized Dll4 but not Notch 
signalling whereas the adjacent stalk cells have Notch activity. In addition, there are 
regions where endothelial cells display both internalized Dll4 as well as Notch 
signalling (Figure 19B and Figure 20). This observation can be explained by the long 
half-life of eGFP protein, which does not give a true depiction of the transient nature 
of Notch signalling. Alternatively, due to the multicellular organization of blood 
vessels, it is also possible that an adjacent cell expressing a Notch ligand could at the 
same time stimulate the cell with internalized Dll4, therefore triggering Notch 
activity. 
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3.2.2 SUPPRESSION OF NOTCH SIGNALLING IN VIVO BY DAPT RESULTS IN 
EXCESSIVE FILOPODIA FORMATION AND INCREASE IN VESSEL SPROUTING 
AND DENSITY. 
To investigate the function of endothelial Notch signalling during sprouting 
angiogenesis, early postnatal mice (P4 or P5) were treated subcutaneously with 
DAPT, a γ-secretase inhibitor, at 100mg/kg. γ-secretase is required for Notch 
activation by catalyzing the proteolytic cleavage of the Notch intracellular domain 
(NICD) from the plasma membrane.  Treatment with DAPT for 3 hours resulted in 
an increase in endothelial filopodia protrusion at the migrating front of the 
vasculature (Figure 21B, E) when compared with vehicle-treated animals (Figure 
21A). 6-hour treatment led to an increase in filopodia protrusion (Figure 21D, E) as 
well as an increase in vessel density (Figure 22B). Prolonged treatment (48 hours) 
produced a vascular plexus that is even denser. Quantification of vessel branchpoints 
revealed a significant increase in vessel density after 48 hours of DAPT treatment 
when compared to vehicle-treated animals (Figure 22C-E). The ectopic increase in 
sprouting after DAPT treatment occurred in the retinal region that underwent 
vascularization during the period of treatment, indicating that the effect of γ-
secretase inhibition was strongest in actively migrating endothelial cells of 
developing vessels compared to endothelial cells of formed vessels. 
 Filopodia protrusion is a morphological feature of endothelial tip cells. To 
examine whether the observed increase in filopodia formation after DAPT treatment 
was a consequence of increased tip cell formation, the expression of Pdgfb, which is 
a tip cell indicator, was investigated using wholemount in situ hybridization (ISH) 
and quantitative PCR (qPCR) using RNA isolated from retinas of P5 animals treated 
with vehicle or DAPT for 6 hours (Figure 23). Both techniques revealed a significant 
increase in endothelial cells expressing Pdgfb after inhibition of γ-secretase activity. 
Combined with the observed increase in filopodia, these data indicate an increase in 
endothelial tip cell formation after DAPT treatment. 
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Figure 21. DAPT treatment leads to increased filopodia protrusion. 
Early postnatal mice (P4-P5) were treated with DAPT at 100mg/kg subcutaneously. 
Retinas were stained with Isolectin-B4 and analyzed at 3 (A, B) or 6 (C, D) hours 
post-treatment. E, Graph illustrates the number of filopodia protrusion per vessel 
length at the migrating vascular front of P5 mice that have been treated with either 
vehicle or DAPT for 3 or 6 hours. n ≥ 20. ***, p < 0.0001. Values represent mean ± 
S.E.M. 
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Figure 22. DAPT treatment increases vessel density. 
Early postnatal mice (P4-P5) were treated with DAPT at 100mg/kg subcutaneously. 
Retinas were stained with Isolectin-B4 and analyzed 6 (A, B) or 48 (C, D) hours 
post-treatment. E, Graph illustrates the number of branchpoints per image field of P7 
mice that have been treated with either vehicle or DAPT for 48h (P5 to P7). n ≥ 10. 
***, p < 0.0001. Values represent mean ± S.E.M. 
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Figure 23. Increase in endothelial Pdgfb expression after DAPT treatment. 
Pdgfb ISH (blue) of P5 retinas after 6h of vehicle (A) or DAPT (B) treatment. 
Retinas were counterstained with Isolectin-B4 (green). Graph in C illustrates the 
percentage of vessels expressing Pdgfb mRNA in 6h vehicle- and DAPT-treated 
retinas. ***, p > 0.0001; n = 10. D shows relative expression of Pdgfb in retinas of 
P5 animals after 6h vehicle or DAPT treatment. *, p = 0.026; n ≥ 7. Values represent 
mean ± S.E.M. 
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3.2.3 DAPT TREATMENT INHIBITS ENDOTHELIAL NOTCH SIGNALLING. 
In addition to Notch receptors, γ-secretase also cleaves other molecules such as 
CD44, E-cadherin and ErbB-4, which are modulators of angiogenesis (Boulton et al., 
2008). It was therefore important to determine whether Notch activity was altered 
after DAPT treatment and that the morphological changes in endothelial cells were a 
result of altered Notch signalling. Two approaches were used to examine Notch 
activity after short-term treatment of mice with DAPT: i) assessment of Notch 
receptor cleavage by using an antibody against Notch1 intracellular domain (NICD1) 
and ii), transcriptional regulation of downstream endothelial Notch target genes 
Hey1, Hey2 and Nrarp in the retina by qPCR and ISH.  
 In retinas of control mice that have been treated with vehicle for 3 hours, the 
NICD1 antibody labelled the nuclei of endothelial cells at the leading front of 
angiogenic vessels as well as those of microglia and astrocytes (Figure 24A). At the 
sprouting front, nuclear NICD1 staining was observed in many but not all endothelial 
cells. However, after 3 hours DAPT treatment, there was a marked decrease in 
endothelial nuclear NICD1 staining (Figure 24B), indicating a decrease in Notch1 
proteolysis by γ-secretase. 
 Inhibition of γ-secretase activity for 6 hours resulted in a decrease of ~25% in 
Hey1 and Hey2 expression and a significant decrease of ~70% in Nrarp expression 
(p < 0.0001) when compared to control retinas (Figure 24E). To determine whether 
there was down-regulation of Notch-induced transcription in endothelial cells, 
whole-mount retinal ISH was performed for Nrarp mRNA expression. In control 
retinas, Nrarp expression is prominent in endothelial stalk cells at the vascular front; 
however, this endothelial expression decreased after 6h DAPT treatment (Figure 
24D). Together with the NICD1 immunofluorescence data, the Nrarp ISH 
experiments show that short-term DAPT treatment inhibited Notch activity in retinal 
endothelial cells. 
 As Notch signalling also regulates the expression of Notch ligands such as 
Dll1 (de la Pompa et al., 1997), the expression of the endothelial specific Notch 
ligand, Dll4, in the retina was also examined after 6 hours of DAPT treatment by 
ISH and qPCR. The qPCR result showed a significant decrease of 20% in Dll4 
expression compared to control retinas (p = 0.0286; Figure 25A), suggesting that 
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Figure 24. Short-term DAPT treatment in vivo leads to down-regulation of 
endothelial Notch signalling in the retina. 
A and B, Immunofluorescence of Notch1 intracellular domain (NICD1, green) in the 
vascular front of P5 retinas. Red, Isolectin-B4; Blue, DAPI. Arrows point to 
endothelial nuclear localization of NICD1, indicating active Notch signalling. 
Arrowheads indicate endothelial cells that lack Notch signalling. There is a decrease 
in NICD1 staining after 3 hours DAPT treatment (B). C and D, Nrarp ISH in P5 
retinas. There is a marked decrease in endothelial Nrarp mRNA expression after 6h 
DAPT treatment. E, qPCR of Notch target genes. There is a decrease in retinal 
expression of Hey1, Hey2 and Nrarp after 6h DAPT treatment. ***, p < 0.0001. 
Control, n = 9; DAPT, n = 11. Values represent mean ± S.E.M. 
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Figure 25. Short-term DAPT treatment alters Dll4 expression in vivo. 
After DAPT treatment for 6 hours in P5 mice, retina Dll4 qPCR and ISH were 
performed. A, qPCR data shows a significant decrease in retinal Dll4 mRNA 
expression after DAPT treatment. *, p = 0.0286. Control, n = 9; DAPT, n = 11. 
Values represent mean ± S.E.M. Dll4 ISH, however, shows a more widespread 
expression of Dll4 (blue), indicated by the red line with arrows, after DAPT 
treatment (C) compared to vehicle-treated mice (B).  
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Notch signalling induces Dll4 expression. However, the ISH experiment showed a 
more diffused expression of Dll4 in the endothelial cells at the migrating front of the 
vessels when compared to the control retinas, where Dll4 expression in endothelial 
cells is more distinct and salt-and-pepper-like (Figure 25B,C). A possible 
explanation for this diffused expression pattern is the loss of Notch-induced lateral 
inhibition. Lateral inhibition creates a feedback loop that renders the level of ligand 
expression in neighbouring cells interdependent i.e. an increase in the expression of a 
ligand in one cell will drive the decrease in its neighbours. In the case of DAPT-
treated animals, there is a decrease in endothelial Notch activity and therefore Notch-
induced lateral inhibition, which may result in unregulated and more diffused Dll4 
expression even though the level of expression was decreased. 
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3.2.4 GENETIC DELETION OF DLL4 IN MICE LEADS TO INCREASED TIP CELL 
FORMATION. 
Mice with Dll4 haploinsufficiency are embryonically lethal (Duarte et al., 2004; Gale 
et al., 2004; Krebs et al., 2004). However, some Dll4+/- mice survive when Dll4+/- 
embryonic stem cells are injected into ICD host embryos and bred on an ICD 
background (Duarte et al., 2004). It was therefore possible to study the function of 
Dll4 during sprouting angiogenesis in early post-natal mouse retina. Loss of one Dll4 
allele in mice resulted in a vascular phenotype that is very similar to mice that have 
been treated with DAPT or other γ-secretase inhibitors: blood vessels displayed an 
increase in filopodia protrusion and vessel density (Figure 26, Hellstrom et al., 2007; 
Lobov et al., 2007; Suchting et al., 2007)).  In addition, by performing retina ISH and 
qPCR, there was an increase in the tip cell indicator Pdgfb in Dll4+/- mice (Figure 
26), indicating that there was an increase in endothelial tip cell formation.  
Together, data from the DAPT experiments and genetic inactivation of one 
Dll4 allele in mice demonstrate that endothelial Notch signalling negatively regulates 
endothelial tip cell formation. The loss of Notch signalling increased endothelial 
sprouting as a consequence of increased tip cell formation.  
 
 
Figure 26. Increase in tip cell indicator Pdgfb in Dll4+/- retinas. 
ISH of Pdgfb expression (blue) in P5 Dll4+/+ (A) and Dll4+/- (B) retinas. Retinas have 
been counterstained with Isolectin-B4 (green).  
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3.2.5 ALTERATION OF VEGF-A AND VEGF RECEPTOR EXPRESSION AFTER 
INHIBITION OF NOTCH SIGNALLING. 
Endothelial tip cell filopodia formation and polarity are dependent on a gradient of 
astrocyte-derived VEGF-A (Gerhardt et al., 2003). We therefore investigated 
whether Notch inhibition by DAPT affected astrocytes or VEGF-A expression. 
GFAP staining showed normal astrocytic patterning in the retinas treated with DAPT 
for 6 hours when compared to control retinas (Figure 27A,B). However, there was a 
significant increase of 13% in the level of Vegfa mRNA produced after 6 hours 
DAPT treatment (p = 0.0066; Figure 27C). In control retinas, a gradient of Vegfa 
expression with strongest expression ahead of the vessels was observed (Figure 
27A). The amount of Vegfa produced by astrocytes decreased upon contact with the 
vascular network so that a boundary of high and low expression is formed at the 
vascular front (highlighted by the dotted line in Figure 27A). However, treatment of 
DAPT for 6 and 48 hours led to an expansion of the area of Vegfa expression 
towards the region of increased vessel density (Figure 27B, F). Astrocytes are 
induced to express Vegfa during hypoxia. We therefore assessed whether the increase 
in Vegfa expression from DAPT treatment was a result of increased hypoxia in the 
retina. Analysis of the hypoxia marker solute carrier family 2 member 1 (Scl2a1) by 
qPCR did not show an increase in hypoxia in the retina after 6h DAPT treatment 
(Figure 27D). Like DAPT-treated retinas, there was an expansion of Vegfa 
expression within the vascular plexus in P5 Dll4+/- retinas when compared to 
littermate Dll4+/+ retinas, as observed by ISH (Figure 28).In a separate study using 
Dll4-Fc, a protein that inhibits endogenous Dll4 activity, there was also an increase 
of ~10% in retinal Vegfa mRNA expression(Lobov et al., 2007). These data suggest 
that the vascular abnormalities from DAPT treatment could be an effect of increased 
Vegfa expression. However, there was no significant increase in the total amount of 
VEGF-A protein and isoforms 120, 144, 164 and 188 in P5 retinas after 48 hour 
DAPT treatment when compared to vehicle-treated littermates (Hellstrom et al., 
2007). Therefore, even though there was an increase in Vegfa transcription, total 
VEGF-A protein level remained unchanged after long-term DAPT treatment 
suggesting that the increase in endothelial sprouting may not be caused by alteration 
in the level VEGF-A expression. However, the technique used to assess VEGF-A 
protein level does not provide spatial information on VEGF-A expression in the
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Figure 27. DAPT treatment increases Vegfa expression in the retina.  
A, B, E, F, Vegfa ISH (black) of retinas from mice that have been treated with DAPT 
for 6h (A,B) or 48h (E,F). A-B, P5 mice; E and F, P6 mice. Retinas were 
counterstained with Isolectin-B4 (green). Dotted red line indicates the boundary at 
the vascular plexus where Vegfa expression decreases in normal retina. Dotted red 
line with arrows indicates expansion of Vegfa expression in the vascular plexus in 
DAPT-treated retinas. qPCR of Vegfa (C) and Slc2a, a hypoxia-regulated gene (D), 
in retinas of P5 mice treated with vehicle or DAPT for 6 hours. * *, p < 0.01. control, 
n = 8; DAPT, n = 9. Values are mean ± S.E.M. 
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the retina after DAPT treatment. 
The increase in Vegfa mRNA expression may therefore be a secondary effect 
of Notch inhibition. The excessive vessels that form at the migrating vascular front 
upon Notch inhibition may not all be functional i.e. some vessels may be poorly 
perfused. This was demonstrated in tumours overexpressing Dll4-Fc, a soluble 
dimerized version of Dll4 that inhibits endogenous Dll4 activity and consequently, 
Notch activity. Despite an increase in blood vessel density, tumours overexpressing 
Dll4-Fc have increased hypoxia as a result of poor vascular perfusion (Noguera-
Troise et al., 2006). In the retina, DAPT treatment may lead to a greater area of 
hypoxia compared to control retinas, leading to increased Vegfa expression by 
astrocytes at the vascular front (Figure 27B). Although we did not observe an 
increase in Slc2a expression after DAPT treatment, we cannot exclude the possibility 
that there may be regional hypoxia that was not detected by the qPCR experiment, 
which only assessed the total level of gene expression in the retina. 
 VEGF-A binds, with varying affinities, to Flt1 (also known as VEGFR1) and 
Kdr (VEGFR2). Additionally, the splice isoform VEGF-A165 binds to the co-receptor 
Neuropilin 1 (Nrp1). Activation of VEGF receptors results in many biological effects 
on endothelial cells such as migration, proliferation, survival, endothelial 
differentiation and induction of endothelial gene expression (Siekmann et al., 2008). 
We next examined whether there were any changes in VEGF receptor expression in 
the retina that may mediate the phenotypic changes we had observed after DAPT 
treatment by qPCR. The level of Kdr was not significantly altered (there was a 
decrease of 14%; Figure 29). However, there was a significant decrease of 47% in 
Flt1 expression (p = 0.047) and a significant increase of 41% in Nrp1 expression (p 
= 0.0022) when compared to control retinas (Figure 29).  
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Figure 28. Loss of one allele of Dll4 increases Vegfa expression in the retina. 
A and B, Vegfa ISH (black) of retinas from P5 Dll4+/+ and Dll4+/- mice. Isolectin-B4 
staining is in green. Dotted red line indicates the boundary at the vascular plexus 
where Vegfa expression decreases in normal retina. Dotted red line with arrows 
indicates expansion of Vegfa expression in the vascular plexus in DAPT-treated 
retinas. 
 
Figure 29.  DAPT treatment alters the expression of VEGF receptors. 
The relative expression of Flt1 (VEGFR1), Kdr (VEGFR2) and Nrp1 were assessed 
by qPCR. P5 mice were treated with vehicle or DAPT for 6 hours before obtaining 
retinas for RNA isolation. * *, p < 0.01. Control, n = 9; DAPT, n = 11. Values are 
mean ± S.E.M. 
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3.2.6 ECTOPIC ACTIVATION OF NOTCH SIGNALLING RESULTS IN DECREASED 
FILOPODIA ACTIVITY AND VESSEL BRANCHING. 
The loss-of-function experiments described above indicate that endothelial Notch 
signalling suppresses endothelial tip cell phenotype. To further corroborate this 
hypothesis, a gain-of-function experiment was performed whereby Notch signalling 
was ectopically activated using a synthetic peptide corresponding to the 
δ/serrate/Lag-2 (DSL) domain of the human Jag1 protein that has been reported to be 
a Notch receptor agonist (Weijzen et al., 2002). To determine whether this peptide 
also activates Notch signalling in vivo in the blood vessels of the retina, the Jag1 
peptide was injected subcutaneously into P5 TNR mice for 6 hours. There was a 
marked increase in GFP signal in the vasculature compared to littermate controls 
where a scrambled Jag1 (scJag1) peptide was administered (Figure 30A,B). 
Furthermore, there was a significant increase of 22% in Hey2 expression in the retina 
after 6 hours of Jag1 peptide treatment (p = 0.0354, Figure 30C). However, Hey1 
expression remained unchanged and there was a unexpected decrease of 60% in 
Nrarp expression (p < 0.0001) after treatment (Figure 30C). These results suggest 
that the expression of Notch target genes is differentially regulated by Jag1-induced 
Notch activation. 
 Short-term treatment with Jag1 peptide for 6 hours produced a phenotype that 
is opposite to that of DAPT treatment. There was a significant decrease of 35% in the 
number of filopodia formed at the leading edge of the migrating vessels (Figure 31A-
C). A longer duration of Jag1 peptide treatment (48 hours) resulted in a vascular 
network that was much sparser compared to scJag1 peptide-treated mice (Figure 
31D-F). This was particularly prominent in arterial regions of the vascular plexus 
(Figure 31F). There was a decrease of 45% in the number of branchpoints formed in 
vessels where Notch signalling was ectopically activated when compared to control 
mice (Figure 31D). 
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Figure 30. Jagged1 peptide treatment upregulates endothelial Notch signalling 
in vivo. 
A and B, Treatment with Jagged1 (Jag1) peptide but not scrambled Jag1 (scJag1) 
peptide results in increased Notch activity in TNR mouse. Notch activity is detected 
in green/yellow and Isolectin-B4 in red. C, qPCR of Notch target genes in retinas of 
P5 C57Bl6/J mice treated with either scJag1 or Jag1 peptide for 6 hours. *, p = 
0.0354; **, p < 0.0001. scJag1, n = 11; Jag1, n = 12. Values represent mean ± S.E.M. 
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Figure 31. Jag1 peptide treatment decreases filopodia formation and vessel 
density in vivo.  
There is a significant decrease in filopodia protrusion from endothelial cells of 
migrating vessels in the retina after 6 hours Jag1 peptide treatment (B) that is not 
observed in scJag1-treated retinas (A). Boxed regions in A and B are magnified in A’ 
and B’, respectively. Isolectin-B4 staining is in white. C, number of filopodia 
protrusion per 100µm vessel length at the migrating vessel front of P5 C57Bl6/J 
mice treated with scJag1 or Jag1 peptide for 6 hours. ***, p < 0.0001. scJag1, n = 20; 
Jag1, n = 20. Values represent mean ± S.E.M. D, number of vessel branchpoints in 
200µm2 area of P5 C57Bl6/J mice treated with scJag or Jag1 peptide for 48 hours. 
***, p < 0.0001. scJag1, n = 22; Jag1, n = 33. Values represent mean ± S.E.M. E and 
F, Retinas of C57Bl6/J mice were stained with Isolectin-B4 (red) after 48 hours (P4-
P6) of scJag1 or Jag1 treatment. A, artery. 
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3.3 DISCUSSION 
3.3.1 NOTCH REGULATES THE FORMATION OF ENDOTHELIAL TIP AND STALK 
CELLS DURING SPROUTING ANGIOGENESIS. 
During angiogenesis, new vessels emerge from existing vessels to form new sprouts. 
This requires the selection of a tip cell from a population of quiescent endothelial 
cells. The newly formed endothelial tip cell then becomes the leader of a new sprout 
and guides the trailing stalk cells in the patterning of a new vascular plexus. Data 
from the DAPT experiments and genetic deletion of one Dll4 allele show that the 
formation of new endothelial tip cells has to be tightly regulated since excessive tip 
cell formation resulted in a poorly-patterned, hyperdense vessel network that may not 
be functional. The data also show that the Notch signalling pathway is important in 
the regulation of tip cell formation and that it functions to maintain the stalk cell 
phenotype i.e. it promotes a non-sprouting endothelial phenotype. Furthermore, 
studies from two other independent groups also support this conclusion (Lobov et al., 
2007; Suchting et al., 2007). The cell autonomous role of Notch signalling in 
suppressing tip cell formation was confirmed by specific deletion of Notch1 in 
endothelial cells using the tamoxifen-inducible VE-cadherin-CreERT2 conditional 
mouse that has been crossed to the Cre reporter mouse called R26R (Hellstrom et al., 
2007). Because Cre recombination was infrequent (10 – 30%), it was possible to 
analyze Notch1-deficient endothelial cells, which are LacZ-positive, in an otherwise 
normal retina. By counting the number of endothelial cells that are LacZ-positive and 
–negative at the leading front of the vessels, the authors discovered that 73% of 
LacZ-positive endothelial cells exhibit tip cell characteristics whereas within the 
LacZ-negative cell population, there was a 50:50 distribution of tip and stalk cells 
(Hellstrom et al., 2007). This mosaic analysis indicates that endothelial Notch1 
activity suppresses tip cell formation. Indeed, the retinas of VEcad-
CreERT2/R26R/Notch1lox/lox mice exhibit regions of increased vessel density and 
filopodia protrusion (Hellstrom et al., 2007). 
The regulatory role of Notch signalling in endothelial tip/stalk formation is 
not limited to the mouse. In the zebrafish, DAPT treatment, Dll4 protein knockdown 
by morpholino oligonucleotide and genetic deletion of Dll4 resulted in excessive 
sprouting and branching during the development of ISVs and dorsal longitudinal 
anastomotic vessels (DLAV) (Leslie et al., 2007; Siekmann and Lawson, 2007). 
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Excessive branching is also obtained when notch1b (Leslie et al., 2007) and rbpsuh 
(also known as CSL, Siekmann and Lawson, 2007) were knocked-down. 
Importantly, the cell-autonomous function of Notch signalling in limiting tip cell 
formation was demonstrated in a mosaic experiment where rbpsuh-deficient 
Tg(fli1:EGFP)y1 cells were transplanted into wild-type zebrafish embryos (Siekmann 
and Lawson, 2007). Data from this experiment showed that rbpsuh-deficient, and 
therefore Notch-deficient, endothelial cells have increased propensity to occupy the 
DLAV but have reduced base cell localization when compared to wild-type to wild-
type transplantation experiments (Siekmann and Lawson, 2007). Furthermore, there 
is increased endothelial cell motility and proliferation so that a significantly higher 
number of endothelial cells migrate from the dorsal aorta to newly formed ISVs 
(Siekmann and Lawson, 2007).  
Over-activation of Notch signalling, on the other hand, reduces the migratory 
behaviour of endothelial cells. This was demonstrated by the reduction of filopodia 
formation by Jag1 peptide administration (Figure 30B) and overexpression of Dll4 in 
the mouse decreased endothelial cell migration and sprouting from the dorsal aorta to 
form intersomitic vessels (Trindade et al., 2008). In the zebrafish, overexpression of 
the Notch intracellular domain using a GAL4-UAS technique inhibited the migration 
and filopodia activity of endothelial cells to form ISVs (Leslie et al., 2007; Siekmann 
and Lawson, 2007).  Furthermore, when Tg(fli1:EGFP)y1 cells with activated Notch 
were transplanted into wild-type zebrafish embryos, these cells show increased 
incorporation at the base of the ISV but did not occupy positions in the DLAV 
(Siekmann and Lawson, 2007). These experiments demonstrate that Notch signalling 
regulates angiogenic behaviour of endothelial cells by limiting the number of cells 
that become tip cells. 
The formation of a new vessel does not only require the selection of an 
endothelial tip cell but also requires endothelial cell proliferation in order for the 
sprout to elongate. In endothelial cell cultures, Notch1 and Notch4 activity inhibit 
proliferation by transcriptional downregulation of p21CIP1 and consequent reduction 
in nuclear translocation of cyclin D and cdk4 and downregulation of cyclin D-cdk4-
mediated Rb phosphorylation (Noseda et al., 2004). Indeed, suppression of Notch 
signalling resulted in increased endothelial cell proliferation in both mouse and 
zebrafish. In the mouse, there is a small increase in endothelial cell proliferation that 
may contribute to increased vessel diameter and branching after DAPT treatment 
 99 
(Hellstrom et al., 2007), neutralization of Dll4 activity by Dll4-Fc (Lobov et al., 
2007) and in Dll4+/- mutants (Suchting et al., 2007). In the zebrafish, the increase in 
proliferation and aberrant migratory behaviour of endothelial cells result in an 
increased number of endothelial cells that compose ISVs in rbpsuh-deficient 
zebrafish (Siekmann and Lawson, 2007). Conversely, overexpression of Dll4 in 
mouse decreased endothelial cell proliferation (Trindade et al., 2008).  
In summary, Notch signalling promotes endothelial cell quiescence by 
suppressing tip cell formation and endothelial cell proliferation. Furthermore, these 
experiments revealed that the phenotypes of endothelial cells are not permanent but 
can be altered and that Notch signalling modulates the phenotypic switch between tip 
cells and stalk cells. 
 
3.3.2 NOTCH SIGNALLING MODULATES VEGF RECEPTOR EXPRESSION AND 
SIGNALLING. 
In the experiments described above, DAPT treatment resulted in significant decrease 
in Flt1 and increase in Nrp1 expression levels, but no apparent change in Kdr level, 
in the mouse retina (Figure 29). Other published in vivo data where Notch signalling 
has been suppressed by different means partially support this result. In Dll4+/- retinas, 
a decrease in Flt1 expression has also been shown (Suchting et al., 2007). However, 
data on Kdr expression after suppression of Notch signalling is conflicting. In Dll4+/- 
retinas, there is an increase in Kdr expression (Suchting et al., 2007); conversely, in 
retinas where Dll4 activity has been neutralized by Dll4-Fc for 24 hours, there is a 
decrease in Kdr expression (Lobov et al., 2007). The disparity between my data and 
those published may be a result of different approaches used to isolate RNA for PCR 
analysis. In my experiments, I have used whole retina lysates. However, Suchting et 
al isolated RNA from retinal endothelial cells for their PCR experiments. As 
neuronal cells in the retina also express Kdr, it may be possible that any change in 
endothelial Kdr expression after DAPT treatment is masked by neuronal Kdr 
expression.  
Further insight into VEGF receptor regulation by Notch signalling can be 
sought from Notch overexpression studies. In Dll4-overexpressing mice, there is an 
increase in Flt1 and a decrease in Kdr expression (Trindade et al., 2008), and 
overexpression of Dll4 in HUVECs results in significant decreases in Kdr and Nrp1 
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levels (Harrington et al., 2008; Williams et al., 2006) and increase in Flt1 protein as 
well as the inhibitory soluble alternative splice variant of Flt1 (sFlt1) (Harrington et 
al., 2008). Collectively, data gathered from in vitro and in vivo studies demonstrate 
an inhibitory regulation of Kdr and Nrp1 expression and a stimulatory regulation of 
Flt1 expression by Notch (Figure 32B).  
In addition, Notch signalling regulates the expression of a third member of 
the VEGF receptor family, Flt4 (also known as VEGFR3), in both mouse and 
zebrafish. In the zebrafish, tip cells of ISVs selectively express Flt4 during sprouting 
angiogenesis. Inhibition of Notch signalling by morpholino knockdown of rpbsuh 
results in an increase in flt4 expression and its continual expression even after ISV 
and DLAV are formed (Siekmann and Lawson, 2007). Similarly in the mouse, Flt4 
expression is high in endothelial cells of sprouting blood vessels of the retina and its 
expression is negatively regulated by Notch activity (Figure 32B; Tammela et al., 
2008). 
Although I have not shown any evidence for increased Kdr activity after 
DAPT treatment, it seems likely that this may occur for the several reasons. Firstly, 
Flt1 acts as a ‘decoy’ receptor by restricting the accessibility of VEGF-A for Kdr 
since it has a higher affinity for VEGF-A (Hiratsuka et al., 2005). Because Flt1 
undergoes weak autophosphorylation in response to VEGF (Seetharam et al., 1995; 
Waltenberger et al., 1994), its activity is not essential for transmitting a mitogenic 
response. The decrease of Flt1 expression observed after DAPT treatment may 
translate to a down-regulation of endothelial Flt1 protein expression, and thereby 
increase the availability of VEGF-A for Kdr, whose level remained unchanged after 
DAPT treatment. Secondly, the increase in Nrp1 expression (and consequent 
increase in Nrp1 protein) may potentiate Kdr activity since Nrp1 stabilizes 
VEGF164/Kdr signalling complex and therefore enhances Kdr signalling.  
There is experimental evidence demonstrating that the inhibition of Notch 
signalling increases VEGF signalling. In the zebrafish, inhibition of VEGF signalling 
pharmacologically by SU5416, an inhibitor of Kdr tyrosine kinase activity, blocked 
the excessive sprouting observed in dll4 mutants (Leslie et al., 2007). Furthermore, 
co-injection of rbpsuh and flt4 morpholinos led to a partial rescue of the rbpsuh 
morphant phenotype (Siekmann and Lawson, 2007) and in the mouse, blocking Flt4 
activity in the retina partially rescues the effect of DAPT treatment (Tammela et al., 
2008). These experiments suggest that the excessive sprouting observed in dll4 
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mutants and rbpsuh morphants may be caused by increased VEGF signalling and 
that, in zebrafish, Notch activation normally represses flt4 expression to limit 
angiogenic behaviour in developing ISVs.  
3.3.3 CROSS-TALK BETWEEN VEGF AND NOTCH SIGNALLING PATHWAYS 
REGULATES SPROUTING ANGIOGENESIS. 
The complexity between Notch and VEGF signalling pathways is further increased 
by the discovery that VEGF induces Dll4 expression in the retina (Lobov et al., 
2007; Noguera-Troise et al., 2006; Suchting et al., 2007) and in human arterial 
endothelial cultures (Figure 32A, Liu et al., 2003; Patel et al., 2005). This presents a 
situation where in regions of high VEGF-A expression (see Figure 33), such as at the 
migrating front of the retinal vascular plexus, Dll4 expression is induced through 
VEGFR signalling (although the mechanism is currently unclear) on endothelial 
cells. This Dll4-expressing cell then triggers Notch signalling in adjacent cells so that 
the ability of these cells to respond to VEGF is dampened due to downregulation of 
Kdr/Flt4 expression and increase in Flt1 and sFlt1 expression. The decrease in 
Kdr/Flt4 activity has two consequences. The first is that the endothelial cell becomes 
quiescent i.e. it adopts a non-motile, non-invasive behaviour so that it maintains a 
connection to the patent blood vessel from which the sprout originally emanated, and 
secondly, Dll4 expression decreases since there is down-regulation in Kdr/Flt4 
activity. These phenotypic and molecular differences among endothelial cells would 
therefore lead to the selection of an endothelial cell to become a tip cell, a Dll4-
expressing cell that is highly motile with multiple filopodia. The stalk cell, however, 
 
Figure 32. Proposed interaction between VEGF and Notch signalling pathways. 
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is less motile with high Notch activity and low Dll4 expression. The difference 
between the two endothelial cell subpopulations reinforces the establishment and 
function of a tip cell in vessel guidance. Notch signalling therefore limits the number 
of tip cells formed by the activation of Notch on neighbouring cells via Dll4. 
 The model proposed above illustrates the regulation of Notch-VEGF 
signalling in endothelial cells by Dll4. However, endothelial cells also express other 
DSL ligands. In the mouse retina, there are overlapping as well as spatial differences 
in the expression of Dll4, Jag1 and Dll1 (Hofmann and Luisa Iruela-Arispe, 2007). 
Endothelial tip cells selectively express Dll4, but not Jag1 or Dll1. Endothelial cells 
located at arterial junctions express Jag1, but not Dll1 and Dll4 endothelial cells. 
However, Dll1, Dll4 and Jag1 are all expressed in endothelial cells of capillaries and 
arteries (Hofmann and Luisa Iruela-Arispe, 2007). However, it is unclear whether all 
DSL ligands activate the same Notch receptors and also, some Jagged and Delta-like 
ligands have been reported to have opposing activities on Notch receptor binding 
(D'Souza et al., 2008). Endothelial cells may therefore have varying degrees of 
Notch activity, depending on the number and type of ligand they are exposed to. 
Given that blood vessels are composed of multiple cell types and are exposed to 
basement membrane components, it is likely that Notch signalling in endothelial 
cells can also be regulated by Notch ligands expressed by non-endothelial vascular 
cells. For example, vascular smooth muscle cells around mature arteries in the retina 
express Jag1 (Hofmann and Luisa Iruela-Arispe, 2007). Also, extracellular matrix 
components may contain non-canonical DSL ligands and one example is MAGP2, 
which inhibits Notch signalling in endothelial cells (Albig et al., 2008). Although 
this was demonstrated in vitro, it may be possible that this can occur in vivo since 
this gene (Mfap5) is expressed in early post-natal retinas (microarray data not 
shown). The regulation of endothelial Notch signalling during angiogenesis is 
therefore very complex, consistent with our observation of a heterogeneous pattern 
of Notch signalling among endothelial cells in the developing vascular plexus of the 
mouse retina (Figure 19A and B). 
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Figure 33. Proposed model for VEGF-Notch signalling in regulating angiogenic 
sprouting. 
The combination of a graded VEGF-A expression in the extracellular milieu and 
endothelial Notch signalling facilitates the formation of endothelial tip cells (Bentley 
et al., 2008; Gerhardt et al., 2003). (1) Selected tip cells become motile and extend 
many filopodia protrusions ahead of the vessel plexus. (2) VEGF-A ahead of the 
migrating vascular plexus binds to Kdr expressed on tip cell filopodia, thereby 
triggering VEGF receptor signalling in tip cells. Through an uncharacterized 
mechanism, VEGF receptor activation induces the expression of Dll4 in tip cells. Tip 
cells therefore have high Dll4 expression, which bind to Notch receptors on adjacent 
stalk cells. (3) Stalk cells subsequently have higher Notch activity than tip cells. 
Notch activation represses the transcription of Kdr, Flt4 and Nrp1 but induces the 
transcription of Flt1. Notch activation also increases the expression of soluble Flt1, a 
splice variant of Flt1. Stalk cells have low VEGF receptor activity due to decreased 
Kdr expression and sequestering actions of Flt1 and sFlt1, and in turn, express less 
Dll4. (4) It is likely that the endothelial cells in the perfused “mother” vessel have 
low Notch activity, due to their proximity to a high Notch/low Dll4 expressing stalk 
cell, and low VEGF receptor activity because of low VEGF-A stimulation. However, 
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upon high VEGF stimulation, a cell of this state can become activated and turned 
into a tip cell.  
 
3.3.4 FUTURE PERSPECTIVES 
The data presented in this chapter, as well as those published in recent years, 
illustrate that endothelial cells of sprouting blood vessels are heterogeneous in their 
behaviour. The collective behaviour of each endothelial cell culminates in the 
formation of an organized, functional vascular plexus. How does a population of 
endothelial cells become different in their response to the same stimulus such as 
VEGF-A? As presented above, endothelial cells exhibit varying levels of Notch 
signalling and since Notch activity modulates VEGF receptor expression, endothelial 
cells of a vessel plexus would respond differently to the same stimulus. This can 
arise from several factors. The first is that different VEGF receptors trigger different 
cellular responses. Due to its weak tyrosine phosphorylation activity, Flt1 only 
weakly stimulates endothelial cell proliferation (Shibuya, 2008). Activation of Kdr, 
however, results in a multitude of endothelial cell behaviours such as cell migration, 
survival, permeability, proliferation and regulation of gene expression (Figure 34; 
Olsson et al., 2006; Shibuya, 2008; Siekmann et al., 2008). The function of the third 
VEGF receptor, Flt4, was previously thought to be selective for lymphatic 
endothelial cell function; however, there is now evidence demonstrating a role of 
Flt4 in blood endothelial cells during sprouting angiogenesis (Siekmann and Lawson, 
2007; Tammela et al., 2008). Furthermore, the activities of VEGF receptors are 
modulated by co-receptors such as Neuropilins and heparan sulphate proteoglycans 
(HSPGs). The VEGF signalling output is therefore in part dictated by the type and 
level of VEGF receptor(s) expressed by the endothelial cell. It has been documented 
that endothelial tip cells express high levels of Kdr (Gerhardt et al., 2003). However, 
it would be of interest to investigate the spatial expression of the different receptors 
and co-receptors in relation to each other during retinal angiogenesis at the protein 
level. This study would confirm the hypothesis that endothelial stalk cells express 
higher levels of Flt1. Presently, the data gathered to support this hypothesis does not 
provide spatial information on receptor expression and is also based on mRNA 
expression.  
  The second factor that determines endothelial cell biological output is the 
downstream   signalling   pathways  triggered   after   receptor   activation  and  
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Figure 34. The VEGF signalling pathways in endothelial cells. 
Upon VEGF binding, VEGF receptors dimerize, leading to the phosphorylation of 
different tyrosine residues. In human Kdr, these include Y951, Y1175 and Y1214. 
Phosphorylation elicits differential downstream signalling events. Y951 influences 
actin remodelling by binding to TSAd (T-cell-specific adaptor) (Matsumoto et al., 
2005) therefore affecting endothelial cell migration. Phosphorylation of Y1214 has 
similar effects on migration, but acts via the activation of p38/MAPK. The most 
important tyrosine residue on Kdr is Y1175, which directly affects PLCγ1 signalling 
and thereby influences gene expression and cell proliferation. Y1175 also binds to 
Shb, which in turn activates PI3K and Akt. The PI3K/Akt pathway regulates vessel 
permeability, endothelial cell survival and migration. From (Siekmann et al., 2008). 
 
 
phosphorylation of specific tyrosine residues (Figure 34). Differential occupancy of 
single phosphorylated residues within activated Kdr can lead to distinct cellular 
outputs (Siekmann et al., 2008). For example, phosphorylation of Y1175 in 
endothelial cells activates the PI3K/Akt and RAF/Mek/Erk pathways. However, 
these two signalling pathways promote different endothelial functions. The PI3K/Akt 
pathway generally promotes angiogenesis by driving endothelial cell migration and 
survival while the RAF/Mek/Erk pathway promotes maturation and differentiation of 
blood vessels (Harrington et al., 2008; Hong et al., 2006). Interestingly, these two 
pathways have opposing roles during arterial-venous differentiation. In the zebrafish, 
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activation of Akt antagonizes signalling through the PLCγ1/PKC/ERK pathway to 
block arterial endothelial differentiation (Figure 34; Hong et al., 2006). Even more 
interestingly, in vitro studies using endothelial cells demonstrate that VEGF-induced 
phosphorylation of Erk is inhibited by Dll4 (Harrington et al., 2008), suggesting that 
Notch signalling suppresses the RAF/Mek/ERK pathway. In light of this finding, one 
may ask whether endothelial tip cells have higher RAF/Mek/ERK activity than stalk 
cells. To address this, it would be necessary to examine phosphorylated Erk protein 
localization by immunohistochemistry during retinal angiogenic sprouting. Notch 
signalling may also modulate the balance between PI3K/Akt and PLCγ1/PKC/ERK 
pathways by regulating the expression of PTEN, a negative regulator of PI3K 
(Palomero et al., 2008; Whelan et al., 2007). However, it is still unclear whether this 
mode of regulation also occurs in endothelial cells and whether Notch up- or down-
regulates PTEN. Again, it would be of interest to investigate the spatial expression of 
PTEN among endothelial cells during angiogenesis. 
 
3.4 SUMMARY 
In this chapter, I have shown that Notch signalling negatively regulates endothelial 
tip formation during sprouting angiogenesis. Also, I have presented data suggesting 
that Notch modulation of tip and stalk cell formation is mediated through Notch 
regulation of VEGF receptor expression. 
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4 Nrarp stabilizes nascent blood vessel during 
angiogenesis 
4.1 INTRODUCTION 
This chapter of the thesis is devoted to the study of a less well-known Notch effector, 
the Notch-regulated ankyrin repeat protein or Nrarp. At the start of this project, there 
was nothing known about the function of Nrarp in angiogenesis. We therefore sought 
to investigate a role of Nrarp in vascular development in the mouse and the 
zebrafish. 
4.1.1 NRARP IS A NOTCH TARGET GENE THAT NEGATIVELY REGULATES NOTCH 
SIGNALLING. 
In the mouse, the Nrarp gene encodes a small protein of 114 amino acids with two 
ankyrin repeat domains. In the zebrafish, two nrarp paralogues, nrarp-a and nrarp-b, 
encode proteins of 112 and 111 amino acids, respectively (Topczewska et al., 2003). 
Nrarp is also expressed in human, rat, Xenopus, Fugu and Tetraodon. The human, 
mouse and rat sequences are identical, suggesting an evolutionarily conserved 
function for Nrarp proteins in vertebrates. Sequence alignment reveals an 80% amino 
acid sequence identity between Nrarp proteins of mouse, zebrafish, Xenopus, Fugu 
and Tetraodon (Topczewska et al., 2003). 
The expression of Nrarp is directly induced by Notch signalling through the 
CSL-dependent pathway (Krebs et al., 2001; Lamar et al., 2001; Pirot et al., 2004; 
the CSL pathway is described in Chapter 1.3.1). During mouse and zebrafish  
 
 
Figure 35. Alignment of deduced amino acid of Nrarp proteins from various 
species.  (Topczewska et al., 2003) 
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embrygenesis, Nrarp is expressed in several tissues such as the presomitic mesoderm 
in which cellular differentiation is regulated by Notch signalling (Krebs et al., 2001; 
Topczewska et al., 2003). In Notch1 null mice, Nrarp expression is downregulated 
(Krebs et al., 2001). Similarly, mindbomb zebrafish mutants, in which Notch 
signalling is abrogated, have reduced nrarp-a and nrarp-b expression (Topczewska 
et al., 2003). These findings indicate that Nrarp expression is positively regulated by 
Notch signalling in vivo. Studies in Xenopus revealed that Nrarp forms a ternary 
complex with NICD and CSL and, in doing so, disrupts the NICD/CSL complex to 
suppress CSL-dependent transcription (Lamar et al., 2001). Furthermore, 
overexpression of Nrarp destabilizes NICD in Xenopus (Lamar et al., 2001) and 
zebrafish (Ishitani et al., 2005) embryos. Thus, Nrarp is a negative regulator of Notch 
signalling. 
There are currently few known functions of Nrarp. By overexpressing Nrarp 
in mouse haematopoietic stem cells, it was discovered that Nrarp blocks T cell 
lineage commitment and progression through early stages of thymocyte maturation 
(Yun and Bevan, 2003). In the zebrafish, knockdown of nrarp-a expression by 
antisense morpholino oligonucleotide revealed that nrarp-a is required for migratory 
activity and pigment-cell fate specification of neural crest cells (NCCs) (Ishitani et 
al., 2005). Interestingly, the authors of this study showed that the regulation of NCC 
development by nrarp-a is conducted through the Wnt signalling pathway. This is 
mediated by the ability of Nrarp to bind to Lef1, a transcription factor in the Wnt 
signalling pathway. This interaction prevents Lef1 ubiquitination and degradation, 
thereby stabilizing Lef1 to positively regulate Wnt signalling (Ishitani et al., 2005). 
 
4.1.2 WNT SIGNALLING. 
The Wnt signalling pathway is evolutionarily conserved in metazoans where it 
regulates many cellular and biological processes such as cell adhesion, polarity, 
migration and proliferation, as well as differentiation of multiple cell lineages and 
stem cell self renewal (van de Schans et al., 2008). Proteins from the Wnt family are 
therefore essential in a wide range of developmental and physiological processes.  
 Wnts are secreted lipid-modified glycoproteins of several hundred amino 
acids in size (Willert et al., 2003). At least 19 Wnt proteins have been identified in 
mammals and they bind to at least two types of receptors: the serpentine receptors of 
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the Frizzled (Fz) family (10 members in mammals) and members of the low-density-
lipoprotein-related protein (LRP) family at the plasma membrane. In addition, 
proteins from the Ror and Ryk family, both tyrosine kinase receptors, have also been 
identified as receptors for Wnt proteins (Kikuchi et al., 2007). Wnt proteins induce 
several pathways that include the Wnt/β-catenin pathway, which is also known to as 
the “canonical” Wnt pathway. In this pathway, signalling is achieved through the 
stabilization of β-catenin or Ctnnb1. Wnt proteins also activate other signalling 
pathways and these are referred to as “non-canonical Wnt signalling”. These include 
the Wnt/JNK pathway, which involves activation of small GTPases such like Rac, 
Rho and Cdc42 (Kikuchi et al., 2007) and the Wnt/Ca2+ pathway, which requires 
intracellular increase of Ca2+ (Kikuchi et al., 2007). 
 In the canonical Wnt pathway, β-catenin acts as a second messenger of Wnt 
signalling. When Frizzled receptors are not engaged by Wnt, a β-catenin degradation 
complex consisting of adenomatous polyposis coli (APC), Axin, Glycogen Synthase 
Kinase-3β (GSK-3β) and Casein Kinase-1 (CK-1) bind to newly synthesized β-
catenin (Hinoi et al., 2000). Axin facilitates the phosphorylation of serine/threonine 
residues 33, 37 and 41 at the amino terminus of β-catenin by CK-1 and GSK-3β. The 
resulting phosphorylated footprints recruit a β-TrCP-containing E3 ubiquitin ligase, 
which targets β-catenin for proteasomal degradation (Kimelman and Xu, 2006). The 
level of free β-catenin in the cytoplasm therefore remains low. β-catenin-mediated 
Wnt signalling is initiated when a Wnt ligand binds to a complex formed by a 
Frizzled receptor and an LRP co-receptor. Frizzled receptor occupancy inhibits the 
kinase activity of the β-catenin degradation complex by an incompletely understood 
mechanism involving the direct interaction of Axin with the Axin-binding molecule 
Dishevelled (Dsh, (Cliffe et al., 2003)). As a consequence, β-catenin accumulates in 
the cytoplasm and translocates to the nucleus, where it binds to the N-terminus of 
DNA-binding proteins of the T-cell factor (Tcf)/Lymphoid enhancer factor (Lef) 
family of high mobility group (HMG)-box proteins (Behrens et al., 1996; Reya and 
Clevers, 2005). In vertebrates, there are four Tcf genes (Tcf1, Lef1, Tcf3 and Tcf4) 
and each gives rise to a variety of specialized isoforms. In the absence of β-catenin, 
Tcf/Lef assemble alternative complexes with transcriptional co-repressors such as 
CBP and Groucho and become transcriptional (Hoppler and Kavanagh, 2007). The 
binding of β-catenin to Tcf/Lef facilitates the assembly of multimeric complexes  
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Figure 36. Canonical Wnt pathway. 
In the absence of Wnt ligand, the cells are in the “off” state. GSK-3β is constitutively 
active and cells maintain low cytoplasmic and nuclear levels of β-catenin. In the 
presence of extracellular Wnt signalling, a combination of LRP-axin interaction and 
Dvl phosphorylation blocks the APC-axin-GSK-3β-CKI complex from 
phosphorylating β-catenin. The accumulated β-catenin then enters the nucleus, 
where it converts Tcf/Lef1 into a transcriptional activator.  Adapted from 
(Eisenmann, 2005). 
 
 
containing transcriptional co-activators such as Pygo (Stadeli and Basler, 2005), 
thereby converting Tcf/Lef to transcriptional activators of target genes.   
 
4.1.3 AIMS OF PROJECT. 
The aims of this project were: i) analysis of Nrarp expression during sprouting 
angiogenesis and ii) investigate whether Nrarp has an angiogenic function. 
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4.2 RESULTS 
4.2.1 NRARP EXPRESSION DURING MOUSE EMBYRONIC DEVELOPMENT AND IN 
EARLY POSTNATAL RETINA. 
To determine whether Nrarp is expressed in endothelial cells during angiogenesis, 
we studied the expression pattern of Nrarp mRNA by wholemount in situ 
hybridization in mouse embryos and in early postnatal mouse retinas. In mouse 
E10.5 embryos, Nrarp is predominantly expressed in the central nervous system and 
in the presomitic mesoderm, as reported previously (Figure 37A; Krebs et al., 2001). 
It is also expressed in the intersomitic vessels (arrowheads in Figure 37B) and in 
vessels of the limb buds (Figure 37C). Counterstaining of blood vessels with 
Endomucin indicated the strongest signal at vascular branchpoints (Figure 37C’, 
inset). Confocal microscopy of the double-labelled limb buds confirmed Nrarp 
mRNA localization to endothelial cells located at branchpoints (arrowheads in Figure 
37D). It is interesting to note that endothelial cells located between branchpoints do 
not express Nrarp (arrows in Figure 37D). 
 Nrarp is also expressed in endothelial cells of the developing retinal 
vasculature. In the early postnatal mouse retina, Nrarp expression is prominent in 
endothelial cells at the migrating front of the vasculature (Figure 38A-C). Strongest 
expression was regularly detected in the stalk cells (red arrowheads). The distribution 
of Nrarp expression therefore coincides with regions of high Notch activity, as 
revealed by the transgenic Notch reporter mouse (TNR) and the nuclear localization 
of Notch1 intracellular domain (NICD1) in the previous chapter. Close observation 
of Nrarp expression in 200 Isolectin-B4 labeled sprouts in three P5 retinas revealed 
Nrarp mRNA in only 7%±2.6 of the leading tip cells. For comparison, 84%±10 of 
the tip cells were positive for Dll4 mRNA, consistent with the idea that tip cells 
signal through Dll4 to induce Notch signalling, and hence Nrarp expression, in stalk 
cells. Like in the embryonic limb bud vasculature, Nrarp expression is also highly 
expressed by endothelial cells located at vessel branchpoints (red arrowheads in 
Figure 38A-C). 
 However, Nrarp expression is not confined to endothelial cells at the 
migrating front of the vasculature. As angiogenesis progresses, Nrarp expression 
becomes more widespread within the proximal vascular plexus (Figure 38D and D’).  
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Figure 37. Nrarp is expressed in endothelial cells of developing blood vessels in 
mouse embryos. 
A-D, Nrarp ISH in E10.5 mouse embryos. The embryos were counterstained with 
anti-endomucin antibody (red) to visualize blood vessels. Nrarp is predominantly 
expressed in the central nervous system including the neural tube (NT) and the 
presomitic mesoderm (arrow in A, PSM). Nrarp is expressed in mouse embryonic 
(E10.5) intersomitic vessels (arrowheads in B) and limb bud vessels (C). In the limb 
bud, Nrarp expression is prominent at vessel branchpoints. D is a 3D reconstruction 
of confocal images of limb bud blood vessels (outlined in dotted red line) showing 
Nrarp (blue) expression in endothelial cells (green) located at branchpoints 
(arrowheads in D). Endothelial cells between branchpoints lack Nrarp expression 
(arrows in D). 
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Figure 38. Nrarp is expressed in endothelial cells of retinal blood vessels. 
Nrarp ISH (blue) of early mouse postnatal retinas (P3 to P7). Retinas were 
counterstained with Isolectin-B4 to visualize blood vessels (green). Nrarp is 
expressed by ECs at various regions of the developing vascular plexus: the migrating 
vascular front (A-C) and the capillary plexus (D). White arrows indicate Nrarp 
expression in endothelial tip cells; red arrows indicate stalk cells that express Nrarp; 
and red arrowheads indicate endothelial cells of vessel branchpoints that express 
Nrarp. 
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4.2.2 NRARP EXPRESSION IN ZEBRAFISH EMBRYOS. 
In the zebrafish, the two paralogues nrarp-a and nrarp-b are highly expressed in the 
neural tube and in the presomitic mesoderm (Figure 39A,B). Additionally, we 
observed nrarp-a expression in the dorsal aorta at 24hpf (Figure 39C’, E). By 
analyzing wholemounts and sections at higher magnification, nrarp-a expression is 
also detected in some endothelial cells of the intersegmental vessels (arrows in 
Figure 39D), but appears absent from the posterior cardinal vein. However, we were 
not able to detect nrarp-b expression in blood vessels in the zebrafish embryos at 
24hpf or 48hpf. Nevertheless, we cannot exclude that nrarp-a and nrarp-b are 
expressed in other vascular segments albeit at lower levels. Furthermore, its 
detection may be undetectable by the in situ hybridization procedure.  
 
 
 
 
 
 
 
 
 
Figure 39. Expression of nrarp-a and nrarp-b in the zebrafish embryo. 
ISH of nrarp-a (A, C-E) and nrarp-b (B) in 24hpf (hours post-fertilization) zebrafish 
embryos. Like mouse Nrarp, nrarp-a and -b are predominantly expressed in the CNS 
and also in the PSM (arrowheads in A and B). C and C’ are transverse images of the 
same region of the zebrafish trunk taken at different focal planes. In C, nrarp-a 
expression is detected in some cells (white arrows) between somite boundaries. 
These cells may be neural crest cells. Boxed area in C is magnified in D, which 
shows nrarp-a expression in ECs of ISV (arrows). The somite boundary is outlined 
by a dotted line. nrarp-a is expressed in the dorsal aorta (arrow in C’). E is a cross-
section of zebrafish trunk showing nrarp-a expression in the dorsal aorta (circled) 
and the neural tube (arrows). NT, neural tube; NC, notochord; DA, dorsal aorta; CV, 
cardinal vein. nrarp-a ISH in C-D were produced by Jonathan D. Leslie. 
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4.2.3 NRARP PROTEIN EXPRESSION – ATTEMPTS TO GENERATE AN ANTI-NRARP 
ANTIBODY. 
At the start of this project, no known antibodies against Nrarp protein had been 
generated. We therefore proceeded to produce one.  
 In one attempt, a recombinant mouse Nrarp protein was generated and used 
to raise an anti-Nrarp antibody (Nrarp Ty32). Unfortunately, the antibody generated 
was unspecific. The Nrarp protein is predicted to be 12.5kDa. When used in Western 
Blotting, a band of about 17kDa was detected (arrow in Figure 40). However, many 
unspecific and stronger bands of higher molecular weight were also detected. 
Furthermore, the 17kDa protein band was also detected in Nrarp null retinas, 
indicating that this antibody is not specific. 
  
 
Figure 40. Antibody raised against recombinant Nrarp protein. 
Antibody raised against the recombinant Nrarp protein (Nrarp Ty32) was tested on 
protein lysates of P5 retinas from Nrarp+/+, Nrarp+/- and Nrarp-/- by Western Blot. 
Arrow points to a protein band that may be that of Nrarp. However, this band is also 
present in the Nrarp-/- sample. 
 
In another attempt to generate an anti-Nrarp anitbody, we designed three 
peptides that corresponded to distinct regions of the mouse Nrarp protein. Of these, 
the antibody raised against the amino acid residues 16-29 of Nrarp (Nrarp 16-29c) 
showed potential as an antibody against the protein (Figure 41). By doing 
immunofluorescence on a mouse brain endothelial cell line (bEND5), strong 
labelling was detected in the nuclei of cells (Figure 41B). This staining pattern was 
barely detectable in the negative control sample, where cells were only incubated 
with secondary antibody (Figure 41A). However, no specific staining was observed 
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when the same antibody was used on wholemount retina preparations (data not 
shown). The antibody was also tested by Western Blotting to detect Nrarp expression 
in bEND5 cells as well as P5 retinas. In the Western Blotting, a band of about 20kDa 
that may be Nrarp was observed in both bEND5 cells and in the retina (Figure 41C). 
However, this antibody also recognized other proteins of higher molecular weight. 
Hence, to determine the specificity of this antibody for Nrarp, we need to test it on 
protein lysates isolated from Nrarp null cells or tissues.  
In summary, we have not been able to detect Nrarp protein expression in 
retinas using the two anti-Nrarp antibodies generated. Thus, the only available 
technique available to localize Nrarp expression is in situ hybridazation. 
 
 
Figure 41. Antibody raised against peptide 16-29c of Nrarp protein.  
The antibody that recognizes a peptide corresponding to residues 16-29 of mouse 
Nrarp protein (Nrarp 16-29c) was tested on bEND5 cells by immunostaining. 
Incubation of the antibody at 2µg/ml produced a strong nuclear staining (B) that was 
absent in the negative control (A). A protein of ~20kDa was detected by Western 
Blotting (arrow in C). 
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4.2.4 ENDOTHELIAL NRARP EXPRESSION IS REGULATED BY NOTCH SIGNALLING. 
There is published evidence that Notch signalling directly regulates Nrarp gene 
promoter activity in a CSL-dependent manner (Pirot et al., 2004). However, it is 
unknown whether endothelial Nrarp expression is regulated by Notch signalling in 
vivo. We therefore investigated endothelial Nrarp regulation by Notch using three 
methods. Firstly, Notch signalling was inhibited by the administration of DAPT in 
P5 C57Bl6/J mice. Retinas were isolated from mice 6 hours after treatment and were 
processed for Nrarp ISH and qPCR experiments. By ISH, we detected a significant 
reduction in Nrarp mRNA expression in endothelial cells after DAPT treatment 
(Figure 42B) when compared to vehicle-treated mice (Figure 42A). qPCR analysis of 
Nrarp expression in whole retina lysates revealed a significant decrease of 70% in 
DAPT-treatment animals (p < 0.0001; Figure 42C). In the second approach, human 
Dll4-Fc protein was used to inhibit Notch signalling specifically in endothelial cells. 
Dll4-Fc is a soluble version of Dll4 that acts to block endogenous Dll4/Notch 
interactions (Lobov et al., 2007). P5 mice were injected once intravitreally with Dll4-
Fc and retinas were analyzed for Nrarp expression 24 hours later by qPCR. There 
was a significant decrease of 30% in Nrarp expression when compared to mice 
treated with a human-Fc (p = 0.0004; Figure 42C). These two experiments 
demonstrate that Notch signalling positively regulates Nrarp expression in 
endothelial cells. 
 In the third experiment, we stimulated Notch signalling using the Jag1 
peptide (described in 3.2.6) and examined Nrarp expression by qPCR. There was no 
change in Nrarp expression after 3 hours of Jag1 treatment as compared to 
scrambled peptide treatment. Longer treatment of Jag1 peptide for 6 hours led to a 
significant decrease of ~60% in Nrarp expression when compared to scrambled 
peptide treatment (p < 0.0001; Figure 43C). By wholemount retina ISH, we observed 
a decrease in blood vessel density at the vascular front, which is a Notch gain-of-
function phenotype, as well as a decrease in endothelial Nrarp expression (Figure 
43B). In contrast, the same peptide has been demonstrated to induce significant 
increases in Nrarp expression in retinas from mice treated for 6, 12 and 24 hours 
(Tammela et al., 2008). The disparity between the published data and mine is hard to 
explain and may well be due to different experimental conditions. 
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 Collectively, data from my own experiments and from published works 
indicate that Nrarp expression is positively regulated by Notch signalling in vivo.  
 
 
 
 
Figure 42. Endothelial Nrarp expression is suppressed after DAPT and Dll4-Fc 
treatment. 
P5 C57Bl6/J mice were injected once with DAPT at 100µg/g subcutaneously (A-C) 
or with 4µg Dll4-Fc or hFc (control) intravitreally (C). Nrarp expression in retinas 
was analyzed by whole-mount ISH (A,B) or by qPCR (C). Nrarp ISH revealed a 
significant decrease in endothelial Nrarp expression after 6h DAPT (B) compared to 
vehicle-treated animals (A). qPCR analyses showed a significant decrease in Nrarp 
expression after 6h DAPT and after 24h Dll4-Fc treatment compared to their 
respective controls. ***, p ≤ 0.0004. Vehicle and DAPT treatments, n ≥ 7; hFc, n = 
4; Dll4-Fc, n = 6. Values represent mean ± S.E.M.  
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Figure 43. Nrarp expression is suppressed after Jag1 peptide treatment. 
P5 C57Bl6/J mice were injected subcutaneously once with 0.5mg/g Jag1 or scJag1 
peptide. Retinas were analyzed 3 hours (C) or 6 hours (A-C) later. 6h Jag1 treatment 
revealed a decrease in vessel density at the migrating front of the vessel plexus (B) 
compared to scJag1 treatment (A). Nrarp ISH showed a decrease in endothelial 
Nrarp expression (B). C, qPCR result of Nrarp expression in retinas 3 or 6 hours 
after scJag1 or Jag1 treatment. There is a significant decrease in Nrarp expression 
after 6 hours Jag1 treatment compared to control. ***, p < 0.0001. 3h treatment: 
scJag1, n = 3; Jag1, n = 5. 6h treatment: scJag1, n = 11; Jag1, n = 12. Values 
represent mean ± S.E.M. 
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4.2.5 MICE DEFICIENT IN NRARP EXHIBIT RETINAL VASCULAR DEFECTS. 
We next investigated whether Nrarp has a function in angiogenesis. To examine this 
in the mouse, we obtained an Nrarp mutant mouse line that was generated by 
Regeneron using the Velocimouse technology. The breeding of Nrarp+/- mice 
produced offspring of the appropriate Mendelian ratio. Nrarp-/- newborn mice had 
normal physical appearance and had a similar weight to wildtype littermates. 
Furthermore, mice null for Nrarp survive until adulthood and we have not observed 
any striking or overt physical or behavioural abnormalities in these mice. Because 
these mice survive, we were able to analyze their retinas for vascular abnormalities. 
 Nrarp mutants displayed a defect in the radial expansion of the vascular 
plexus from the optic nerve head to the periphery (Figure 44). At P3, there was no 
difference in the distance of vessel migration, indicating that initial migration of 
endothelial cells into the retina was normal. However, from P5 onwards, there was a 
dose-dependent delay in radial expansion when compare to wildtype littermates; the 
loss of two alleles of Nrarp resulted in a greater decrease in vessel migration 
compared to the loss of one Nrarp allele (Figure 44B-D). The decrease in radial 
expansion in Nrarp-/- mice was still significantly decreased compared to wildtype 
littermates at P7. However, radial expansion still continued so that by P14, the 
formation of the primary vascular plexus covering the surface of the retina was 
completed Figure 45A,B). Furthermore, sprouting of new blood vessels into the 
deeper layers of the retina to form the middle and lower vascular capillary beds 
proceeded normally and the plexuses formed were comparable to those of wildtype 
littermates (Figure 45C-J). 
 There was also a reduction in the overall vessel density in both Nrarp+/- and 
Nrarp-/- retinas at P4 to P7, the developmental stages that we have focused on. 
Quantification of vessel density during the formation of the primary vascular plexus 
at P5 revealed a significant reduction in Nrarp-/- and Nrarp+/- retinas compared to 
Nrarp+/+ littermate controls (Figure 46). In the migrating vascular front, there was a 
marked reduction in vessel branchpoints in P5 Nrarp+/- and Nrarp-/- retinas when 
compared to wildtype littermates. Nrarp+/- retinas exhibited a 27% reduction in 
vessel density (p < 0.0001) and Nrarp-/- a 45% reduction (p < 0.0001; Figure 46D). 
The reduction in vessel density was also observed in the more mature plexus of the 
retinal vasculature. In the capillary regions between the veins and arteries, there were 
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significant reductions of 16% and 36% in vessel branchpoints in the capillary 
plexuses of P5 Nrarp+/- (p = 0.0079) and Nrarp-/- (p < 0.0001) retinas, respectively, 
when compared to wildtype littermates (Figure 46E). The analyses of vessel 
branchpoints a revealed a dose-dependent effect of Nrarp expression in regulating 
vessel density. 
At higher magnification, vessels of Nrarp+/- and Nrarp-/- retinas were 
conspicuously narrow at branchpoints and appeared unstable and poorly lumenized. 
This is in marked contrast to vessels of wildtype animals, whose vessels were regular 
in diameter and appeared lumenized (Figure 47A). Also, vascular sprouts of Nrarp-/- 
and Nrarp+/- mice were generally more slender compared to those of Nrarp+/+ mice 
(arrowheads in Figure 47B,C). We next examined whether there was a defect in tip 
cell filopodia formation since loss of Notch signalling induces ectopic filopodia 
protrusion by endothelial cells (Hellstrom et al., 2007; Lobov et al., 2007; Suchting 
et al., 2007). However, by counting the number of filopodia per 100µm of leading 
endothelial membrane, we discovered that filopodia formation was not affected 
(Figure 47D), suggesting that loss of Nrarp does not regulate endothelial sprouting 
activity.  
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Figure 44. Loss of Nrarp results in delayed radial expansion of retinal blood 
vessels. 
A-C, Overviews of retinas from P5 Nrarp+/+, Nrarp+/- and Nrarp-/- animals that have 
been stained with anti-Collagen IV antibody. D, Graph displays blood vessel radial 
expansion (µm) from the optic nerve head. Loss of Nrarp results in a delay in the 
vascularization of the superficial layer of the retina from P5 to P7. *, p < 0.05; *, p < 
0.01. P3: Nrarp+/+, n = 8; Nrarp+/-, n = 5; Nrarp-/-, n= 4. P5: Nrarp+/+, n = 6; Nrarp+/-, n 
= 15; Nrarp-/-, n= 4. P6: Nrarp+/+, n = 3; Nrarp+/-, n = 4; Nrarp-/-, n= 4. P7: Nrarp+/+, n 
= 3; Nrarp+/-, n = 4; Nrarp-/-, n= 5. Values represent mean ± S.E.M. 
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Figure 45. Retina vascularization in Nrarp-/- mice is normalized by P14. 
P14 Nrarp+/+ and Nrarp-/- retinas were stained with Isolectin-B4 (white or green). A and 
B, overview images of retinas. C and D, confocal Z-stack of Nrarp+/+ and Nrarp-/- retinas 
revealing three vessel plexuses in the retina. The primary vessel plexus on the superficial 
layer of the retina (E,F), the middle vessel plexus (G,H) and the lower plexus (I,J) of 
wildtype and Nrarp-/- are shown. Vessel density in Nrarp-/- retinas appears similar to 
wildtype littermates in the three vascular plexuses. However, the vessels of the primary 
plexus of Nrarp-/- (F) appear tortuous compared to that of wildtype retina (E). A, artery; 
V, vein. 
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Figure 46. Loss of Nrarp leads to decreased vessel density in the retina. 
There is a decrease in vessel density in P5 Nrarp mutants. A-C, representative images of 
P5 Nrarp+/+, Nrarp+/- and Nrarp-/- retinas that have been stained with Isolectin-B4. Box-
and-whisker graphs show the number of vessel branchpoints per 100µm2 in the 
migrating vascular front (D) and capillary plexus (E) of Nrarp+/+, Nrarp+/- and Nrarp-/- 
retinas. ***, p <0.0001; ** p = 0.0079. Vascular front: Nrarp+/+, n=21; Nrarp+/-, n=29; 
Nrarp-/-, n=18. Capillary plexus: Nrarp+/+, n=41; Nrarp+/-, n=30; Nrarp-/-, n=15. 
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Figure 47. Normal filopodia protrusion in Nrarp-deficient endothelial tip cells. 
A-C, Confocal images of tip cells of P5 Nrarp+/+, Nrarp+/- and Nrarp-/- retinas stained 
with Isolectin-B4. Arrowheads indicate narrow vessels in Nrarp-deficient animals. D, 
box-and-whisker graph shows number of filopodia extended per 100µm vessel length. 
There are similar numbers of filopodia protrusions in P5 Nrarp+/+, Nrarp+/- and Nrarp-/- 
retinas. Nrarp+/+, n=20; Nrarp+/-, n=23; Nrarp-/-, n=19. m, microglia. 
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4.2.6 ZEBRAFISH EMBRYOS WITH DECREASED NRARP-A AND NRARP-B 
EXPRESSION DISPLAY ABNORMAL ISVS. 
The zebrafish expresses two nrarp paralogues, nrarp-a and nrarp-b. As their roles in 
angiogenesis have not been evaluated, we sought to determine whether, like in the 
mouse, the zebrafish also requires the function of nrarp during angiogenesis. The 
expression of nrarp-a and nrarp-b was knocked-down in Tg(fli1:EGFP)y1 zebrafish 
using morpholinos that block their protein translation (Ishitani et al., 2005) and the 
formation of ISVs in the morphants was examined 48-56 hours post fertilization 
(hpf). 
 At 56hpf, control morpholino-injected embryos had developed ISVs that 
extended dorsally between somite boundaries on both sides of the notochord and had 
formed the dorsal longitudinal anastomotic vessel (DLAV) (Figure 48A, A’). In 
addition, parachordal vessel (PAV) formation indicating the second wave of 
angiogenesis had commenced. nrarp-a and nrarp-b morphants also developed ISVs 
that reached the dorsal roof of the neural tube (Figure 48B’,C’). However, the 
morphology of the ISVs that formed was abnormal; ISVs were irregular in diameter 
and do not appear lumenized (Figure 48B’-D’). In addition, we also observed loss of 
vessel continuity in nrarp-a and –b morphants (yellow arrowheads in Figure 48B-D). 
Analyses of 80 ISVs from 10 embryos revealed that ~18% of ISVs of nrarp-a 
morphants displayed vessel disconnection; 12.5% occurred between the ISV and 
dorsal aorta, 1.25% within the ISV and 5% were at the ISV-DLAV junction (Figure 
48E). In nrarp-b morphants, 15% of ISVs display disconnections; 3.75% were at the 
ISV-DA junction, 2.5% within the ISVs, and 8.75% at the ISV- dorsal aorta junction 
(Figure 48E). In contrast, we rarely observed ISV disconnection in control 
morphants (2.5%). These observations indicate that reduced nrarp-a and nrarp-b 
function resulted in unstable interendothelial contacts, especially at vessel 
branchpoints. Knockdown of both nrarp-a and nrarp-b expression by injection of 5ng 
of each morpholino resulted in deformed ISV formation, vessel disconnections as 
well as misguidance in vessel patterning, a phenotype that was only observed upon 
knockdown of both proteins (Figure 48D). 
The observation that ISVs frequently disconnected from the dorsal aorta led 
us to ask whether there was ectopic vessel regression when nrarp-a or nrarp-b 
function was decreased. To address this, we performed time-lapse confocal laser 
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scanning microscopy of the morphants from 48hpf onwards for 4 to 8 hours (Figure 
49A-C). The movies acquired revealed that a decrease in nrarp-a or nrarp-b 
expression resulted in unusual endothelial cell retraction and consequent regression 
from the dorsal aorta as well as from the DLAV. In the movie of the control 
morphant, the ISVs remained connected with the dorsal aorta and the DLAV during 
the period of 4 hours of movie acquisition (Figure 49A). nrarp-a knockdown 
however, resulted in the gradual regression of the dorsal part of the ISV from the 
existing DLAV (arrowhead in Figure 49B). The movie also shows that the ISV on 
the far left had very poor connection with the dorsal aorta and the DLAV and failed 
to form a lumenized vessel (arrows in Figure 49B). On the other hand, the ISV on the 
far right of the image appeared patent and a secondary sprout from the PCV is 
observed adjacent to this ISV, indicating that secondary angiogenesis proceeded in 
nrarp-a morphants. In the movie of nrarp-b morphant, the ventral end of the middle 
ISV had already disconnected from the dorsal aorta at the 48hpf (Figure 49C). As 
imaging continued, the vessel regressed even farther from the dorsal aorta 
(arrowhead in Figure 49C). Furthermore, the tip cell of this vessel failed to 
anastomose with the adjacent tip cell to form the DLAV. Instead, the cell regressed 
away from the adjacent tip cell (arrowhead in Figure 49C).  
These movies provide evidence that reduction in nrarp-a and nrarp-b function 
results in dynamic vessel regression during sprouting angiogenesis. The observed 
regression explains the disconnection of blood vessels and also some missing ISVs 
that are occasionally observed at 56hpf in nrarp-a and nrarp-b morphants (Figure 
50C). It is also interesting to note that the migration and formation of new vascular  
 
Figure 48. Knockdown of nrarp-a and nrarp-b in zebrafish embryos results in 
defective ISV formation. 
A-D, Tg(fli1:EGFP)y1 zebrafish were injected with 10ng control (A), nrarp-a (B), 
nrarp-b (C) and 5ng each of nrarp-a and -b (D) morpholinos and analyzed at 
~56hpf. The anterior end of each embryo is to the left of the images. Defective ISVs 
were observed with reduced nrarp-a and -b function. Yellow arrows indicate very 
poor connection of the ISV to the dorsal aorta (B’,D’). Arrowheads indicate 
disconnected ISVs (B’-D’) and * indicate ISVs with delayed dorsal migration 
(B’,D’). White arrows show misdirected ISV formation (D’). E, Graph illustrates the 
percentage of ISVs in morphants that display disconnections between ISV and dorsal 
aorta, within ISV or between ISV and DLAV at 56hpf. 10 embryos (8 ISVs/embryo) 
were analyzed for each morphant. DLAV, dorsal longitudinal anastomotic vessel; 
ISV, intersegmental vessel; PAV, parachordal vessel; DA, dorsal aorta; PCV, 
posterior cardinal vein. 
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Figure 49. There is abnormal ISV regression in nrarp-a and nrarp-b morphants.  
Confocal time-lapse movies of Tg(fli1:EGFP)y1 zebrafish embryos that have been 
injected with 10ng control (A), nrarp-a (B) or nrarp-b (C) morpholino. Image 
acquisition began at 48hpf and continued for 4 to 8 hours. The ISVs of control 
morphants remained connected to the DA and DLAV (A). Note that the middle and 
right ISVs of the control morphant is out-of-focus. Knockdown of nrarp-a and nrarp-
b resulted in ectopic vessel regression. Arrowheads in B and C indicate ISVs that 
have regressed. Yellow arrows point to abnormally thin and non-patent vessels with 
weak connections to the DA or DLAV.  
 
 
sprouts were not affected upon decrease in nrarp-a and nrarp-b activity. This 
conclusion is based on the finding that the DLAV was formed, albeit poorly, in the 
presence of vessel regression (Figure 48C’, Figure 49B) indicating that the tip cell of 
each ISV continued to migrate dorsally even after losing adhesion with the adjacent 
endothelial cell. 
 132 
4.2.7 THE DEFECT IN ISV FORMATION IN NRARP-A AND NRARP-B MORPHANTS IS 
INDEPENDENT OF SOMITE FORMATION. 
Malformation of ISVs is often a result of defective somite formation. To ascertain 
that this was not the cause of the ISV defects observed when nrarp-a and nrarp-b 
expression was knocked-down, we examined the formation of myotome boundaries 
in the morphants at 48hpf using an antibody against Collagen XII. Collagen XII is 
expressed along myotendinous junctions at myotome boundaries as well as 
boundaries between the neural tube and notochord, the notochord and the dorsal 
aorta, and also along the developing PAVs (Figure 50A). We observed myotome 
boundary formation in nrarp-a, nrarp-b and double nrarp-a and -b morphants 
(Figure 50B-D) at 48hpf, indicating that the ISV malformations in these morphants 
are independent of myotome formation. The collagen XII staining also revealed that 
neural tube formation in nrarp-a morphants is slightly defective. The border between 
the neural tube and notochord is more irregular than that in uninjected embryos 
(Figure 50A and B). 
 
 
 
 
 
 
 
 
 
Figure 50. Defects in ISVs formation in nrarp-a and nrarp-b morphants are 
independent of somite formation. 
Wholemount anti-Collagen XII (red) staining of 48hpf fli1:(EGFP)y1 zebrafish 
embryos that were uninjected (A), injected with 10ng nrarp-a (B), 10ng nrarp-b (C) 
or 5ng nrarp-a and 5ng nrarp-b (D) morpholinos. Collagen XII is expressed along 
myotome boundaries (1 in A), boundaries between the neural tube and notochord (2), 
the notochord and dorsal aorta (DA, 4) and also along the developing parachordal 
vessels (PAVs, 3). There is unspecific staining in the yolk stalk. Arrows in B-D 
indicate absence of or regressing ISVs in the presence of myotome boundary. 
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4.2.8 LOSS OF NRARP EXPRESSION ALSO RESULTS IN ECTOPIC VESSEL 
REGRESSION IN THE RETINA. 
The observations made from zebrafish time-lapse movies prompted us to examine 
Nrarp-deficient mice for excessive vessel regression. As dynamic imaging of mouse 
retina is not yet possible, we resorted to immunostaining retinas for the basement 
membrane component, collagen IV, and endothelial cell junction proteins such as 
Claudin 5 and VE-cadherin. Collagen IV is produced by endothelial cells as they 
mature so that its expression regularly co-localizes to endothelial markers such as 
Isolectin-B4 (Figure 51) and endomucin (not shown). However, during the process 
of vessel pruning or regression, empty basement sleeves often remain after 
endothelial cells have regressed. In the retina, pruning is a physiological component 
of network remodeling and is most prominent in areas where there is high oxygen 
tension, such as areas in close proximity to arteries (Figure 51; Claxton and Fruttiger, 
2005). Empty collagen IV sleeves are frequently observed in proximal regions of the 
artery closest to the optic nerve head (arrowheads in Figure 51A), indicating the 
previous existence of vessels that were connected to the artery but have since 
regressed. This method of detecting vessel regression has previously been used 
(Baffert et al., 2006). Another means of determining regressing vessels is by 
examining endothelial cell junction expression. Junction proteins such Claudin 5 are 
often localized to interendothelial junctions in a continunous manner (Figure 51B). 
An exception to this localization is during vessel regression when Claudin 5 is no 
longer confined to intermembrane junctions but is instead internalized to vesicular 
structures (yellow arrows in Figure 51B). Also, the loss of junctional continuity 
between two connecting vessels is also an indicator of vessel regression (white arrow 
in Figure 51B). These changes in junctional arrangement were frequently detected 
before complete vessel disconnection has occurred, suggesting that this event 
precedes vessel regression. Therefore, by triple staining retinas with antibodies 
against Collagen IV, Claudin 5 and Isolectin-B4, we were able to assess whether 
there was increased vessel regression by increased empty Collagen IV sleeves and 
abnormal endothelial cell junction staining in Nrarp-deficient retinas.  
At the sprouting vascular front of P5 Nrarp+/+ retinas, Collagen IV regularly 
co-localized with endothelial Isolectin-B4 staining, suggesting that newly formed 
vessels in  
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Figure 51. Vessel regression profiles along the artery in the retina. 
P6 wildtype retinas were immunostained with antibodies against Claudin 5 (red), 
Collagen IV (green) and Isolectin-B4 (blue). Empty Collagen IV sleeves 
(arrowheads A, C and E) were often detected along the length of the artery, 
especially towards the optic nerve head (bottom of image). B-E, high magnification 
of boxed area in A, where vessel pruning is on-going as indicated by redistribution of 
Claudin 5 (yellow arrows and * in B) and remnants of Collagen IV (arrowheads). In 
the artery, Claudin 5 is localized along the length of the vessel at interendothelial 
junctions. However, in regressing vessels, it is accumulated in vesicular-like 
structures (yellow arrows in B) and there is a loss of junctional connection between 
the smaller vessel and the artery (white arrow in B). Another common feature in 
regressing vessels is the jagged appearance of Claudin 5 staining (* in B). 
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Figure 52. Increased vessel regression in the sprouting front of retinal vessels of 
Nrarp-/- mice. 
Vascular front of P5 Nrarp+/+ (A) and Nrarp-/- (B ,C) retinas that have been 
immunostained with antibodies against Claudin 5 (green), Collagen IV (red) and 
Isolectin-B4 (blue). In Nrarp+/+ retinas, vessel regression occurs behind the sprouting 
front (dots in A). However in Nrarp-/- retinas, vessel regression is observed at, as 
well as behind, the sprouting front (dots in B). Endothelial junctions in Nrarp+/+ 
retinas are frequently in continuum with junctions of adjacent vessels (A’). In Nrarp-
/- retinas, there are regions where there is a loss of continuum so that endothelial 
junctions in the same vessel appeared segregated or constricted (yellow arrows, B’). 
In C’, three consecutive vessels have lost junctional connection with the adjacent 
vessel (yellow arrows).  
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Figure 53. Increased vessel regression and loss of endothelial junctional stability 
in capillary plexus of Nrarp-deficient mice. 
A-H, Capillary plexuses of P6 Nrarp+/+ (A-D) and Nrarp-/- (E-H) retinas that have 
been stained with for Claudin 5 (green), Collagen IV (red), and Isolectin-B4 (blue). 
In Nrarp+/+ retinas, there is some vessel regression in the capillary plexus (dots in B) 
and tight junctions are continuous between endothelial cells that form adjacent 
vessels (A, C, D). C and D are magnified images of boxed regions in A and B. 
However, in Nrarp-/- retinas, there is increased vessel regression (dots in F) and 
discontinuous endothelial junctions (arrows and arrowheads in E, G, and H). G and 
H are magnified images of boxed region in E and F, illustrating discontinuity of 
endothelial junctions between vessels. Yellow arrows indicate punctate claudin 5 
staining whereas white arrows point to loss of claudin 5 continuity between vessels. 
I, box-and-whisker graph shows the ratio of Isolectin-B4-positive vessels to collagen 
IV-positive vessels. Values below 1 indicate increased vessel regression. Nrarp+/- 
and Nrarp-/- mice undergo significantly more vessel regression in the capillary plexus 
compared to Nrarp+/+ mice. ***, p < 0.0005. Nrarp+/+, n=13; Nrarp+/-, n=8; Nrarp-/-, 
n=20. 
 
the vicinity of high VEGF production rarely regress (Figure 52A). However, some 
vessel regression is observed behind the vascular front (dots in Figure 52A). In P5 
Nrarp-/- retinas, we detected vessel regression profiles at, as well as behind, the 
vascular front, where sprouting occurs (dots in Figure 52B). Additionally, there are 
regions along vessels where endothelial junctions are not continuous but appeared 
segregated from each other (Figure 52B’) and in some regions, there is loss of 
junctional connectivity between adjacent vessels (Figure 52C’). Such junctional 
staining suggests that nascent vessels in Nrarp-/- retinas are unstable. 
Vessel regression occurs in the capillary plexus of wildtype retinas (dots in 
Figure 53 B). By quantifying vessel regression, we discovered a significant increase 
in vessel regression in the capillary plexus of Nrarp+/- (p = 0.0004, Figure 53I) and 
Nrarp-/- retinas (p = 0.0001, Figure 53I; dots in Figure 53F) when compared to 
wildtype littermates. This is accompanied by a marked change in endothelial junction 
arrangement. In the capillary plexus of Nrarp+/+ mice, we observed continuous 
interendothelial junctions along vessels and between vessels (Figure 53A,C). 
However, in Nrarp-/- mice, there were many areas where junctions within and 
between vessels have become discontinuous so that junctions appear isolated (white 
arrows in Figure 53E, G and H) and often all that remained were punctate Claudin 5 
staining (yellow arrows in Figure 53E, G and H).  
These observations suggest that excess vessel pruning occurred 
concomitantly with sprouting even in regions of strong growth factor stimulation in 
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Nrarp-deficient retinas. Such an event would favour vessel regression rather than 
vessel growth. The observed increase in vessel regression in the sprouting region 
could very well explain both the delayed retinal vascularization and the reduced 
vascular density in Nrarp deficient retinas.  
Likewise in the zebrafish, we observed a change in the stability of 
interendothelial junctions between ISVs and dorsal aorta in zebrafish nrarp-a 
morphants. To visualize cellular junctions, zebrafish embryos were stained with anti-
ZO1 antibody (Blum et al., 2008) and analyzed by confocal microscopy. At 48hpf in 
uninjected embryos, the base of ISV was composed of 2 endothelial cells that formed 
a firm, ring-shaped interendothelial junction with the dorsal aorta (Figure 54A). In 
nrarp-a and –b morphants, interendothelial junctions are formed; however, the 
formation of firm junctions between the ISVs and the dorsal aorta was frequently lost 
in nrarp-a morphants (Figure 54B) and also in nrarp-b morphants (data not shown). 
Instead, interendothelial junctions frequently appeared detached from the dorsal aorta 
(arrows in Figure 54). The connection between ISV and dorsal aorta of nrarp-a and –
b morphants were frequently lost (12.5% and 8.75%, respectively; Figure 54E). The 
observation that nrarp-a and –b morphants display poorly formed interendothelial 
junctions suggest that vessel regression is preceded by a loss of endothelial junction 
integrity. 
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Figure 54. nrarp-a morphants display abnormal endothelial junctions. 
A and B, Zona occludens 1 (ZO1, red) staining in uninjected and nrarp-a 
morpholino-injected Tg(fli1:EGFP)y1 (green) zebrafish embryos at 48hpf. A’ and B’ 
are magnified Z-stack images of the boxed regions in A and B, respectively. 
Endothelial junctions are illustrated by red tracing in A” and B”. Arrow points to 
poor interendothelial junction between ISV and dorsal aorta in nrarp-a morphants. 
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4.2.9 LOSS OF NRARP FUNCTION DOES NOT LEAD TO ECTOPIC APOPTOSIS. 
Hyaloid vessel regression is triggered by endothelial cell apoptosis (Lobov et al., 
2005). We therefore examined whether ectopic vessel regression observed in Nrarp-
deficient mice and in nrarp-a and –b zebrafish morphants was also a result of 
endothelial apoptosis.  
 In mammalian cells, caspase 3 is a key mediator of apoptosis. We therefore 
investigated whether there was aberrant apoptosis in Nrarp mutants by 
immunostaining for active caspase 3. In wildtype P5 retinas, active caspase 3 
staining was observed in some neuronal cells of the retina but not in any endothelial 
cells of the developing vasculature (Figure 55A). Similarly in Nrarp-/- retinas, we 
were not able to detect apoptotic endothelial cells (Figure 55B).  
 
 
 
 
 
Figure 55. Active caspase 3 staining in the retina. 
P5 retinas were stained with anti-active caspase 3 antibody (red) and Isolectin-B4 
(green). In wildtype retinas, some neuronal cells (arrowheads) and macrophages 
(arrow) are apoptotic (A). However, apoptosis was not detected in endothelial cells. 
In Nrarp+/+ retinas, we did not observe endothelial cells undergoing apoptosis (B).  
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Figure 56. TUNEL staining in zebrafish embryos. 
A-F, uninjected (A,B), nrarp-a (C,D) and nrarp-b (E,F) morpholino-injected 
Tg(fli1:EGFP)y1 embryos were processed for wholemount TUNEL (red) staining at 
48hpf. Arrows in D and F indicate ISVs that have regressed from the DA. There is 
no ectopic endothelial apoptosis. 
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To assess apoptosis in the zebrafish, wholemount TUNEL (Terminal 
deoxynucleotidyl transferase dUTP nick end labelling) assay was performed at 
48hpf. At this developmental stage, apoptosis is observed in some cells at the very 
end of the tail Figure 56A). Some apoptotic cells were also observed in the trunk 
region of the embryo (Figure 56B); however, none of these cells were endothelial. In 
zebrafish embryos that have been injected with 10ng nrarp-a morpholino, there was 
an expansion in apoptosis in the tail bud region so that apoptosis is no longer 
confined to the tail end (Figure 56C). There was also a slight increase in the TUNEL 
staining in the trunk region of the embryos (Figure 56D). However, we were not able 
to detect apoptosis in endothelial cells, even in ISVs that have regressed from the 
dorsal aorta (arrows in Figure 56D). We also did not observe an increase in apoptosis 
in nrarp-b morphants (Figure 56E, F). 
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4.2.10 NORMAL ASTROCYTE NETWORK AND PERICYTE COVERAGE IN NRARP 
MUTANTS. 
The proper development of blood vessels in the retina requires tight interaction with 
two other cells types: astrocytes and pericytes. The astrocytic network guides vessel 
patterning (Gerhardt et al., 2003) as well as stimulating blood vessel growth by 
secreting VEGF-A (Fruttiger, 2002; Zhang and Stone, 1997). Although we detected 
Nrarp expression predominantly in endothelial cells in the superficial layer of the 
retina, other cell types in the inner nuclear layer of the retina also express Nrarp 
(Blackshaw et al., 2004). It was therefore important to examine whether other cell 
types in the retina developed normally in Nrarp-/- animals and to ensure that the 
vascular phenotype we observed was not a secondary effect from abnormal 
development of other retinal cells.  
 Astrocytes were visualized by staining the retinas for glial fibrillary acidic 
protein (GFAP). GFAP expression is strongest when astrocytes are mature and this is 
observed in regions where they are associated with blood vessels (Gariano, 2003; 
West et al., 2005). Immunostaining of both P4 Nrarp+/+ and Nrarp-/- retinas showed 
strong GFAP expression in the central regions of the retina that became weaker 
towards the periphery of the retina (Figure 57A and B). The density of the astrocytic 
network developed in Nrarp-/- retinas (Figure 57B,D) was similar to that in wildtype 
littermates (Figure 57A,C). In wildtype retinas, astrocytes were often associated with 
blood vessels (Figure 57C’). However, in Nrarp-/- retinas, there were many regions 
where astrocytes were not associated with blood vessels (Figure 57D’). This can be 
explained by the reduction in vessel density in Nrarp-/- retinas (Figure 46). This 
finding indicates that there is normal astrocyte density in Nrarp-/- retinas and that the 
vascular phenotype in Nrarp mutants is independent of astrocyte development. 
During vessel maturation, the supportive functions of pericytes contribute to 
vessel stability (Hoffmann et al., 2005; Holash et al., 1999). Accordingly, inhibition 
or genetic inactivation of PDGF-B signalling or alteration of the Ang-1/Ang-2 
balance promotes loss of pericytes followed by selective vessel regression (Enge et 
al., 2002; Hammes et al., 2004; Sennino et al., 2007). We therefore investigated 
whether the excess vessel regression in Nrarp-deficient mice is caused by a decrease 
in pericyte coverage of blood vessels. In P7 wildtype retinas, pericytes were tightly 
associated with blood vessels at the vascular front (Figure 58A) and in the capillary 
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plexus (Figure 58C). An exception is at sprouting vessels, which were not covered 
by pericytes. In Nrarp-/- retinas, vessels at the vascular front (Figure 58B) and 
capillary plexus (Figure 58D) were also associated with pericytes. This finding 
indicates that the ectopic vessel regression that occurs in the absence of Nrarp 
expression is independent of pericyte recruitment. 
 
 
Figure 57. Normal astrocyte network in Nrarp-/- retinas. 
P4 Nrarp+/+ and Nrarp-/- retinas were stained with anti-GFAP antibody (red) to 
visualize astrocytes and Isolectin-B4 (green) to visualize blood vessels. Astrocytic 
networks formed in the retinas are similar in both wildtype and Nrarp-/- animals. 
Arrows point to astrocytes that are not associated with blood vessels. This is more 
frequent in Nrarp-/- retinas (D’). OpN, optic nerve.  
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Figure 58. Normal pericyte coverage of blood vessels in Nrarp-/- mice. 
Antibody against chondroitin sulfate proteoglycan 4, more commonly known as 
NG2, was used to detect pericytes (red) in the retina. Apart from endothelial tip cells 
at the migrating front of the vasculature, pericytes are associated with blood vessels 
(green, Isolectin-B4) of P7 Nrarp+/+ (A,C) and Nrarp-/- (B,D) mice. Arrowheads 
indicate cell bodies of pericytes. 
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4.2.11 LOSS OF NRARP EXPRESSION RESULTS IN DECREASED ENDOTHELIAL CELL 
PROLIFERATION. 
Notch signalling regulates endothelial cell proliferation. In the absence of Notch 
signalling, more endothelial cells proliferate and adopt the explorative migrating tip 
cell behaviour, leading to excessive numbers of endothelial cells in the ISVs (Leslie 
et al., 2007; Siekmann and Lawson, 2007). In the mouse, loss of Notch signalling 
also leads to an increase in endothelial cell proliferation (Hellstrom et al., 2007; 
Lobov et al., 2007; Suchting et al., 2007). We therefore investigated whether Nrarp 
has a role in regulating endothelial proliferation by BrdU incorporation. 
 Nrarp+/+, Nrarp+/- and Nrarp-/- mice were treated with BrdU intraperitoneally 
at P5 and retinas were analyzed for BrdU incorporation 3 hours later. There was a 
significant decrease in endothelial cell proliferation in Nrarp-/- retinas at P5 (p = 
0.0328; Figure 59C,D) when compared to wildtype littermates (Figure 59A,D). 
Proliferation was normal in Nrarp+/- retinas (Figure 59B,D). 
In the zebrafish, endothelial cells undergo controlled proliferation during ISV 
formation. To study proliferation in the zebrafish, embryos were exposed to BrdU 
from 19hpf, when endothelial cells began to migrate from the dorsal aorta, until 
48hpf, when the ISVs and DLAV have formed. During this period, any cells within 
the ISV that have divided were detectable by BrdU staining. In the control 
morphants, all endothelial cells within the ISV showed BrdU incorporation (99%; 
Figure 60A,D). We found a clear reduction in the number of BrdU-positive 
endothelial cells in both nrarp-a and nrarp-b morphants (nrarp-a MO, 17.5%, p = 
0.0003; nrarp-b MO, 19%, p = 0.0086; Figure 60B-D). In some ISVs, no endothelial 
cell had undergone division, indicating that these ISVs formed solely by migrating 
endothelial cells from the dorsal aorta. In addition, wholemount BrdU staining of the 
zebrafish embryos revealed that other cell types in the neural tube, notochord and 
myotome had proliferated during the period of BrdU incorporation. However, we 
noticed proliferation in some cells in the dorsal fin of control zebrafish (Figure 60A) 
that were absent in nrarp-a (Figure 60B) and nrarp-b (Figure 60C) morphants. 
The significant decrease in endothelial cell proliferation offers an explanation 
for the decrease in the number of endothelial cells that composed the ISVs in nrarp-a 
and nrarp-b morphants. In control embryos, the number of endothelial cell nuclei
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Figure 59. Decreased endothelial cell proliferation in Nrarp-/- mice. 
P5 Nrarp+/+, Nrarp+/- and Nrarp-/- mice were injected with BrdU intraperitoneally and 
retinas were analyzed for BrdU incorporation 3 hours later. There is a significant 
decrease in endothelial cell proliferation in Nrarp-/- retinas. A-C, retinas were stained 
with anti-BrdU antibody (red) and Isolectin-B4 (green). BrdU-positive endothelial 
cells are circled. Other BrdU-positive nuclei are those of astrocytes and pericytes. D, 
bar graphs show number of proliferated endothelial cells in 10,000µm3 retinal 
vessels after 3 hours of BrdU incorporation. *, p=0.0328. Nrarp+/+, n=17, Nrarp+/-, 
n=8; Nrarp-/-, n=14. Values represent mean ± S.E.M. 
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Figure 60. Decreased endothelial cell proliferation and number in ISVs of 
nrarp-a and nrarp-b morphants. 
Control, nrarp-a and nrarp-b morpholino-injected Tg(fli1:EGFP)y1 zebrafish 
embryos were exposed to BrdU (red) from 19 to 48hpf. There is a decrease in 
endothelial cell proliferation upon knockdown of nrarp-a and nrarp-b expression. In 
A-C, all endothelial cells along ISVs at 48hpf have been circled, and arrows indicate 
endothelial cells that have proliferated. D, graph shows the percentage of endothelial 
cells composing ISVs that are BrdU-positive: control MO, 99.5%; nrarp-a MO, 
82.5% and nrarp-b MO, 81%. **, p = 0.0086; ***, p = 0.0003. Control MO, n = 8 
(31 ISVs); nrarp-a MO, n = 6 (47 ISVs); nrarp-b MO, n = 14 (66 ISVs). Values 
represent mean ± S.E.M. There is a decrease in the number of endothelial cell nuclei 
that composed ISVs in nrarp-a and nrarp-b morphants. E, bar graph shows the 
percentage of ISVs containing x number of endothelial cell nuclei per ISV at 48hpf. 
Control MO, n=17; nrarp-a MO, n=16; nrarp-b MO, n=21. At least 8 embryos were 
analyzed and 8 ISV/embryo were counted. 
 
 
within ISVs varied from 1 to 6, with the largest percentage (35.5%) of vessels having 
four nuclei (Figure 60E). However, in both nrarp-a and nrarp-b morphants, there 
was a decrease in endothelial cell nuclei within the ISVs. Most ISVs contained only 
two endothelial cell nuclei (nrarp-a MO, 43%; nrarp-b MO, 41%; Figure 60E).  
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4.2.12 LOSS OF NRARP EXPRESSION ALTERED VEGF RECEPTOR EXPRESSION. 
As described in the previous chapter, Notch signalling negatively and positively 
regulates Kdr and Flt1 expression, respectively. We therefore investigated whether 
the expression of VEGF receptors were altered in Nrarp mutant retinas by qPCR. It 
was also important to address whether there was a decrease in VEGF-A expression 
in Nrarp mutants since withdrawal of VEGF-A rapidly leads to loss of blood vessel 
connections in adult mice (Baffert et al., 2006; Inai et al., 2004). Thus, reduction of 
VEGF-A levels appears sufficient to induce vessel pruning. We therefore also 
investigated whether there was a decrease in Vegfa expression in Nrarp mutant 
retinas. 
We observed increases in Vegfa and Kdr mRNA expression levels in Nrarp-/- 
when compared to Nrarp+/+ retinas; however, these increases were statistically 
insignificant (Figure 61). There was also a dramatic increase in Flt1 mRNA 
expression in Nrarp-/- compare to Nrarp+/+ retinas. However, this increase was again 
insignificant because of the big variance in the Flt1 mRNA expression from Nrarp-/- 
retinas. 
 
 
Figure 61. Vegfa, Flt1 and Kdr expression in P5 retinas from Nrarp mutant 
mice. 
Graph illustrates the relative expression levels of Vegfa, Flt1 and Kdr mRNA in 
wildtype, Nrarp+/- and Nrarp-/- P5 retinas. t-test analysis revealed no significant 
difference in the expression between animals of different genotypes. Nrarp+/+, n = 5; 
Nrarp+/-, n = 6; Nrarp-/-, n = 6. Values represent mean ± S.E.M. 
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4.2.13 LOSS OF NRARP EXPRESSION INCREASED NOTCH SIGNALLING. 
Nrarp has been reported to act as a negative regulator of Notch signaling (Ishitani et 
al., 2005; Lamar et al., 2001). A mechanism for this negative regulation is through 
destabilization of the Notch intracellular domain (NICD) by Nrarp, which has been 
shown in Xenopus and zebrafish (Ishitani et al., 2005; Lamar et al., 2001). However, 
the negative regulatory role of Nrarp in Notch signalling has not been demonstrated 
in the mouse.  
 We initially planned to determine the regulation of Nrarp on Notch signalling 
at a cellular resolution in the developing mouse retinal vasculature by breeding 
Nrarp-deficient mice with the TNR Notch reporter mouse. Unfortunately, these mice 
no longer expressed GFP in the retina nor in other tissues examined e.g. embryonic 
neural tube. We were therefore unable to determine whether there was an increase in 
GFP signal in Nrarp-/-;TNR+ mice and if there was, where the increase was within 
the different endothelial cell populations in the retinal vasculature. 
We therefore resorted to investigating Notch activity using whole retinal 
lysates. Firstly, analysis of NICD1 in the retina by Western Blotting revealed a slight 
increase of 22% in NICD1 protein level in P5 Nrarp-/- retinas when compared to 
Nrarp+/+ (Figure 62A). This finding confirms previous reports that Nrarp destabilizes 
NICD1 so that NICD1 is degraded (Ishitani et al., 2005; Lamar et al., 2001). 
Secondly, qPCR analyses revealed significant increases in the expression of Notch 
target genes Hey2 (p = 0.0426) and Lunatic fringe (Lnfg, p = 0.0025) in Nrarp-/- 
retinas when compared to Nrarp+/+ retinas (Figure 62B). There was also a slight but 
significant increase in Lnfg expression in Nrarp+/- retinas (Figure 62B, p=0.015), 
suggesting a dose-dependent negative regulation of Notch signalling through Nrarp. 
 We next investigated whether the negative regulation of Notch signalling by 
Nrarp also occurs in endothelial cells, since the experiments described above used 
whole retina lysates. To address this, endothelial cells were isolated from lungs of 
adult Nrarp+/+ and Nrarp-/- mice and cultured on plates coated with recombinant Dll4 
to stimulate Notch signalling. The expression of Hey2 in endothelial cells from 
Nrarp+/+ and Nrarp-/- were subsequently compared by qPCR. As shown in Figure 
62C, loss of Nrarp in endothelial cells resulted in a significant increase of 146% in 
Hey2 expression (p = 0.0004) when compared to Nrarp+/+ endothelial cells. 
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 The experiments described here show, as well as support existing data, that 
Nrarp negatively regulates Notch signalling in the mouse. Furthermore, we have 
demonstrated that this regulation also exists in endothelial cells. 
 
Figure 62. Loss of Nrarp 
leads to increase in Notch 
signalling in the mouse 
retina and in isolated 
endothelial cells. 
A, NICD1 level in P5 
retinas of Nrarp+/+. 
Nrarp+/- and Nrarp-/- mice 
were examined by Western 
Blotting. There is an 
increase of 22% in the 
NICD1 level when Nrarp 
expression is lost. 
However, this difference is 
not significant after t test 
analysis.  
B, the expression of Notch 
target genes Hey1, Hey2 
and Lnfg in P5 retinas 
were investigated by 
qPCR. There are increases 
in Hey1, Hey2 and Lnfg 
expression in Nrarp-/- 
retinas. Only Lnfg 
expression is increased in 
Nrarp+/- retinas. **, 
p<0.01; *, p<0.05. 
Nrarp+/+, n=5; Nrarp+/-, 
n=6; Nrarp-/-, n=6. C, 
relative Hey2 expression in 
endothelial cells isolated 
from adult lungs by qPCR. 
There is a significant 
increase in Hey2 
expression in Nrarp-/- ECs. 
***, p = 0.0004. n = 6 for 
each genotype. Values in B and C show mean ± S.E.M. 
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4.2.14 DAPT TREATMENT PARTIALLY RESCUED NRARP-/- VASCULAR DEFECT. 
We subsequently asked whether the increase in Notch signalling is the cause of the 
observed vascular phenotype in Nrarp-/- mice. If so, inhibition of Notch signalling in 
Nrarp-deficient retinas would rescue the vascular phenotype. To test this hypothesis, 
we inhibited Notch signalling in vivo pharmacologically by administrating the γ-
secretase inhibitor, DAPT, subcutaneously once every 24 hours for 48 hours from P5 
onwards. At the end of the treatment (P7), the retinas were stained with anti-
Collagen IV antibody and Isolectin-B4.  
 DAPT treatment resulted in an increase in vessel density in retinas of 
Nrarp+/+ (Figure 63A) and Nrarp+/- (Figure 63B) mice, especially in the plexus that 
underwent sprouting angiogenesis during the period of treatment. Although not as 
obvious, there was also an increase in vessel sprouting in Nrarp-/- (Figure 63C) that 
is clearly evident at the vascular front (Figure 63K). This increase in sprouting 
restored vessel density in Nrarp-/- to normal wildtype density. We next investigated 
whether there was a reduction in vessel regression in the capillary plexus after DAPT 
treatment by measuring the ratio of Isolectin-B4-positive vessel to Collagen IV-
positive vessels in P7 retinas. Firstly, this analysis revealed that at P7, the extent of 
vessel regression is similar in both Nrarp+/+ and Nrarp-/- retinas (Figure 63F). This is 
in contrast to the significant increase in vessel regression at P5 in Nrarp-/- compared 
to wildtype retinas of the same age (Figure 53I). This observation suggests that the 
ectopic increase in vessel regression upon loss of Nrarp is transient during retinal 
angiogenesis so that by P7, the extent of vessel regression is similar to wildtype 
animals. In fact, some regions in the capillary plexus of P7 Nrarp-/- retinas have an 
Isolectin/Collagen IV ratio of > 1 (Figure 63F), suggesting that there is increased 
sprouting in Nrarp-/- retinas. This analysis also showed that DAPT treatment 
significantly increased vessel sprouting in Nrarp+/+ retinas (p = 0.0024, F). However, 
there is no significant change in vessel regression in the capillary plexus of DAPT-
treated Nrarp-/- retinas when compared to untreated Nrarp-/- retinas (Figure 63F). 
Nevertheless, we did observe an increase in vessel sprouting in some regions of the 
capillary plexus by immunostaining (arrows in Figure 63E). This increase in vessel 
sprouting may “mask” empty collagen IV sleeves, so that it is not possible to 
ascertain whether there is a difference in vessel regression between untreated and 
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Figure 63. DAPT treatment restored vessel density but not vessel morphology in  
Nrarp-/- mice.  
A-E, P5 Nrarp+/+. Nrarp+/- and Nrarp-/- mice were injected with DAPT for 48 hours. 
Retinas were stained with anti-Collagen IV antibody (red) and Isolectin-B4 (green) 
at P7. A-C, overviews of retinas from 48h DAPT-treated Nrarp+/+. Nrarp+/- and 
Nrarp-/- mice. Double-ended arrows indicate an increase in vessel density in Nrarp+/+ 
and Nrarp+/- retinas (A,B). D and E, capillary plexuses of DAPT-treated Nrarp+/+ 
and Nrarp-/- retinas, respectively, displaying anti-Collagen IV and Isolectin-B4 
staining. There is increased vessel sprouting in both images (arrows). F, 
quantification of vessel regression or vessel sprouting in P7 Nrarp+/+ and Nrarp-/- 
retinas with or without DAPT treatment. **, p = 0.0024. untreated Nrarp+/+, n = 11; 
DAPT Nrarp+/+, n = 8; untreated Nrarp-/-, n = 10; DAPT Nrarp-/-, n = 18. G, relative 
expression of Flt1, Kdr, Hey2 and Lnfg in 48h DAPT-treated Nrarp-/- retinas 
compared to untreated Nrarp-/- retinas. There is no significant difference in 
expression. Untreated, n = 3; DAPT, n = 5. Values show mean ± S.E.M. H-J, high 
magnification of sprouting front of P7 Nrarp+/+, Nrarp-/- and 48h DAPT-treated 
Nrarp-/- retinal vasculature. There is increased filopodia protrusion and vessel 
formation in DAPT-treated Nrarp-/- retinas (J) compared to untreated Nrarp-/- retinas 
(I). Arrowheads indicate thin and poorly connected blood vessels in untreated and 
DAPT-treated Nrarp-/- retinas.  
 
 
DAPT -treated Nrarp-/- retinas.  
 In the previous chapter, I have shown that DAPT treatment for 3 or 6 hours 
inhibits Notch signalling in the retinal blood vessels (Figure 24). We therefore 
examined whether DAPT treatment for 48 hours reduced the increases in Hey2, Lnfg 
as well as Flt1 and Kdr expression in Nrarp-/- retinas by qPCR (Figure 63G). The 
expression of all four genes was not significantly different from vehicle-treated 
Nrarp-/- retinas (Figure 63G). One way of interpreting this result is that DAPT 
treatment for 48 hours failed to decrease Notch signalling. However, it is premature 
to state this since, firstly, we have not assessed the transcriptional changes in Notch 
target genes after 48h DAPT treatment in wildtype retinas. We therefore do not know 
whether this length of DAPT treatment inhibits expression of Notch target genes. 
However, a Notch loss-of-function vascular phenotype was obtained, suggesting that 
48h DAPT treatment did inhibit Notch signalling even though we did not detect a 
decrease in Notch transcriptional activity by qPCR. Secondly, we previously showed 
that there was significant increase in Hey2 and Lnfg in P5 Nrarp-/- retinas, when 
compared to Nrarp+/+ retinas. The animals that we have used for the DAPT rescue 
experiments were P7 at the time of qPCR analysis. There may therefore be 
developmental stage differences in Notch activity at P5 and P7 wildtype retinas. In 
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addition, we do not know whether the increase in ectopic Notch signalling still 
occurs at P7 in Nrarp-/- retinas. Thus, further experiments need to be performed to 
investigate the expression of Notch target genes in wildtype P7 retinas and compare 
that to those in wildtype P5. Furthermore, absolute quantitative PCR may be a better 
choice for the PCR analysis as apposed to relative quantitative PCR. Additionally, a 
more specific inhibitor of Notch signalling such as Dll4-Fc should be used in 
conjunction with DAPT in the attempt to decrease ectopic endothelial Notch 
signalling in Nrarp-/- retinas. 
High magnification of the sprouting vessels in DAPT-treated Nrarp-/- (Figure 
63J) revealed an increase in filopodia protrusion by endothelial tip cells when 
compared to untreated Nrarp-/- (Figure 63I). In addition, there was also an increase in 
the formation of blood vessels (Figure 63J); however, the vessels that formed were 
still thin and poorly connected like those found in untreated Nrarp-/- (arrowheads in 
Figure 63I). Thus, DAPT treatment did not normalize Nrarp-/- blood vessel 
morphology to those of Nrarp+/+ animals (Figure 63H).  
In summary, 48h DAPT treatment of Nrarp-/- retinas did not normalize the 
abnormally thin and poorly connected vessels that form when Nrarp expression is 
lost (Figure 63I). This finding suggests that the vascular phenotype in Nrarp-
deficient mice may not be a result of increased Notch signalling.  
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4.2.15 LOSS OF NRARP EXPRESSION DECREASED WNT SIGNALLING. 
We next investigated whether Nrarp can function through the Wnt signalling 
pathway to regulate blood vessel morphogenesis. Ishitani et al reported that zebrafish 
nrarp-a binds to and stabilizes the Lymphoid enhancer factor 1 (Lef1) by preventing 
its degradation (Ishitani et al., 2005). In human umbilical vein endothelial cells 
(HUVECs), endogenous LEF1 protein co-immunoprecipated with Myc-tagged 
mouse Nrarp, confirming the interaction between Nrarp and LEF1 in endothelial 
cells (Figure 64A). We next examined the level of Lef1 protein in the retina of 
Nrarp-/- mice by Western blotting. We observed a reduction in Lef1 in Nrarp+/- and 
Nrarp-/- retinas when compared to wildtype littermates (Figure 64B), suggesting that 
Nrarp also regulates Lef1 stability in the mouse. 
 In order to determine whether Nrarp regulates Wnt signalling in endothelial 
cells, two approaches were undertaken. The first was isolation of endothelial cells 
from adult lungs of Nrarp+/+ and Nrarp-/- mice. Isolated endothelial cells were 
cultured on recombinant mouse Dll4-coated plates and the expression of CyclinD1, 
whose expression is directly regulated by the β-catenin/Tcf/Lef1 complex (Shtutman 
et al., 1999; Tetsu and McCormick, 1999) was compared between wildtype and 
Nrarp-/- endothelial cells by qPCR. Indeed, there was a significant decrease of 42% 
in CyclinD1 expression in Nrarp-/- endothelial cells (p = 0.0190; Figure 64B). The 
same cells also displayed an increase in Hey2 expression (p = 0.0004; Figure 64B). 
These data, therefore, show that Nrarp differentially regulates Notch and Wnt 
signalling in endothelial cells. 
The second method employed to investigate Nrarp regulation of Wnt 
signalling  in endothelial cells was the use of the TOPFlash luciferase reporter in 
HUVECs combined with knockdown of NRARP expression by siRNA. The 
TOPFlash reporter contains eight Tcf/Lef1 binding sites in the promoter that drives 
the transcription of luciferase (Veeman et al., 2003). Stimulation of HUVECs with 
Wnt3a, a Wnt ligand, resulted in an increase in TOPFlash activity when compared to 
unstimulated HUVECs (Figure 64D). Knockdown of NRARP suppressed the increase 
in TOPFlash activity that was induced to basal level (p = 0.0002; Figure 64D). We 
also investigated whether stimulation of both Wnt and Notch signalling would 
potentiate TOPFlash activity. Stimulation by rhDll4 alone did not stimulate 
TOPFlash activity (Figure 64D). However, co-stimulation with Wnt3a and Dll4 led 
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Figure 64. Nrarp promotes Wnt signalling in endothelial cells. 
A, Coimmunoprecipitation experiment in HUVECs transfected with Nrarp-Myc. 
Endogenous LEF1 coimmunoprecipitated with Nrarp-Myc (arrow). An empty vector 
(pcDNA) was used as a control. B, Immunoblot of Lef1 protein in P5 Nrarp+/+, 
Nrarp+/- and Nrarp-/- retinas. There is a decrease in Lef1 protein level in Nrarp+/- and 
Nrarp-/- retinas. C, fold differences in expression of Hey2 and CyclinD1 in 
endothelial cells of Nrarp-/- compared to Nrarp+/+ mice. There is a significant 
increase in Hey2 expression and a significant decrease in CyclinD1 expression in 
Nrarp-/- ECs. *, p = 0.019; ***, p = 0.0004. n = 6. D, TOPFlash reporter activity in 
HUVECs after NRARP siRNA treatment. Knockdown of NRARP suppressed Wnt3a-
induced TOPFlash activity. NRARP siRNA treatment for 24 hours resulted in a 70-
80% reduction NRARP mRNA expression compared to scrambled siRNA (data not 
shown). *, p = 0.0014; ***, p = 0.0002. n = 3 for each condition. Data in A and D 
were produced by Michael Potente. 
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to a slight potentiation in Wnt signalling (Figure 64D), which was abolished by 
NRARP knockdown (p = 0.0114; Figure 64D). 
Together, the data show that Nrarp positively regulates Wnt signalling under 
Wnt stimulatory conditions.  
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4.2.16 HETEROGENEOUS ENDOTHELIAL WNT ACTIVITY IN RETINAL 
VASCULATURE. 
We next investigated where Wnt signalling is active in the vasculature in vivo, and 
whether Wnt activity co-localizes with Notch activity. To do this, we crossed the 
BATlacZ Wnt reporter mouse with the TNR Notch reporter mouse that was 
described in the previous chapter. In the BATlacZ mouse, a siamois promoter with 8 
Tcf/Lef binding sites drives the expression of LacZ-NLS (Nakaya et al., 2005). Thus, 
the BATlacz mouse has been designed to detect Wnt/β-catenin-regulated 
transcriptional activation that is mediated by Tcf/Lef proteins i.e. it is a reporter of 
canonical Wnt signalling. Indeed, this mouse shows expression in the embryonic 
node and primitive streak that is partially lost in Wnt3a-/- embryos (Nakaya et al., 
2005).  
Several problems arose in the attempt to visualize Wnt and Notch activity in 
the retina. First of all, we were unable to detect LacZ expression in the retina by X-
Gal staining (a process whereby X-Gal is hydrolyzed by beta-galactosidase to yield a 
blue precipitate) or by anti-β-Galactosidase antibody staining. However, the failure 
to detect Wnt activity in the BATlacZ does not translate to lack of Wnt signalling in 
the retina. In fact, it has been documented that several Tcf reporters fail to label sites 
of known Wnt/β-catenin signalling (reviewed in (Barolo, 2006)). We subsequently 
examined the retinas of another Tcf reporter mouse called BAT-gal, which differs 
from the BATlacZ mouse by having one less Tcf/Lef binding site in the promoter 
(Maretto et al., 2003). In this case, β-galactosidase activity was detected successfully 
in the retinal vasculature by immunofluorescence (Figure 65). Wnt signalling was 
prominent in endothelial cells situated behind the migrating front (Figure 65A) and 
in the vascular plexus (Figure 65B). The strongest reporter activity regularly 
localized to endothelial cells situated at vessel branchpoints. The second problem 
that arose in this experiment was that the TNR Notch reporter mouse had lost its 
GFP expression for unclear reasons. Hence, we were unable to colocalize Wnt and 
Notch activity using this approach. In another bid to colocalize Wnt and Notch 
signalling in the retina, we attempted Nrarp mRNA ISH in BAT-gal mice followed 
by anti-β-galactosidase antibody staining. Unfortunately, the conditions for ISH were 
not suitable for anti-β-galactosidase antibody staining. 
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Figure 65. Wnt activity in a subpopulation of endothelial cells in the retina of 
BAT-gal TCF reporter mouse. 
A and B, P4 retinas of BAT-gal mice that have been immunostained with anti-β-
galactosidase antibody (green) and Isolectin-B4 (red). Wnt activity is prominent at 
branchpoints at arterial and veinous ends (A) and also at branchpoints of capillary 
vessels (B). This experiment was performed by Daniel Nyqvist. 
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4.2.17 LEF1-DEFICIENT MICE DISPLAY INCREASED VESSEL REGRESSION IN THE 
RETINA. 
Given that Nrarp modulates the Wnt signalling pathway by stabilizing Lef1 ((Ishitani 
et al., 2005), Figure 64B) and that Wnt signalling is downregulated upon reduction in 
Nrarp expression and function (Figure 64C, D), we next investigated whether mice 
deficient in Lef1 also display ectopic vessel regression. Wholemount staining with 
Isolectin-B4 of retinas from P4 to P5 mice revealed a significant decrease of ~40% in 
blood vessel density in Lef1-/- (p < 0.0001; Figure 66B,D,E) that is accompanied by a 
reduction in radial expansion of the retina plexus when compared to wildtype 
littermates (Figure 66A,C). However, there was no difference in blood vessel density 
between wildtype and Lef1+/- mice (Figure 66E).  
 We next examined whether the decrease in vessel density was also the result 
of increased vessel regression, which was observed in Nrarp-deficient mice. Indeed, 
co-staining of retinas with anti-Collagen IV antibody revealed a significant increase 
in empty Collagen IV sleeves in Lef1-/- mice when compared to wild-type littermates 
(Figure 67 and Figure 68). We observed ectopic vessel regression in the migrating 
front (Figure 67B), in arterial regions (Figure 67C) and in capillary regions (Figure 
67D, Figure 68B) of the vascular plexus. Quantification revealed a significant 
increase of ~14% in vessel regression in the capillary regions of Lef1-/- retinas 
compared to the same vascular region in wildtype (p = 0.0002; Figure 68C) and 
Lef1+/- (p = 0.048; Figure 68C) littermates. In addition, vessels of Lef1-/- animals 
appeared narrower compared to wildtype littermates and staining for Claudin 5 
showed an increase in discontinuous endothelial junctions in Lef1-/- vessels (Figure 
68D). 
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Figure 66. Reduced vessel density in Lef1-/- mice. 
P5 Lef1+/+ (A,C) and Lef1-/- (B,D) were stained with Isolectin-B4. There is a decrease 
in vessel density (D, E) and radial expansion (B) in Lef1-/- mice. E, graph illustrates 
the number of vessel branchpoints/100µm2 area in Lef1+/+, Lef1+/- and Lef1-/- P5 
retinas. There is a significant decrease in vessel density in Lef1-/- animals. *, p = 
0.0150; ***, p < 0.0001. Lef1+/+, n = 41; Lef1+/-, n = 8; Lef1-/-, n = 8. Values represent 
mean ± S.E.M.  
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Figure 67. Blood vessel regression profiles in Lef1-/- retinas. 
P5 Lef1-/- retinas were stained with anti-Collagen IV antibody (green) and Isolectin-
B4 (blue). Ectopic vessel regression (arrows) is observed at the vascular front (B), 
arterial end (C) and capillaries (D) of the vascular plexus. 
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Figure 68. Increase in vessel regression in Lef1-/- retinas. 
A and B are images of capillary regions of Lef1+/+ and Lef1-/- retinas, respectively, 
that have been stained with anti-Collagen IV antibody (red) and Isolectin-B4 (green). 
Arrows highlight regression profiles. There is significantly more vessel regression in 
Lef1-/- retinas (B and C). C, Quantification of vessel regression in the capillary 
plexus of Lef1+/+, Lef1+/- and Lef1-/- P5 retinas. **, p = 0.048; ***, p = 0.0002. 
Lef1+/+, n = 13; Lef1+/-, n = 9; Lef1-/-, n = 9. D, Lef1-/- retinas stained with anti-
Claudin 5 antibody (red), anti-Collagen IV antibody (green) and Isolectin-B4 (blue). 
Discontinuous junctions are observed in capillary plexus of mutant retinas 
(arrowheads in D’). 
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4.2.18 MORPHOLINO KNOCKDOWN OF LEF1 IN THE ZEBRAFISH. 
We next returned to the zebrafish to investigate whether we could recapitulate the 
nrarp-a and –b morphant vascular phenotype when lef1 expression is knocked-
down. At 56hpf, the dorsal aorta, posterior cardinal vein, ISVs and DLAV were well 
formed and patent in the control morphant (Figure 69A and A’). Preliminary 
experiments show that knockdown of lef1 expression resulted in vessel defects 
ranging from mild (Figure 69B and B’) to severe (Figure 69C and C’). In the mild 
morphants, vessels with irregular diameter and poor ISV connections to the dorsal 
aorta and DLAV were observed (arrows). In addition, the dorsal aorta appeared 
poorly formed with a lack of lumen (* in Figure 69B’). In the more severe morphant, 
the dorsal aorta, posterior cardinal vein and ISVs were severely deformed. The dorsal 
aorta was disintegrated along its length and is separated from the posterior cardinal 
vessel (indicated by double-ended arrows in C and C’). The ISVs were also very 
fragmented so that endothelial cells were no longer adhered to each other within 
ISVs and between ISV and the dorsal aorta (Figure 69C). Cross-section of the severe 
lef1 morphant revealed an enlarged axial vessel (* in Figure 69C’).  
 Thus, knockdown of lef1 expression and function in the zebrafish resulted in 
a vascular phenotype that is similar to that of decreased of nrarp-a and –b function. 
Furthermore, decreasing lef1 expression led to a more severe vessel defect compared 
to decreasing nrarp-a or –b. However, because loss of lef1 results in tail truncations 
and loss of paraxial mesoderm (Dorsky et al., 2002), more thorough analysis needs to 
be more performed to examine the cell autonomous role of lef1 in endothelial cell 
function during ISV formation in the zebrafish. 
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Figure 69. Knockdown of lef1 expression in the zebrafish. 
Tg(fli1:EGFP)y1 zebrafish were injected with 2ng control (A, A’) or lef1 (B, B’, C, 
C’) morpholinos and analyzed at ~56hpf. A-C are lateral views of ISVs at the 
zebrafish trunk. A’-C’ are cross-sections of the trunk showing the 3D vascular 
network. B and C are images of different lef1 morphants showing mild and severe 
vascular defects, respectively. Arrows indicate poor vessel connections. Arrowhead 
indicates vessel disconnection. Double-ended arrows indicate vessel segregation e.g. 
between DA and PCV. * indicate poorly formed dorsal aorta and posterior cardinal 
vein. DLAV, dorsal longitudinal anastomotic vessel; ISV, intersegmental vessel; 
PAV, parachordal vessel; DA, dorsal aorta; PCV, posterior cardinal vein. 
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4.2.19 INDUCIBLE ENDOTHELIAL-SPECIFIC DELETION OF CTNNB1 LEADS TO 
EXCESSIVE VESSEL REGRESSION. 
We next examined whether β-catenin activity regulates vessel stability during 
angiogenesis in the postnatal retina. To investigate this, we genetically deleted the 
gene that encodes β-catenin, Ctnnb1, in endothelial cells in an inducible manner by 
crossing the Ctnnb1lox/lox mouse, where the Ctnnb1 gene is flanked by two lox sites 
(Brault et al., 2001) with the tamoxifen-inducible Pdgfb-iCreER line that expresses 
EGFP (Claxton et al., 2008). We first examined Cre-mediated recombination 
efficiency in endothelial cells by crossing Pdgfb-iCreER mouse with the Cre-reporter 
line Rosa26R-EYFP (Srinivas et al., 2001). Single bolus injection of 4OH-tamoxifen 
for 48 or 72 hours resulted in widespread endothelial-specific recombinase activity, 
as observed by the nuclear EFYP staining in P6 retinas (arrows Figure 70). 
Furthermore, the use of Pdgfb-driven Cre activity is prominent in endothelial cells of 
the vascular front.  
We next crossed the Pdgfb-iCreER mice with Ctnnb1lox/lox mice and 
examined β-catenin protein levels in blood vessels. There was a marked reduction in 
junctional β-catenin in Ctnnb1lox/lox; Pdgfb-iCreER+/- mice compared to Cre-negative 
littermates (Figure 71B). Staining for other junctional proteins such as ZO-1 and VE-
cadherin revealed normal junctional localization of these proteins in the absence of 
endothelial Ctnnb1 expression (Figure 71), indicating that loss of β-catenin does not 
cause endothelial cell junctional disassembly. The redundant activity of γ-catenin and 
the increased incorporation of desmoplakin in adhesion junctions are possible 
explanations for intact endothelial cell junctions in the absence of endothelial β-
catenin (Cattelino et al., 2003). 
Deletion of endothelial Ctnnb1 for 72 hours resulted in a significant reduction 
in vascular density in Pdgfb-iCreER-positive mice (Figure 72E). There was a 
significant decrease of ~40% in the number of capillary vessel branchpoints in 
Ctnnb1-deficient mice compared to littermates expressing Ctnnb1 (p = 0.0279). High 
magnification analysis indicated that sprouting occurred normally (Figure 72B). 
However, anti-Collagen IV staining revealed excessive empty basement membrane 
sleeves and vessel regression at the vascular front and venous regions of Ctnnb1-
deficient mice (dots in Figure 72B, D). Thus, loss of endothelial Ctnnb1 
recapitulated the phenotype observed in Nrarp-and Lef1-deficient mice, suggesting 
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that endothelial Wnt signalling controls vascular stability. Because we observed 
intact endothelial junctions in the absence of endothelial β-catenin, the excessive 
vessel regression observed upon reduction in canonical Wnt signalling may be a 
result of changes in Wnt-regulated transcriptional events.  
 
 
Figure 70. Endothelial specific Cre-mediated recombination using the Pdgfb-
iCreER conditional line. 
P3 Pdgfb-iCreER+/-;Rosa26R-EYFP mice were given a single dose of 4OH-
tamoxifen intraperitoneally. Retinas were analyzed 48 hours later at P5. The Pdgfb-
iCreER mouse also carries an EGFP gene, whose expression is specific to blood 
vessels in the retina, especially in endothelial cells of the migrating front (green in A 
and B). Its expression is predominantly localized to endothelial cell membrane. After 
4OH-tamoxifen injection, we observed nuclear EYFP (red) in endothelial nuclei 
(arrows in A’’ and B), indicating that recombination persisted 48 hours after 
induction by 4-OH tamoxifen injection. This experiment was conducted by Jane 
Babbage and Holger Gerhardt. 
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Figure 71. Endothelial-specific deletion of Ctnnb1 leads to a specific loss of β-
catenin from endothelial cell junctions. 
Ctnnb1lox/lox mice were bred with Ctnnb1lox/lox;Pdgfb-iCreER+/- mice. The offspring 
were all injected once with 4OH-tamoxifen at P3. Eyes were harvested 72 hours later 
at P6. A and B, retinas were triple-stained with anti-β-catenin (green), anti-ZO1 (red) 
and anti-VE-cadherin (blue) antibodies. There is a specific loss of β-catenin from 
endothelial cell junctions of retinal blood vessels of Ctnnb1lox/lox;Pdgfb-iCreER+/- 
mice (B) compared to Ctnnb1lox/lox;Pdgfb-iCreER-/- littermates (A). Tight junction 
protein ZO1 and adherens junction protein VE-cadherin remained localized to 
endothelial cell junctions (B). This experiment was conducted by Jane Babbage and 
Holger Gerhardt. 
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Figure 72. Deletion of endothelial Ctnnb1 postnatally results in decreased vessel 
density due to increased vessel regression. 
A-D, confocal images of retinas stained with anti-Collagen IV antibody (red) and 
Isolectin-B4 (blue). There is increased blood vessel regression (dots) at both the 
vascular front (B) and the venous regions (D) of retinas from Ctnnb1lox/lox;Pdgfb-
iCreER+/- mice when compared to Ctnnb1lox/lox;Pdgfb-iCreER-/- littermates. Graphs 
illustrate the number of branchpoints/100µm2 (E) and the extent of vessel regression 
(F) in the capillary plexuses of Cre negative and Cre positive littermates. *, p = 
0.0279; ***, p = 0.0005. n ≥ 8 for each group. Jane Babbage and Holger Gerhardt 
performed the experiment; I conducted the quantification of vessel regression. 
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4.2.20 ENDOTHELIAL-SPECIFIC ACTIVATION OF CTNNB1 FAILED TO RESCUE 
VESSEL   REGRESSION IN NRARP MUTANT MICE. 
Given that loss of Lef1 and endothelial Ctnnb1 resulted in ectopic vessel regression 
during angiogenesis in the retina, we hypothesized that over-expression of Ctnnb1, 
and therefore canonical Wnt signalling, specifically in endothelial cells would rescue 
the increased vessel regression observed in Nrarp-deficient mice. To address this 
hypothesis, we crossed Nrarp-deficient mice with the Ctnnb1lox(ex3) mice, whose 
exon3 is flanked by loxP sequences (Harada et al., 1999). Exon3 of the β-catenin 
protein contains many serine/threonine residues that are phosphorylated by the APC-
axin-GSK3β complex, an event that signals β-catenin for proteosomal degradation. 
Therefore, the deletion of exon 3 (Ctnnb1Δex3) confers β-catenin enhanced stability 
and activity of β-catenin within the cell. Again, we used the Pdgfb-iCreER 
conditional mouse line to induce endothelial-specific activation of β-catenin in Nrarp 
mutant mice. P3 pups born from Nrarp+/-;Ctnnb1lox(ex3)/lox(ex3) or Nrarp+/-
;Ctnnb1+/lox(ex3) mice crossed with Nrarp-/-; Ctnnb1lox(ex3)/lox(ex3); Pdgfb-iCreER+/- 
were treated with 4OH-tamoxifen once and retinal blood vessels were examined 72 
hours later at P6. 
 The gain of one or two alleles of Ctnnb1ΔEx3 failed to decrease vessel 
regression in Nrarp-deficient mice. We still observed an excessive amount of vessel 
regression profiles in the capillary plexus and arterial regions of Nrarp-/-;Ctnnb1+/ΔEx3 
retinas (dots in Figure 73B and D). Furthermore, the gain of two alleles of 
Ctnnb1ΔEx3 appeared to increase the range of vessel regression in Nrarp-deficient 
mice so that the minimum data point in Ctnnb1ΔEx3/ΔEx3 is lower than that of 
Ctnnb1+/+ mice (compare plot 3 to 1 in Figure 73). In other words, there were some 
regions in Nrarp+/-; Ctnnb1ΔEx3/ΔEx3 that have a higher degree of vessel regression 
than in Nrarp+/-;Ctnnb1+/+ mice. However, there were no significant differences in 
the extent of vessel regression among the animals of different genotypes. 
 The failure to observe a reduction of vessel regression in Nrarp-deficient 
mice in the presence of constitutive β-catenin may be due to the fact that Lef1 
protein level was still decreased. Wnt-induced transcription requires the formation of 
a complex comprising β-catenin and a member of the Tcf/Lef family. As β-catenin 
alone is unable to bind to DNA, overexpression of β-catenin is insufficient to 
increase the transcription of Wnt target genes if the level of Tcf/Lef is limiting. This 
 174 
 
Figure 73. Overexpression of Ctnnb1 in endothelial cells failed to normalize 
vessel regression in Nrarp-deficient retinas. 
Nrarp+/-;Ctnnb1lox(ex3)/lox(ex3) or Nrarp+/-;Ctnnb1+/lox(ex3) mice were crossed with 
Nrarp-/-; Ctnnb1lox(ex3)/lox(ex3); Pdgfb-iCreER+/-. The offspring were all injected once 
with 4OH-tamoxifen at P3. Eyes were harvested 72 hours later at P6. Retinas were 
subsequently stained with anti-Collagen IV antibody (red) and Isolectin-B4 (green). 
A is a representative image of Nrarp-/-;Ctnnb1+/+ retinas. B and D are images of 
Nrarp-/-;Ctnnb1+/Δex3 retinas that show the range of vessel regression after gaining 
one allele of constitutive β-catenin. In B, there appears to be an increase in vessel 
density after ectopic activation of β-catenin when compared to Nrarp-/- retinas. In D, 
there appears to be a decrease in vessel density and increase in vessel regression after 
ectopic activation of β-catenin. Dots in the images indicate vessel regression profiles. 
D, quantification of vessel regression in the capillary plexus of mice from various 
genotypes. All animals are Pdgfb-iCreER+/-. There is no significant difference in 
vessel regression between Nrarp+/- or Nrarp-/- with or without endothelial Ctnnb1 
overexpression. Nrarp+/-;Ctnnb1+/+,  n = 6; Nrarp+/-; Ctnnb1+/Δex3, n = 16; Nrarp+/-; 
Ctnnb1Δex3/Δex3, n = 8; Nrarp-/-; Ctnnb1+/+, n = 19; Nrarp-/-; Ctnnb1+/Δex3, n = 19; and  
Nrarp-/-;Ctnnb1Δex3/Δex3, n = 5. 
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may be a possible scenario in Nrarp-deficient animals, where there is a decreased 
Lef1 protein level. However, it would be necessary to determine the lack of an 
increase in canonical Wnt signalling in Nrarp-/-; Ctnnb1ΔEx3/ΔEx3 to confirm this 
speculation.  
 
4.3 DISCUSSION 
4.3.1 NRARP MODULATES THE NOTCH AND WNT PATHWAYS 
Previous studies have shown that Nrarp inhibits Notch signalling by disrupting the 
NICD/CSL transcriptional complex (Ishitani et al., 2005; Lamar et al., 2001). In our 
study, we confirmed the negative regulatory function of Nrarp in Notch signalling in 
Nrarp mutant mice. There was a significant increase in the expression of Hey1, Hey2 
and Lnfg in retinas and of Hey2 in endothelial cells of Nrarp null mice. Nrarp+/- mice 
also displayed a slight increase in Lnfg expression. Intriguingly, this increase in 
Notch signalling in Nrarp mutant mice did not produce the same phenotype obtained 
from ectopic activation of Notch signalling by systemic injection of Jag1 peptide 
(Hellstrom et al., 2007). In Jag1-treated retinas, there was significantly less filopodia 
formation at the sprouting front of the vessel, supporting the conclusion that Notch 
signalling suppresses endothelial tip cell formation (Figure 31). Similarly, ectopic 
activation of Notch signalling in the zebrafish using an inducible Gal4/UAS system 
blocks sprouting of intersegmental vessels (Leslie et al., 2007; Siekmann and 
Lawson, 2007). However, Nrarp deficiency does not affect sprouting activity or 
filopodia formation (Figure 47). Also, we could not find evidence for increased 
vessel regression following Jag1 peptide injection in the mouse retina and regression 
of existing vessels has not been observed in zebrafish in which Notch signalling is 
ectopically activated.   
Why, then, are there different phenotypic outcomes from ectopic increase in 
Notch signalling? Conceptually, the loss of an intrinsic negative regulator of NICD 
such as Nrarp should give rise to a cell-autonomous increase in Notch signalling, 
whereas a general genetic or pharmacological activation of Notch signaling will 
affect the entire endothelial cell population independent of their position in the tip or 
stalk. Study of Nrarp expression by ISH revealed strong Nrarp expression in stalk 
cells and endothelial cells at vessel branchpoints (Figure 37D and Figure 38). Thus, 
the loss of Nrarp should only lead to an increase in Notch signalling in a  
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Figure 74. Nrarp differentially modulates Notch and Wnt signalling. 
In endothelial cells, Dll4 stimulates Notch signalling and positively regulates the 
expression of Nrarp in a CSL-dependent manner. Nrarp negatively regulates Notch 
signalling by disrupting the formation of NICD and CSL transactivation complex 
and by promoting the degradation of NICD. Stimulation of endothelial cells by Wnt 
ligands such as Wnt3a induces canonical Wnt signalling. β–catenin is stabilized and 
binds to a member of the Tcf/Lef1 transcription factor family. Nrarp positively 
modulates Wnt signalling by binding to and stabilizing Lef1 protein by preventing its 
degradation. Consequently, there is increased β–catenin/Lef1 formation to activate 
expression of Wnt-target genes. 
 
 
subpopulation of cells that already received Notch signaling, leaving the sprouting 
tip cells and their filopodia formation unaffected. 
Another explanation for the phenotypic difference is that the stabilizing role 
of Nrarp on blood vessels is mediated via Wnt signalling. We have shown that i)  
Nrarp binds to LEF1 in HUVECs, ii) loss of Nrarp function leads to decreased 
expression of a Lef1 target gene, CyclinD1, in endothelial cells isolated from Nrarp-/- 
lungs, and iii) by using the TOPFlash Wnt reporter to examine Wnt activity, 
knockdown of NRARP expression by siRNA significantly decreased Wnt activity in 
HUVECs in the presence of Wnt3a (Figure 64). Furthermore, genetic deletion of 
Lef1 and endothelial Ctnnb1 resulted in a very similar vascular phenotype: increased 
vessel regression during development of the retinal vasculature. Analysis of BAT-gal 
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retinas revealed strong Wnt activity in endothelial cells at vessel branchpoints 
(Figure 65), which is also where Nrarp is strongly expressed. It is tempting to 
speculate that Nrarp integrates with canonical Wnt signalling especially at vessel 
branchpoints to stabilize nascent vessels during angiogenesis. We have shown that 
the controlled endothelial cell proliferation during angiogenesis is important in 
stabilizing nascent vessels in Nrarp null retinas and it is likely that both Notch and 
Wnt signalling regulate this process in endothelial cells. Ex vivo, activation of Notch 
signalling in endothelial cells induces cell cycle arrest through retinoblastoma protein 
de-phosphorylation and down-regulation of p21CIP expression (Noseda et al., 2004). 
In contrast, activation of Wnt signalling promotes endothelial cell proliferation 
(Masckauchan et al., 2006; Masckauchan et al., 2005) and the β-catenin/Lef1 
complex has been demonstrated to directly activate the transcription of CyclinD1 to 
induce cell cycle progression (Shtutman et al., 1999). Thus, Nrarp could drive 
endothelial stalk cell proliferation by reducing Notch-dependent cell cycle arrest and 
increasing Lef1/Wnt signaling-dependent CyclinD1 levels. 
 
4.3.2 WNT SIGNALLING STABILIZES NASCENT BLOOD VESSELS 
The analysis of the Nrarp vascular phenotype has also generated insight into the 
cellular mechanism of vessel regression during vessel morphogenesis in retinal 
vasculature.  
In adult mice, reduction in VEGF-A signalling rapidly leads to loss of vessel 
connections (Baffert et al., 2006; Inai et al., 2004). However, in Nrarp-/- retinas, 
excessive vessel regression occurs in regions of high VEGF-A expression 
concomitant with sprouting, suggesting that the loss of Nrarp disables a molecular 
pathway that normally stabilizes vessels under VEGF-A stimulation. Several groups 
have reported that Notch signalling regulates VEGF receptor expression. Kdr2 
expression is induced by VEGF-A and down-regulated in endothelial cells through 
Notch signaling (Harrington et al., 2008). Suchting et al proposed that increased 
vessel density and tip cell activity in DAPT-treated or Dll4 heterozygous retinas is 
caused by up-regulation of Kdr (Suchting et al., 2007). Conversely, vascular 
regression in Nrarp-/- retinas could be mediated by Notch-dependent repression of 
Kdr. However, we observed slightly increased levels of Vegfa and Kdr expression in 
Nrarp-/- retinas (Figure 61). Although pharmacological inhibition of VEGF-Kdr 
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signalling leads to vascular regression (Baffert et al., 2006), it is unclear whether 
reduced Kdr expression levels would have similar effects. Flt1, which functions as a 
high affinity decoy receptor for VEGF-A, is up-regulated by Notch signalling 
(Harrington et al., 2008). Consistent with the observed increase in Notch signalling, 
Nrarp-/- retinas express higher levels of Flt1 mRNA (Figure 61), suggesting that 
enhanced Flt1-mediated sequestration of VEGF-A may contribute to the vessel 
regression. 
In the introduction of the thesis, I described the importance of pericytes in 
stabilizing blood vessels. Inhibition or genetic inactivation of PDGF-B signalling or 
alteration of the Angiopoietin-1/Angiopoietin-2 balance promotes loss of pericytes 
followed by selective vessel regression (Enge et al., 2002; Hammes et al., 2002; 
Hammes et al., 2004; Rao et al., 2007; Sennino et al., 2007; Uemura et al., 2002). In 
Nrarp-/- retinas, vessel regression occurs despite apparently normal pericyte 
recruitment (Figure 58). Furthermore, we have not been able to detect significant 
expression of Nrarp in retinal pericytes. We therefore conclude that the vascular 
phenotype in Nrarp-/- retinas reflects an endothelial cell-autonomous role of Nrarp in 
vessel stabilization. 
Published work on the study of hyaloid vessel regression demonstrated that 
this process requires the induction of endothelial cell apoptosis mediated by Wnt 
signalling in a Fzd4- and Lrp5-dependent manner (Lobov et al., 2005). In these 
vessels, Wnt signalling functions to promote endothelial cell cycle entry but in the 
absence of survival factors like VEGF-A or Angiopoietin-1 or in the presence of 
inhibitors of these survival factors, endothelial cells of hyaloid vessels receiving Wnt 
signalling undergo apoptosis. However, we did not find evidence for apoptosis-
induced vessel regression in Nrarp-deficient endothelial cells in the retinal 
vasculature. Therefore, in the context of retinal blood vessels, endothelial Wnt 
signalling is required for vessel maintenance rather than regression.  
Instead, we discovered that reduced endothelial cell proliferation and 
excessive junctional rearrangement contribute to vessel regression in retinal vessels. 
Analyses of Nrarp null mice and nrarp-a and –b zebrafish morphants revealed a 
decrease in endothelial cell proliferation and consequently, endothelial cell number 
in nascent blood vessels. One can imagine that a decrease in endothelial cell number 
in growing vessels would cause junctional stress. This is exemplified in nrarp-a and 
–b morphants where the sprouting and migratory activities of endothelial cells were 
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unaffected. The combination of reduced endothelial cell number and continuous 
dorsal migration of endothelial cells would impose a strain on the endothelial 
junction between the ventral cells of the ISV and the dorsal aorta. This was 
demonstrated by ZO-1 staining where we observed poorly formed junctions between 
ISVs and the dorsal aorta (Figure 54). Similarly in the postnatal mouse retina, there 
was an increase in junctional segregation and discontinuity when Nrarp expression 
was lost (Figure 53F, H, I). These junctional rearrangements are also observed 
during vessel remodelling when excess vessels are removed in a controlled manner 
by vessel regression to produce a refined vascular network (Figure 51). The finding 
that similar junctional rearrangements also occur in Nrarp mutants suggests that 
endothelial junctions do form in the mutants but become unstable when subjected to 
strain and subsequently culminate in vessel regression.  
 Our study of Lef1 and β-catenin function in angiogenesis points toward a role 
of canonical Wnt signalling in the regulation of vessel stability. A similar role has 
also been observed for Fzd5, a receptor for Wnt5a, Wnt10b and Wnt2, in yolk sac 
and placental angiogenesis in mouse (Ishikawa et al., 2001). Deletion of Fzd5 results 
in vascular phenotypes in the yolk sac that are similar to those found in Nrarp-/- 
retinas: vessels are narrower and the network formed is less branched, and, these 
endothelial cells are frequently detached or degenerated (Ishikawa et al., 2001). In 
addition, the authors could not find evidence for increased endothelial apoptosis but 
did observe a decrease in endothelial cell proliferation, reminiscent of Nrarp-
deficient endothelial cells. Whether Fzd5 is also involved upstream of β-catenin/Lef1 
in the retinal endothelial Wnt signalling pathway that is modulated by Nrarp remains 
unclear, as embryonic lethality of these mutants precluded retinal analysis. A similar 
retinal phenotype, however, has been observed with the loss of Lrp5 in the mouse. 
Lrp5-/- retinas have significantly reduced blood vessel density from P5 to P7 
compared to wildtype littermates (Phng et al, submitted). Recent work identified a 
mouse mutation in the Lrp5 gene (Lrp5r18) that caused a truncation in the C-terminal 
interaction domain required for Wnt/β-catenin signalling (Xia et al., 2008). The 
authors reported retinal vascular defects including collapsed lumen, decrease in tight 
junction formation between endothelial cells and attenuated vascularization, leading 
to incomplete development of the retinal vasculature. A similar retinal vascular 
phenotype was also observed in the Lrp5 null mouse (Xia et al., 2008). Previous 
study has demonstrated that mutant LRP5 proteins without the last three PPP(S/T)P 
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motifs in the C-terminal intracellular domain are unable to bind to Axin, a process 
that is required to prevent degradation of β-catenin, and failed to activate LEF1 (Mao 
et al., 2001). In the Lrp5r18 mutant, the last three PPP(S/T)P motifs in the C-terminus 
are disrupted, which would probably eliminate the docking site for Axin binding to 
Lrp5 (Xia et al., 2008). Thus, Lrp5 truncated mutant proteins are probably unable to 
stabilize β-catenin, leading to decreased β-catenin/Tcf/Lef1 transcriptional complex 
formation and activation of canonical Wnt target genes that are essential for the 
development of the retinal vasculature (Cao et al., 2007). Another line of evidence 
indicating Wnt signalling in retinal vascular development is Norrin-dependent 
activation of Fzd4 (Xu et al., 2004). Loss of Fzd4 activity also results in a delay in 
retinal vascularization {Xu, 2004 #233). However, whereas Norrin, Fzd4 or Lrp5 
deficiency leads to severe and persistent attenuation of retinal vascularization, most 
of the defects caused by the loss of Nrarp resolve after the first post-natal week. 
 
4.3.3 FUTURE PERSPECTIVES 
Much remains to be explored with the phenotypes of the Nrarp mutant mice. 
Although we have not performed experiments to address lumen formation in Nrarp 
null mice, immunofluorescent staining of endothelial cells by Isolectin-B4 suggests 
that lumen formation in these mice may be defective. To examine this process, one 
would have to do vessel perfusion experiments as well as electron microscopy to 
analyze the ultrastructure of Nrarp null blood vessels. Electron microscopy would 
also allow us to study the formation of adherens and tight junctions in the mutants. 
Although Claudin 5, and therefore tight junctions, was observed in Nrarp null mice 
by immunofluorescence, such a method does not reveal the integrity of the junctions 
formed.  
Although we have only documented vascular defects in the retina, it may be 
possible that there are vascular abnormalities in other tissues and also in certain 
physiological processes where angiogenesis is re-initiated, such as during pregnancy. 
The latter theory is based on the frequent inability of Nrarp-/- females to produce 
offspring and also on published literature describing the roles of Fzd4 and Norrin in 
reproductive angiogenesis. Fzd4 null females are infertile due to failure of embryos 
to implant (Hsieh et al., 2005). Examination of the corpus luteum of these mutant 
mice revealed defective arborisation of blood vessels and degeneration of the tissue, 
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consequently resulting in infertility (Hsieh et al., 2005). In Norrin null mice, 
implantation of the foetus occurs but bleeding is observed at the implantation site 
and the chorioallantois fails to develop, depriving the embryo of placental support 
(Luhmann et al., 2005). It would therefore be interesting to see whether Nrarp null 
female mice also display defects in reproductive angiogenesis. 
There are 19 Wnt ligands known to date in the mouse genome, and of these, 
only a few e.g. Wnt3a and Wnt7b are recognized to have angiogenic effects. 
Similarly, there are a large number of Frizzled receptors (10 in mammals) and co-
receptors of the Wnt pathway whose angiogenic functions are unknown. To further 
understand the angiogenic function of Wnt signalling in vivo, such as in the retina, it 
is important to analyze the expression pattern of different Wnt ligands, Frizzled 
receptors, such as Fzd4 and Fzd5, and co-receptors including Lrp5 and Lrp6, at 
different stages of retinal vascular development. The Gerhardt laboratory already has 
preliminary data indicating that loss of Lrp5, Fzd4 and Norrin result in decreased 
vessel density in the retina. However, it is unclear how the loss of these Wnt 
components resulted in decreased vessel density. Is it through increased vessel 
regression, as in Nrarp mutants?  
Another fundamental question that has yet to be answered is the mechanism 
underlying vessel regression. A possible mechanism is through regulation and 
stabilization of endothelial junctions. As well as being a transcriptional activator, β-
catenin is also a component of adherens junctions. However, the loss of endothelial 
β-catenin did not prevent the formation of adhesion junctions since intact VE-
cadherin immunostaining in interendothelial junctions in bctnn1lox/lox;Cre+/- mice was 
observed (Figure 67B). The canonical Wnt/β-catenin pathway also regulates the 
expression of tight junction molecules Claudin 3 and Claudin 5 in endothelial cells 
(Liebner et al, 2008, in press). Conditional inactivation of β-catenin in endothelial 
cells resulted in an impairment of blood-brain-barrier in mice, highlighting the 
importance of the transcriptional regulatory role of the canonical Wnt signalling in 
maintaining tight junction integrity (Liebner et al, 2008, in press). One can therefore 
ask whether canonical Wnt signalling also stabilizes endothelial junctions of nascent 
vessels by up-regulating the expression of “stabilizing genes” to promote vessel 
homeostasis. If so, does physiological pruning of blood vessels during vessel 
network maturation involve loss of Wnt signalling? Or is it an active process that 
requires remodelling of junctional and cytoskeletal components? The mechanism(s) 
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underlying vessel regression is still elusive and much work needs to be done to solve 
the question. Whatever the mechanism is, it will likely be transient and dynamic in 
nature to prevent excessive vessel regression.  
4.4 SUMMARY 
Ishitani et al first showed Nrarp regulation of Wnt signalling in the zebrafish 
(Ishitani et al., 2005). Here, we also demonstrate that Nrarp modulates Wnt 
signalling in the mouse as well as in human endothelial cells. There is therefore a 
conserved role of Nrarp in integrating Notch and Wnt signalling pathways across 
different species. The function of Nrarp, however, is not essential since Nrarp null 
mice are healthy and viable. Instead, we believe that Nrarp modulates and integrates 
Notch and Wnt signalling to fine-tune vessel patterning at a specific phase of 
angiogenesis, as shown in the postnatal retina, to stabilize nascent blood vessels. 
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5 Conclusion 
The research I have conducted during the course of my studies has contributed to 
understanding the role of Notch signalling in regulating blood vessel formation and 
patterning during angiogenesis. Prior to the commencement of my projects, the 
Notch pathway was implicated in arterial-venous and vascular smooth muscle cell 
differentiation. However, as we have discovered very recently, this signalling 
pathway has a more diverse role in vascular development. 
 At the start of my studies, one of the many unanswered questions in vessel 
guidance is how endothelial tip cells are regulated. Gerhardt et al showed that a 
graded VEGF-A expression in the extracellular milieu is essential for polarization of 
tip cells and guidance of blood vessels (Gerhardt et al., 2003). However, it is still 
unknown how endothelial tip cells form although we know that both Notch 
signalling and a gradient of VEGF-A expression are required for robust selection and 
formation of tip cells. In Chapter 3, I presented data demonstrating that Notch 
regulation of tip cell formation is important for regulating vessel density. 
Suppression of Notch signalling in endothelial cells by genetically deleting one allele 
of Dll4 or endothelial Notch1 or by pharmacological inhibition of γ-secretase all 
resulted in an increase in vessel sprouting (Hellstrom et al., 2007). Conversely, 
ectopic activation of Notch signalling in endothelial cells by the Jag1 peptide led to a 
decrease in vessel sprouting and consequently, a decrease in vessel density. These 
experiments demonstrate that tip cell formation requires tight regulation; too many 
tip cells create a hyperdense, non-functional vessel network and too few tip cells 
create a sparse network that may not be sufficient to support tissue growth. 
There is an accumulation of data supporting a regulatory role of Notch 
signalling in VEGF receptor expression. The expression of Kdr, Flt4 and Nrp1 are 
down-regulated by Notch signalling whereas Flt1 is up-regulated (Harrington et al., 
2008; Siekmann and Lawson, 2007; Tammela et al., 2008; Figure 75). Thus, the 
changes in the level and type of VEGF receptor expression induced by Notch 
signalling may contribute to the phenotypic differences in subpopulations of 
endothelial cells. For example, a decrease in VEGF receptor activity decreases the 
expression of Dll4 and suppresses cell motility, thereby producing a non-sprouting 
endothelial cell such as the stalk cell, which is capable of switching into a tip cell 
under the right stimulatory conditions. 
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Figure 75. Proposed model showing integration of Notch and Wnt signalling in 
promoting non-sprouting endothelial cells. 
An endothelial cell such as the tip cell with high Kdr activity and high Dll4 
expression triggers Notch activation in the adjacent cell. Notch receptor activation 
triggers expression of Nrarp, Hey1, Hey2 and Lunatic fringe in a CSL-dependent 
manner. Nrarp negatively regulates Notch signalling by disrupting NICD-CSL 
complex and promoting the degradation of NICD. In an unidentified mechanism, 
Notch activation represses the expression of p21cip1, Kdr and Nrp1 and induces 
expression of Flt1, leading to a decrease VEGF receptor activity, decreased Dll4 
expression and decreased endothelial cell proliferation in this cell, characteristics of a 
stalk cell. In the presence of Wnt ligand e.g. Wnt3a, the canonical Wnt/β-catenin 
pathway is activated. Formation of the β-catenin/Tcf/Lef1 complex leads to the 
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transcriptional activation of Wnt-target genes such as CyclinD1 to induce endothelial 
cell proliferation. Wnt signalling may also have a role in maintaining junctional 
integrity. Nrarp integrates Notch and Wnt signalling by its ability to bind to and 
stabilize Lef1 protein. Stabilization of Lef1 sustains and/or promotes canonical Wnt 
signalling. Note that it is unclear where interaction between Nrarp and Lef1 occurs in 
the cell. Together, Notch and Wnt signalling promote the acquisition of a stable, non-
sprouting endothelial cell. 
 
 
In Chapter 4, I demonstrated that the downstream Notch effector, Nrarp, also 
has a role in regulating vessel density. Interestingly, the mechanism for regulating 
vessel density appeared to be different from manipulating upstream components of 
the Notch pathway where receptor activity or NICD generation was compromised. 
We discovered that Nrarp regulates vessel density by modulating vessel stability and 
regression, and not by regulating endothelial tip cell formation. Genetic deletion of 
Nrarp resulted in a transient increase in vessel regression during angiogenesis so that 
a decreased vascular density developed. We further showed that Nrarp functions 
through the Wnt signalling pathway to maintain vessel stability. There was a 
decrease in Lef1 protein level in Nrarp null retinas, a decrease in the expression of 
the Ctnnb1/Lef1 target gene CyclinD1 in Nrarp null endothelial cells and, by using 
the TOPFlash Wnt reporter assay, Nrarp knockdown by siRNA inhibited Wnt 
activation after stimulating HUVECs with rWnt3a. Thus, Nrarp integrates Notch and 
Wnt pathways to regulate vessel patterning (Figure 75).  
Importantly, these experiments tell us that the process of vessel patterning is 
tightly regulated at many time-points during the process of angiogenesis. Angiogenic 
sprouting, which is considered the initiation phase of angiogenesis, depends on the 
formation of endothelial tip cells. In recent years, a wealth of studies has shown that 
the formation of tip cells is regulated in time, space and number, and perturbation of 
tip cell formation results in anomalous vessel network that may lead to embryonic 
death, as in the case of Dll4+/- haploinsufficient mice. Furthermore, growing vessels 
require proliferation of endothelial cells. This process has to be tightly regulated as a 
proliferation rate that is too high culminates in increased vessel area for example, 
through increased vessel diameter, and one that is too low results in decreased vessel 
area. In addition, the nascent network that forms needs to be stabilized for a patent, 
functional network to develop. It is assumed that stabilization of vessels occurs after 
formation of new vessel sprouts. However, during the course of my studies, we 
discovered that stabilizing mechanisms work concomitantly with sprouting since in 
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Nrarp-deficient mutants, vessel regression is observed at the sprouting front of the 
migrating vessels. Thus, many cellular processes need to be integrated for an 
organized blood vessel network to form and Notch the pathway serves as one such 
regulator of vessel patterning. 
 The Notch pathway has pleiotropic roles during development of tissues and 
organs. How does one signalling pathway produce such morphological complexity at 
different stages of development? A key to this achievement is the ability of Notch 
signalling to integrate with other signalling pathways, thus forming a larger, more 
complex signalling system known as the hyper-network (Hurlbut et al., 2007). It is 
through such an interconnected system that an extraordinarily diverse output is 
generated by one signalling pathway. As illustrated in this thesis, Notch signalling is 
able to integrate with two distinct signalling pathways, the VEGF receptor tyrosine 
kinase family and the Wnt pathway, to regulate blood vessel patterning during 
angiogenesis through different mechanisms. The cross-talk between Notch and 
VEGF receptor signalling regulates endothelial tip cell formation while that between 
Notch and Wnt modulates vessel stability. It remains to be seen whether the Notch 
pathway can integrate with additional pathways in the temporal and spatial 
regulation of angiogenesis.  
In the past few years, we have begun to understand that different endothelial 
cells have specialized properties and functions. Through studying the regulatory role 
of Notch signalling in developmental angiogenesis, we have learnt that deregulation 
of specific endothelial cells results in different vascular abnormalities. For example, 
increased formation of tip cells results in an overgrown, chaotic vascular network. 
Although such a network is unfavourable during development, the induction of 
excessive tip cell formation and an increased vascular network by blocking Dll4-
Notch signalling is therapeutically beneficial in tumour biology. In tumours, the 
blood vessels induced by blocking Notch activity are non-functional, resulting in 
growth inhibition in a variety of established human and rodent tumour models 
(Noguera-Troise et al., 2006; Ridgway et al., 2006; Scehnet et al., 2007). 
Importantly, blockade of Dll4 can have potent antitumour effects on tumours that are 
resistant to VEGF inhibition (Noguera-Troise et al., 2006; Ridgway et al., 2006), 
raising the possibility of using combination antiangiogenic therapies against VEGF 
and Notch pathways.  
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Alternatively, a dysfunctional tumour vascular network can also be achieved by 
inducing vessel regression. As we have discovered, an established vessel network 
can become destabilized especially when endothelial cells located at vessel 
branchpoints lose junctional integrity. In light of our recent finding that loss of Wnt 
signalling results in ectopic vessel regression during developmental angiogenesis, it 
is possible that inhibition of endothelial Wnt signalling will also have antiangiogenic 
effects in diseases such as cancer. It is tempting to speculate that a combined 
inhibition of Notch and Wnt signalling could produce a more potent antiangiogenic 
effect in tumours. These are interesting avenues to explore towards finding new 
targets for antiangiogenic therapy. 
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